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Immune system 
The immune system protects and defends the body against bacteria, viruses and other 
pathogens to prevent disease. This defence can be divided in reactions of the innate 
immune system and reactions of the adaptive immune system. The adaptive immune 
system can be divided by two types: humoral immune responses mediated by antibodies 
and produced by B lymphocytes and cell mediated immune responses, mediated by T 
lymphocytes. A proper interaction between cells of the innate immune system (e.g. 
monocytes/macrophages, dendritic cells, neutrophils, eosinophil’s, natural killer (NK) 
cells and basophils) and cells of the adaptive immune system (lymphocytes: T cells, B 
cells and NK cells) by communication via direct cell contact or soluble molecules such as 
cytokines, is essential for an intact, fully effective immune response [1]. 
There are some major differences between innate immune cells and adaptive immune 
cells. First of all, the innate immune cells are constitutively present, carry germline-
encoded receptors, and are ready for immediate defence, whereas the adaptive immune 
cells need some time to react to invaders. Furthermore, adaptive immune cells react 
antigen-specifically because of their presence of rearranged receptors and have memory 
and can therefore react more rapid and vigorous on a subsequent exposure, while in 
contrast innate immune cells can react in a generic way to different organisms and have no 
memory [2].  
This thesis is focused on Insect Bite Hypersensitivity, an IgE-mediated skin allergy in 
horses, which involves several immune mechanisms and thus associated immune cells. 
The immune cells that are relevant for this thesis are described in more detail in this 
paragraph of the introduction. 
 
Antigen presenting cells 
Antigen presenting cells (APC’s) are the initiators of the adaptive immune system and 
provide a direct link between innate and adaptive immunity. Dendritic cells (DC’s), 
macrophages and B cells are all employed as (professional) APC’s, but the DC’s are by 
far the most effective in stimulating naïve T cells. 
DC’s can efficiently activate T lymphocytes by processing and presenting peptide 
fragments of a protein antigen to the T cells. Furthermore, DC’s express cell surface co-
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stimulatory molecules (such as CD80 and CD86), which interact with CD28 on T cells 
and are critical to for the activation [3].  
For the recognition of peptides by T cells, they need to be bound to molecules of the 
major histocompatibility complex (MHC) on the surface of the DC. There are two 
different types of MHC molecules, MHC class I and MHC class II, which stimulate 
cytotoxic CD8+ T cells and helper CD4+ T cells respectively. Endogenous antigens (e.g. 
viral proteins), cut into fragments in the cytosol of the APC bind to MHC class I 
molecules and are recognized by the cytotoxic T cells, which can then directly kill these 
virus-infected target cells. Exogenous antigens (e.g. proteins from foreign micro-
organism) are taken up by the APC’s, are processed and presented by MHC class II 
molecules to naïve T helper (Th) cells [1, 4]. After activation, the naïve, activated T cell 
can differentiate into different T cell subsets, depending on differentiating cytokines that 
are present in the micro-environment. Interleukin-12 (IL12) produced by DC’s, often in 
association with IFNγ produced by NK cells, usually induces T cell differentiation into 
Th1 cells. In contrast, Th2 differentiation is usually activated when early IL4, instead of 
IL12 and/ or IFNγ, production occurs. The source of early IL4 production until now 
remains unclear but is most likely induced by the presence of thymic stromal 
lymphopoietin (TSLP), IL25 and IL33 produced by epithelial and endothelial cells [3, 5].  
A less well defined approach for particularly DC’s is to capture exogenous proteins and 
process these into the MHC class I pathway. This form of presentation is called cross-
presentation and seems to be important for the generation of cytotoxic T cell generation to 
a variety of cellular antigens, including viral, tumour and DNA-encoded antigens [6].  
Since DC’s control many T cell responses they have been useful tools to beneficially 
manipulate the T cell responses to recognize specific antigens (mostly viral or tumour 
antigens) in vitro or in vivo [7-9].  
Direct isolation of DC’s from peripheral blood mononuclear cells results in extremely low 
yields (0.1%). However large amounts of DC’s can be generated from peripheral blood 
mononuclear cells (PBMC), bone marrow cells or monocytes cultured in vitro in the 
presence of GM-CSF and IL4 [10-12].  
Equine DC’s from horse peripheral blood monocytes (monocyte-derived DC) were also 
successfully generated using equine IL4 and human or equine GM-CSF and can be used 
for clinical research [13-15].  
General Introduction 
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T cells 
In mammals, approximately 40-80 % of lymphocytes in the blood account for T cells. The 
peptide-binding T cell antigen receptor (TCR) complex is an important structure on the 
surface of the T-lymphocyte that contains many different proteins. These proteins can 
function in antigen binding for signal transduction and usually have a cluster of 
differentiation designation (CD). CD3 for example is a signal transducer that acts when an 
antigen binds the TCR and is therefore found on all T cells. CD4 is expressed on the 
surface of T helper cells that, as previously described, recognize processed exogenous 
antigen-derived peptides in combination with major histocompatibility (MHC) class II 
molecules on the surface of APC’s. CD8 is predominantly found on the surface of 
cytotoxic T cells that recognize processed endogenous antigen-derived peptides in 
combination with MHC class I molecules [1]. In humans, 60 – 70 % of T cells are 
CD4+CD8- and 30-40 % are CD4-CD8+. The remaining 5 – 10% of T cells are said to be 
double negative [16]. Within the CD4+ cell population, regulatory T cells expressing the 
transcription factor FOXP3 and the surface protein CD25 (IL2 receptor α-chain) are 
naturally present. CD4+CD25+FOXP3+ Treg cells have a regulatory function by 
suppressing the activation, proliferation and cytokine production of many immune cells, 
including CD4+ cells CD8+ and APCs. Their dysfunction can result in autoimmune 
disease, immunopathology and allergy. In addition, IL10 secreting Tr1 cells, and 
transforming growth factor beta (TGF) secreting T helper 3 cells (Th3) are adaptively 
regulatory: they acquire regulatory functions after specific antigenic stimulation [17].  
Both CD4+ and CD8+ T cells can be differentiated in subpopulations that can be 
distinguished by their cytokine secretion profile. This is best established for CD4+ T cells. 
Upon activation by a processed antigen that is presented by APC’s, the naïve CD4+ Th 
cells begin to produce IL-2 and depending on the cytokines present in the environment, 
they continue to differentiate to designated Th1, Th2 or Th17 cells. Th1 cells express 
transcription factor t-bet, produce IL2, IFNγ and lymphotoxin and support cell mediated 
immune responses. Th2 cells express the transcription factor GATA-3, produce IL4, IL5, 
IL9, IL13 and GM-CSF and support humoral and allergic responses. Th17 cells produce 
IL17, characterized by the transcription factor RORgT and seem to play a key role in 
many autoimmune diseases. Although Th1 and Th2 cells often work together in an 
immune response, the response can become dominantly Th1 or Th2-like [16, 18].    
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Just as in humans, equine T cells can be divided into equine CD4 and CD8 subpopulations 
by the use of antibodies against the homologous equivalents of CD4 and CD8 described in 
man [19]. Within the CD4+ T cells, Th1 and Th2 cells identified by their signature 
cytokines. have been shown to play a central role within several clinical situations of 
horses and they can be associated with either protective or pathological responses [20, 
21]. T cell responses in horses therefore seem to be similar as those in humans and mice, 
with respect to surface markers and cytokine production.  
 
B cells 
Humoral immunity is part of the adaptive immune system and involves the production of 
specific antibody molecules (immunoglobulin’s (Ig)) in response to an antigen which is 
mediated by B cells. Naïve B cells produce IgM, but can undergo antibody heavy-chain 
isotype class switching to IgG, IgE or IgA after activation. Activation of B cells and 
isotype switching is regulated by Th cells expressing CD40 ligand and by cytokines 
produced by the Th cells [22]. IL4 and IL13, produced by Th2 cells, besides interaction 
with up regulated expression of CD40L on these activated T cells mediate isotype 
switching towards IgE [23]. IgE plays a major role in allergic diseases and is described in 
more detail later in this introduction. Th2 cells can also induce IgG4 in humans. IgG4 
production is initiated by the presence of IL10, which inhibits IgE production [23-25].  
Horses have the same immunoglobulin’s as humans, but have 7 subclasses of IgG, instead 
of 4 in humans [26]. Horse IgE, just as IgE in humans, is critically involved in horse 
allergic diseases [27, 28].  
 
Mast cells and basophils 
Basophils and mast cells are important effector cells in response to both parasite infection 
and allergic inflammation [29]. Basophils account for less than 1 % of human leucocytes, 
mature in the bone marrow and are released as mature cells in the peripheral blood. They 
have a life-span of only a few days. Mast cells mature in peripheral tissues, after they are 
generated by precursor cells in the bone marrow that circulate and migrate into peripheral 
tissues. The mature mast cells do not circulate in the peripheral blood, but reside in the 
tissue. Mast cells have a life span for weeks to months [30].  
Mast cells and basophils resemble many features. They both have numerous granules that 
 1 
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contain histamine amongst other mediators. They express fully functional high-affinity 
IgE receptors (FcRI), which can bind IgE antibodies. Antigen and IgE-induced 
crosslinking of FcRI, involving at least 100 to 1000 of these interactions, triggers 
activation of both cells, leading to degranulation of the mediators. The mediators that are 
released, including histamine, are associated with immediate hypersensitivity reactions 
[31].   
An important feature that is specific for basophils and which is absent in the mast cells, is 
their rapid production of IL4 and IL13 after activation, supporting their contribution to 
allergic inflammation [32]. Recent studies have shown that basophils can also function as 
antigen-presenting cells with their MHC class II. Therefore basophils can mediate Th2 
cell differentiation by their capacity to function as APC’s and by their potential to produce 
IL4 [30, 33, 34].  
Due to practical reasons, in vitro diagnostic tests that are available to test the allergenicity 
of candidate allergens in patients with allergies (e.g. the histamine degranulation test) are 
limited to the activation of basophils, since they are circulating in the blood and therefore 
more easily to access than tissue-resident mast cells.  
 
Allergy 
Although the immune system is primarily associated with the protection against disease, it 
is possible that an overactive immune response itself can cause damage. An undesirable 
reaction by the normal immune system causing tissue injury and disease is called 
hypersensitivity.  
Allergic diseases can be classified into two major types of hypersensitivity reactions, 
Type I and Type IV. The Type I hypersensitivity is caused by the release of mediators 
from mast cells and mediated by the presence of allergen-specific IgE antibodies. The 
delayed (Type IV) hypersensitivity is mediated by T cells [35]. The antigen that provokes 
an allergic reaction is called an allergen.  
Similar to humans, horses can suffer from a number of types of allergies with respiratory 
and skin allergy being the most common clinical features. Insect Bite Hypersensitivity is 
the most common skin allergy in horses and mainly involves a Type I (IgE mediated) 
hypersensitivity reaction and will be described in the next paragraph of this chapter.  
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Sensitisation phase and allergic reaction 
The sensitisation phase comprises the induction of Th2 cells and the formation of specific 
IgE antibodies against specific allergens in individuals that are genetically predisposed to 
the development of allergy. This is the initial phase in the development of IgE-mediated 
(Type I) hypersensitivity.  
When an allergen is deposited on mucosal tissues (respiratory and gastrointestinal tracts) 
or skin, it can enter the body where it is taken up by APC’s (primarily DC) that process 
the allergen into smaller peptides. These peptides will be bound to major 
histocompatibility complex MHC class II on the surface of the APC’s and presented to the 
TCR on naïve CD4+ T cells. This leads to the activation of the selected T cell and results 
in specific cytokine production profile. In case of an allergic sensitisation the naïve T cell 
develops into a Th2 cell, leading to a Th2 skewed immune response, which disturbs the 
Th1/Th2 balance. Th2 cells produce cytokines like IL4, IL5 and IL13, and are involved in 
IgE-synthesis by inducing isotype class-switching in B cells. Allergen-specific IgE 
molecules are then secreted by the responding B cells and will subsequently bind to the 
high-affinity IgE receptors (FcR1) on mast cells or basophils. The IgE antibody 
molecules can bind specific amino acids sequences (either continuous of discontinuous 
sequences) leading to the respective linear or conformational epitopes present on the 
allergen. The coating of a mast cells or basophil with these allergen-specific IgE 
antibodies finalizes the sensitisation phase (Figure 1).  
When a subsequent exposure to the same allergen occurs, it will cause the binding of the 
protein to the mast-cell bound IgE. Crosslinking of the IgE bound FcεRI will result in 
intracellular reactions in the mast cell, leading to degranulation and subsequent release of 
the vesicle content such as vasoactive amines (histamine and serotonin), cytokines, like 
TNF-α and other mediators, such as leukotrienes and prostaglandins. This degranulation 
causes vascular permeability, leading to e.g. swelling and itchiness. These complaints 
generally occur within minutes and are the first symptoms of an IgE-mediated allergic 
response.  In addition, the released cytokines IL4, IL9 and IL13 will further enhance IgE 
production and thereby the allergic inflammation in general. Furthermore, released 
mediators from the mast cells will promote the influx of eosinophils, neutrophils, 
basophils and macrophages, which after 4-24 hours comprise the late-phase cell-mediated  
response [35].  
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Allergic reactions can be expressed in different parts of the body, e.g. itchy swellings on 
the skin, acute bronchospasm in aeroallergen-challenged asthmatic patients, food-induced 
diarrhoea and anaphylaxis in the gut, and systemic anaphylactic reactions to insect 
venoms and drugs [36].  
 
Immunoglobulin E  
Immunoglobulin E (IgE) is an immunoglobulin with a four-chain structure (2 identical 
heavy and 2 identical light chains) with a molecular weight (MW) of around 200 kDa and 
which is characterized by the presence of 13% of their molecular weight as carbohydrates. 
In contrast to IgG, IgA and IgD, they have an additional fourth constant domain, which 
results in a higher MW as a monomer.  
Two signals are required for the induction of IgE synthesis. The first signal is provided by 
IL4 and IL13 produced by T cells, mast cells, and basophils, which activates signal 
transducer and activator of transcription 6 (STAT 6), which activates transcription at the 
IgE isotype specific switch region. The second signal involves engagement of the 
constitutively present B cell antigen CD40 with the induced CD40 ligand (CD154), 
expressed on activated T cells, which leads to isotype class switching during 
immunoglobulin synthesis in B cells [32, 37].  
In human serum, IgE is the least abundant antibody class with a concentration of only 
Figure 1: Schematic representation of the sensitisation phase and allergic reaction 
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around 50 ng/ml, in contrast to IgG with serum concentrations of around 5-10 mg/ml. It 
has a short half-life of around 2 days when circulating in the serum, but when bound to 
FcεRI on mast cells, the half-life increases to up to months [36].  
In horses the total IgE concentration is much higher, reaching the µg/ml range, and 
variations between individuals are high. These higher IgE levels in horses are most likely 
caused by generally higher parasitic loads in horses than in humans from western 
civilizations [38]. The total IgE level of horses with skin allergy is not significantly higher 
than in healthy horses kept at the same environment, except for Icelandic horses [39, 40]. 
New-born foals receive high concentrations of maternal IgE through the colostrum, which 
is suggested to have an immunoregulatory effect on the immune response of the new born. 
This maternal IgE becomes undetectable at 2-4 months of age [41]. The delayed 
endogenous IgE production can start as early as 6 months of age [42].  
Studies on IgE-mediated hypersensitivity reactions are dependent on the availability of 
antibodies to detect IgE. The αIgE-134 and αIgE-176 were the first mouse monoclonal 
antibodies produced against horse IgE [40]. They recognize different epitopes and have 
shown to be useful for various in vitro and in vivo immunological applications in horse 
studies. Some years later other anti-IgE monoclonal antibodies were produced [39]. 
 
Allergens 
According to the World Health Organization/International Union of Immunological 
Societies definition, a protein is considered to be an allergen when it elicits a specific IgE 
antibody response in at least five individuals [43]. Major allergens are defined as allergens 
to which at least 50 % of the individuals with a particular allergy are sensitised. According 
to the nomenclature system allergens are named by the first three letters of the genus, the 
first letter of the species name and a number according to, for example, the order of 
allergen discovery (http://www.allergen.org). The protein Ara h 1 is for example, a major 
allergen for people with a peanut (Arachis Hypogaea) allergy. 
The capacity of a protein to bind IgE antibodies does not necessarily mean that this 
protein is allergenic. Allergenicity of an allergen reflects the capacity to induce allergic 
symptoms and thus refers to the presence of at least two IgE-binding epitopes that can 
crosslink IgE antibodies bound to FcRI present on mast cells and basophils leading to 
degranulation and subsequent mediator release.  
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Antigenic epitopes can be classified as either B or T cell reactive epitopes. T cell epitopes 
are linear amino acid sequences that are distributed throughout the primary structure of 
the allergen. They are recognized by T cell receptors after the whole allergen is processed 
by APC’s and presented as small linear peptides (8 to 18 amino acids) in complex with 
MHCI or –II molecules. B cell epitopes recognized by IgE antibodies can be either linear 
or conformational, meaning that the amino acids are not in a linear sequence but brought 
together by folding of the amino acid chain, thus dependent on the 3-dimensional structure 
of the protein. Changes in folding of the protein may therefore lead to loss of B-cell 
epitopes [44, 45].  
Since the existence of recombinant technology, many allergens responsible for human 
allergies have been purified and cloned, revealing a great diversity of proteins based on 
their sequence similarity, crystal structure or biochemical analysis of their properties. The 
major allergens that have been identified are almost all proteins present in the 
environment or diet [46]. Many proteins undergo posttranslational modification, like N- 
and O-glycosylation. IgE-binding has shown to be dependent on glycosylation sites in 
several allergens, mainly pollen and insect allergens [47, 48] and can thus be important for 
the allergenicity of a protein. 
Glycosylation of recombinant allergens is dependent on the expression system that is 
used. The first recombinant allergens were produced in Escherichia coli (E. coli), which 
does not facilitate glycosylation. Although this expression system is still frequently used, 
eukaryotic expression systems can be beneficial when glycosylation and correct folding 
are desired.  
 
Protein expression in Escherichia coli  
The production of recombinant proteins in E. coli remains one of the most attractive 
systems because they offer rapid biomass accumulation, they are easy to handle and 
relatively inexpensive. If recombinant proteins do not require complex post-translational 
modification or do not need to be expressed in a soluble form, E. coli is usually first 
selected for large-scale protein production [49]. 
There are many different types of promoters used for gene expression in E. coli. 
Generally, these promoters are strong, capable of protein production in excess of 10-30% 
of the total cell protein, they should exhibit a minimal level of basal transcription and they 
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should be capable of induction in a simple and cost-effective manner. Chemical and 
thermal induction are widely used for protein production in E. coli [50].  
pET vectors (commercialized by Novagen) are often used for E. coli recombinant protein 
production. Target genes are positioned downstream of the bacteriophage T7 late 
promoter on medium copy number plasmids. This promoter is not recognized by E.coli 
RNA polymerase, but only by T7 RNA polymerase. Production hosts typically contain a 
prophage (ʎDE3) encoding this enzyme under control of the LacUV5 promoter. The 
LacUV5 promoter can be induced with isopropyl-B-D-1-thiogalactopyranoside (IPTG) 
[51].  
A limitation of high expression levels of eukaryotic genes in E. coli is that the target 
protein is often unable to reach a native conformation and undergoes proteolytic 
degradation or forms insoluble aggregates of non-native proteins known as inclusion 
bodies. Inclusion bodies must then be solubilized and refolded into an active 
conformation, which requires considerable optimization. Refolding of proteins using 
established strategies usually results in acceptable yields [49, 52].  
 
Protein expression in baculovirus insect cell expression systems 
The baculovirus-mediated expression in insect cells is widely used for the production of 
numerous recombinant proteins. The advantages of this system are the presence of post-
translational modification machinery, biosafety, because they are non-infectious to human 
and a high recombinant protein yield that can be obtained by the use of the strong 
polyhedrin or p10 promoter [53]. However, insect cells produce structural different N-
glycan’s than mammalian cells and therefore the bioactivity of recombinant mammalian 
proteins produced in baculovirus expression system might be reduced or they even can be 
recognized and induce allergic reactions in mammals [54].  
The Autographa californica nuclear polyhedrosis virus (AcNPV) is the prototype 
baculovirus that is used. The system is based on the replacement of the polyhedron gene 
with foreign DNA and then using these constructed viruses to infect insect cells. The 
polyhedron promoter is extremely strong and activated during the late stages of infection. 
Insect cell lines that are generally chosen as host for AcNPV are Sf9 and Sf21 from the 
fall armyworm, Spodoptera frugiperda, and High-5 (TN5B1-4) from the cabbage looper, 
Trichoplusia ni [53]. 
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In the older traditional method recombinant baculovirus expression vectors are isolated 
using homologous recombination. Transfer plasmid DNA containing the gene to be 
cloned, along with circular wild-type genomic viral DNA is introduced in insect cells. 
This results in only about 0.1% recombinant progeny, in which the heterologous gene is 
inserted in the genome of the parent virus by homologous recombination. This 
recombinant progeny can be improved when the parent virus is linearized and with the 
creation of a large deletion that functionally inactivates an essential gene, thus precluding 
replication of parental virus, increasing the recombinant baculovirus production up to 
90%. A time intensive plaque assay however is always required with these methods to 
purify recombinant virus from the nonrecombinant parental virus [55].  
The Bac-to-Bac® expression system is an efficient method to generate recombinant virus 
via the site-specific transposition of a plasmid containing the gene of interest into a 
bacterial artificial chromosome (bacmid). The bacmid contains the necessary viral 
components for infection and replication within the insect cell. After amplification in E. 
coli, purified recombinant viral DNA is transfected into the insect cells. Plaque 
purification is not necessary using this method and therefore greatly reduces time taken to 
identify and purify recombinant virus [56]. 
 
Allergens for diagnosis and immunotherapy 
Allergies can be diagnosed in vivo by different skin tests and in vitro by basophil 
degranulation tests or different serological tests. Diagnostic tests based on natural allergen 
extracts are composed of relatively ill-defined mixtures of non-allergenic materials, major 
allergens, and cross-reactive allergens, with the result that it is difficult and often 
impossible to precisely identify the disease-eliciting allergen. Furthermore, natural 
allergen extracts might contain proteases or other unwanted components, like allergens 
from other sources which can affect testing for allergenicity [57-59]. Diagnostics with 
such extracts can therefore result in false negative tests due to insufficient amounts or low 
quality of disease-eliciting allergens. Advances in allergen characterization (molecular 
techniques to identify allergens and recombinant DNA technology for the production of 
 recombinant allergen molecules) have provided new tools, such as recombinant allergens, 
that can improve the diagnosis of allergy.  
Immunotherapy is the only causative treatment option for allergies, because it targets the 
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mechanisms underlying the allergy, e.g. increasing the frequency of regulatory T cells 
suppressing the allergen-specific Th2-cells and the generation of allergen-specific 
blocking antibodies. It is based on the administration of increasing doses of allergy-
inducing antigens until a state on non-responsiveness to these allergens is reached [60]. 
However, immunotherapy with natural allergenic extract may result in new IgE 
sensitisation to other antigens present in the extract [61]. For these reasons, defined 
(recombinant) allergens may present a better alternative as an individual patient's IgE 
reactivity profile can be precisely determined with single recombinant allergens or a 
cocktail of few defined recombinant allergens, thus allowing component resolved 
diagnostics (CRD). Subsequently, those allergens to which the patient carries specific IgE 
can be selected for treatment by specific immunotherapy [62].  
However, the question arises if the replacement of natural allergenic extracts by 
recombinant allergens results in similar sensitivity in diagnostic tests. Allergenic extracts 
contain many different allergens and each of those often exist as multiple isoforms that 
can differ in their amino acid sequence and post-translational modifications and thus in 
their allergenicity [63, 64]. Recombinant allergens consist of only one isoform and when 
produced in a prokaryotic expression system have reported to fail to behave comparably 
as its native form [65, 66]. However, CRD with recombinant allergens has lately been a 
major topic for many type I allergy studies and some have demonstrated that recombinant 
allergens can reproduce comparable or result in even better IgE reactivity as the natural 
allergen extracts [67-69].  
Moreover, vaccination with recombinant allergens for specific immunotherapy has been 
reported to be successful in inducing tolerance for different type 1 allergies [70, 71].  
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Insect Bite Hypersensitivity 
Insect bite hypersensitivity (IBH) is the most common seasonal recurrent skin allergy in 
horses caused by the bites of midges of the genus Culicoides [72-74], although other 
insect species, such as Simulium and Stomoxys species, have also been described to be of 
importance [73, 75]. IBH is found worldwide and reported under a variety of other names, 
such as summer eczema [76], sweet itch [77] and Kasen [78]. IBH is clinically 
characterized by intense itch and irritation caused by hypersensitivity reactions to bites of 
the insects. Due to scratching and rubbing, hair loss and excoriations can develop (Figure 
2), which contribute to the development of secondary infections on the skin. In severe 
chronic cases the skin might become thick and rigid due to fibrosis [79]. Skin lesions are 
found predominantly at preferred landing sites of the insects, which are the dorsal midline, 
main and tail region [80] and along the ventral midline and sometimes at the ears [81]. 
Welfare of affected horses is seriously reduced and they can become unsuitable for riding 
or showing purposes, because of the discomfort and disfigurement. Clinical signs are 
present in the warmer months of the year when Culicoides insects are active and regress 
during the colder months when there is no exposure.  
Treatment of IBH is mostly based on insect avoidance by stabling, use of anti-insect 
blankets or insect repellents and suppression of symptoms by the use of corticosteroids. 
Some treatment options, like anti-histamines, dietary supplements and ointments are 
available on the market, but studies on horses using these treatments have shown varying 
results [82-84]. Immunotherapy could be an interesting curative therapy for horses 
suffering from IBH, but so far only few trials have been carried out with Culicoides whole 
body extracts and they showed varying results [85, 86]. Anderson et al. [85], however did 
observe a clear reduction of clinical signs in most and even a complete disappearance in 
some horses after immunotherapy with C. variipenis extract, but more than 10.000 insects 
were required per horse. 
 
Prevalence 
IBH is found all over the world with a prevalence ranging from 3 - 11.6% in areas in the 
UK [87], 37.7% in parts of Germany [88], 10 - 60 % in areas of Queensland, Australia 
[89] and 0 -71.4 % in regions of The Netherlands [90]. IBH is not found in Iceland, where 
Culicoides insects are absent. However, IBH has an especially high prevalence of > 50 % 
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in Icelandic horses exported from Iceland to countries were Culicoides insects are present, 
probably because these horses are not exposed to the antigens of Culicoides insects early 
in life [91, 92]. Furthermore, the risk of IBH for these horses increases with age at import, 
which suggests that the immune system gradually loses its ability to adapt to new 
allergens [93]. Icelandic horses born in a Culicoides infested country do not seem to be 
more susceptible to develop IBH compared to other breeds. Furthermore, when Icelandic 
horses imported from Iceland to Europe, get exposed to allergens around 7-10 months of 
age they do not develop IBH more frequently than Icelandic horses born in Europe, 
suggesting that the development of immune tolerance occurs before 10 months of age 
[93]. Endogenous IgE production in horses starts at an age of 6 months and increases 
during the next three years [42]. Additionally, the risk of getting IBH for locally born 
horses is highest in their third year, but earliest symptoms are reported at an age of about 
14 months [93].  
Although IBH has been described for many horse breeds, e.g. Quarter horses, Arabian 
horses, Thoroughbreds, Warmbloods, Draft horses, Friesian horses, Shire horses and 
different pony breeds [27, 72, 73, 88, 90, 94, 95], certain breeds seem to be more often 
affected, like Shetland ponies and Friesian horses. Based on clinical symptoms, IBH has 
been shown to be genetically heritable in these breeds [96, 97].  
 
Culicoides biology 
Culicoides is the most important insect genus shown to cause IBH in horses. They are also 
vector for many arboviruses, such as African horse sickness virus (AHSV) and bluetongue 
Figure 2: IBH affected main (left) and tail (right) of a Shetland pony 
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virus (BTV) [98]. 
Culicoides are small biting insects, measuring 1-3 mm in size, belonging to the family 
Ceratopogonidae and also known as midges, gnats, no-see-ums and punkies. They 
compromise over 1400 species worldwide of which most are blood suckers, feeding on 
mammals and birds [98]. Species can be differentiated from each other by their size and 
wing pattern [99], although some species are very alike.  
Culicoides are found on virtually all large land masses, with the exception of Antarctica, 
New Zealand and Iceland [98]. In the Netherlands about 25 Culicoides species can be 
found, from which the most abundant species seem to be C. obsoletus, C. impunctatus, C. 
pulicaris and C. dewulfi [100]. 
Female Culicoides insects need a blood meal to support egg production, whereas males 
feed on sugars and nectar. Most of these insects are crepuscular (i.e. active during dawn 
and dusk) that prefer to feed on warm, dry, windless days. Culicoides are therefore mainly 
active around sundown and sunrise in spring and summer months, which explains the 
alternative name of IBH ‘summer eczema’.  
Culicoides have a short flight range reaching up to a few hundred meters from their 
breeding sites [101, 102]. However they can passively reach greater distances when 
carried by the wind [103-105]. Examples of breeding sites are around puddles, tree forks, 
drainage canals, streams and swamp, all with organic material [106]. The development 
from egg to adult can take from a few days up to several months when they overwinter in 
the larval stage, depending on species and temperature. In general, most adult Culicoides 
survive only between 10-20 days [98].  
Many different Culicoides species were found to be associated with IBH, including C. 
obsoletus, C. pulicaris, C. dewulfi, C. sonorensis, C. freeborni C. robertsi C. nubeculosus, 
C. insignis, C. peregrinus, C imicola [78, 80, 89, 107-111]. C. obsoletus is regularly 
reported to be the most abundant Culicoides species attracted to horses in different 
countries [78, 107, 108, 110] and thus likely to be an important species responsible for 
IBH worldwide. C. obsoletus is part of the Obsoletus complex, which in central and 
northern Europe is composed of three species:  C. obsoletus, C. scoticus and C. chiopterus 
[112]. Females of these species are difficult to distinguish based on morphology. C. 
dewulfi was also considered part of this complex for a long time due to its 
morphologically similarity, but was recently reported to belong to a different taxonomic 
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group [113]. In this thesis C. obsoletus refers to Obsoletus complex, because identification 
was based on morphologically characteristics. Therefore, C. dewulfi in this thesis is also 
considered part of Obsoletus complex. Culicoides species that are relevant for this thesis 
are presented in figure 3.  
 
Immunopathology 
The immunopathogenesis of IBH involves IgE (type I) mediated hypersensitivity, which 
has been demonstrated by various studies. 
The first direct evidence for the role of IgE in the pathogenesis of IBH was provided by a 
modified Prausnitz-Kustner experiment. IgE was purified from equine serum from IBH-
affected horses and transferred into the skin of 4 healthy horses by intradermal injection, 
followed by a challenge with a commercial available Culicoides extract at the same sites. 
This resulted in an immediate skin reaction at the injection sites in 2 out of 4 horses. 
These skin reactions were not observed in response to extract alone [28]. Furthermore, 
significantly more IgE protein and IgE mRNA bearing cells were found in lesional skin of 
IBH affected horses than in skin of healthy horses [114].  
Intradermal skin tests have been used many times over the past years to test Culicoides 
Figure 3: Three Culicoides species 
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allergens and extracts for its ability to induce mast cell reactivity in healthy and IBH-
affected horses. IBH-affected horses in general show significantly more immediate skin 
reactions compared to healthy controls and in some horses also late phase reactions are 
observed [115-117]. Moreover, in vitro basophil degranulation in response to Culicoides 
extracts is observed in blood of IBH-affected horses, whereas most control horses do not 
show reactivity [75, 116, 118]. Finally, horses with IBH have more serum IgE antibodies 
against Culicoides salivary proteins, compared to healthy controls [119-122].  
Thus, The IgE-mediated mast cell degranulation is clearly an important reaction in the 
immunopathology of IBH. However, T cells also play an important role in IBH and the 
involvement of these cells has been investigated in the skin as well as cultured PBMC’s of 
IBH affected and healthy controls.  
The Th1/Th2 polarity was compared between healthy and IBH-affected Icelandic horses, 
imported from Iceland to Europe (1st generation) or born in Europe (2nd generation) [123]. 
In summer, but not in winter, IL4 production by PBMC’s (stimulated with Culicoides 
extract or polyclonal) from IBH-affected horses was significantly higher than those of 
healthy controls. Interestingly, 1st generation horses showed higher Th2 cytokine 
production than the 2nd generation horses with the same disease state. An increased level 
of IL10 in supernatant from PBMC’s of healthy 2nd generation horses was observed upon 
Culicoides or polyclonal stimulation. It was suggested that the suppression of the Th2 type 
cytokine IL4 in healthy horses, might be due to regulatory cytokines, like IL10. In a 
follow-up study, adding supernatant of the PBMC’s of healthy 2nd generation horses to the 
cultures of IBH-affected horses 1st generation horses, led to a down-regulation of the IL4 
production. This effect could be imitated when adding both IL10 and TGF1 to the 
cultures. In addition, IL4 production by PBMC’s of healthy control horses could be 
increased by adding anti-IL10 and anti- TGF1 to the cultures [124]. These results have 
indicated the importance of regulatory cytokines in horses with IBH. Recently published 
studies have further investigated the possible role of equine regulatory T cells in IBH 
using FoxP3 as a marker [125, 126].  
FoxP3+ Tcells were detected by immunohistochemical staining in lesional and non-
lesional skin of IBH-affected and healthy control horses [125]. Severely IBH affected 
horses had a lower ratio of Foxp3+ to CD4+ cells in lesions compared to moderately 
affected horses or healthy horses. At mRNA level the results were more convincing, as the 
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expression of FoxP3 in lesional skin of IBH affected horses was significantly lower 
compared to non-lesional and skin of healthy horses. Furthermore non-lesional skin of 
IBH-affected horses also showed a significant reduced Foxp3 expression compared to 
skin of healthy horses. There were no differences observed for Foxp3 expression in the 
blood. However, there was a reduced IL10 expression level in the blood of IBH-affected 
horses compared to healthy horses and IL10 levels were also lower in lesional skin 
compared to non-lesional skin of IBH affected horses. Th2 cytokine expression levels 
were not found to be higher in blood of IBH-affected horses compared to healthy controls, 
but in the skin of IBH-affected horses a significant higher IL13 level was observed [125].  
Hamza et al. [126] focussed on the expression of Foxp3 in CD4+CD25+ T cells in PBMC 
directly after isolation or after C. nubeculosus extract stimulation or with a non-relevant 
control allergen using flow cytometry. They only observed a significant difference in the 
C. nubeculosus stimulated PBMC, which showed a higher expression of Foxp3 by 
CD4+CD25+high and CD4+CD25+dim cells from healthy horses compared to IBH horses. 
The expression of FoxP3 within CD4+CD25+high cells of the healthy horses could be 
significantly decreased by adding IL4 to the cultures stimulated with the C. nubeculosus 
extract.  
In conclusion, IBH can be clearly described as a Th2 type, IgE mediated allergic disease 
and just as in humans, there seems to be a disturbance in the function of the regulatory T 
cells.  
 
Culicoides allergens and cross-reactivity 
Culicoides saliva and whole body extracts consist of many proteins that can bind IgE from 
IBH affected horses [119-122, 127]. Each IBH-affected horse seems to have its own IgE-
affinity pattern for different Culicoides proteins, suggesting that multiple allergens play a 
role in IBH and that they can differ between allergic horses. 
Hellberg et al. [120], identified ten different IgE-binding protein bands from C. 
nubeculosus with molecular weights from 12 kDa to 75 kDa with a large variety in IgE-
binding pattern between each horse, but the corresponding proteins were not identified in 
this study. In a different study, western blot analysis revealed a dominant IgE-binding 
protein band of 65 kDa from a native European species (C. obsoletus) for all allergic 
horses that were tested [115]. A band of similar size (66 kDa), but from a North American 
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species (C. sonorensis), was identified as a dominant IgE-binding protein band for IBH 
affected horses in Germany [121]. This band was further characterized by mass 
spectrometry and bioinformatics and identified to be a maltase and was named Cul s 1. 
Cul s 1 was expressed in a baculovirus expression system and its clinical relevance was 
investigated by in vitro and in vivo diagnostic tests. Most allergic horses showed IgE 
reactivity against the recombinant Cul s 1 which confirmed its allergenicity. Cul s 1 is the 
first allergen described to be relevant for IBH.  
Candidate allergens were also identified from salivary glands from laboratory bred C. 
nubeculosus [127]. Using a proteomics approach two abundant proteins were identified 
with a mass of 40-50 kDa that showed sequence similarity to a hyaluronidase and a 
heavily glycosylated protein of unknown function from an EST library from C. sonorensis 
[128]. The allergenicity of these proteins was not determined in recombinant form, but in 
2D blots these antigens had positive reactions with allergic horses.  
A different approach to isolate IBH relevant allergens was undertaken by using phage 
surface display technology with a cDNA library prepared from salivary gland mRNA 
from either S. vittatum or C. nubeculosus [129, 130]. Seven IgE-binding proteins from S. 
vittatum were identified and expressed in E. coli. Significant higher IgE-levels in IBH-
affected horses compared to healthy controls were found against four of them; antigen-5 
like protein (Sim V 1), a serine protease inhibitor (Sim V 2) and two α-amylases (Sim V 3 
and Sim v 4). Sim V 1 was reported to be an interesting candidate allergen, as the 
proportion of IBH-affected horses reacting against this allergen was higher than for the 
other allergens [129].   
In a follow-up study, a clear cross-reactivity between the antigen-5 like allergen from S. 
vittatum Sim V 1 and an antigen-5 like protein from C. nubeculosus was observed both in 
vivo and in vitro. They were found to share 47.7% sequence identity at primary structure 
level [130]. Cross-reactivity between proteins from these insect species was also observed 
by Hellberg et al. [131]. However IgE from allergic horses reacted with fewer protein 
bands from S. vitattum than from C. nubeculosus. Furthermore a histamine release test 
gave better results with C. nubeculosus extract compared to Simulium extract [75]. 
Cross-reactivity between Culicoides spp has also been investigated. Intradermal tests on 
allergic and healthy control horses in Northern Germany and British Columbia with 
extracts and saliva of native and exotic Culicoides spp, showed no difference between 
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Culicoides species, indicating the presence of species-shared allergens [95, 116]. This is 
also confirmed by Hellberg et al. [120] who reports that most IBH-affected horses show 
IgE-binding to different proteins from C. nubeculosus, a species which is rarely found in 
the country where this study was performed. In contrast, a study in The Netherlands, 
where C. obsoletus was found to be the most common species attracted to horses [107], 
reported the importance to use a native Culicoides species extract for in vivo diagnosis, 
suggesting low Culicoides cross-reactivity [117]. Moreover, IBH-affected horses were 
reported to have stronger IgE responses to proteins from native C. obsoletus compared to 
proteins from C. nubeculosus [127].  
Recently, ten additional IgE-binding proteins from C. nubeculosus were isolated, 
expressed as recombinant allergens and termed Cul n 2 to Cul n 11 [122] with molecular 
masses ranging from 15.5- 68.7 kDa. The authors reported that 44 out of 45 tested IBH 
affected horses reacted with at least one of these allergens in an IgE ELISA.  
An overview of all allergens produced as recombinant proteins that have been associated 
with IBH was recently reviewed and are presented in Table 1 [81].  
Thus in summary, many IBH relevant allergens have lately been identified. However 
these allergens were derived from species that are not native for the countries where they 
were tested. Although some cross-reactivity between Culicoides species has been 
reported, there is also evidence for the lack of cross-reactivity and the use of recombinant 
allergens from native species might therefore be important for successful diagnosis and 
future immunotherapy. 
 
Diagnosis 
Observation of clinical symptoms, combined with well documented medical history and 
ruling out other conditions that may lead to pruritus is often considered as the gold 
standard for the definitive diagnosis of IBH [75]. However misdiagnosis can occur and 
because clinical symptoms are absent in colder months the need for a diagnostic test is 
high. Diagnostic tests have lately been developed and can be divided in 1) intradermal 
skin testing [115-117, 132], 2) cellular basophil degranulation tests [75, 116, 133] and 3) 
serological tests that measure allergen-specific IgE in serum [115, 116]. These tests are 
mostly performed with non-standardized crude allergen extracts from Culicoides or 
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sometimes Simulium spp. leading to currently unreliable and/or poorly repeatable 
diagnostic tests.  
 
Intradermal testing 
Intradermal testing has been used in horses for many years to determine sensitisation of 
skin mast cells with Culicoides specific IgE [27, 117, 134].  Mast cell degranulation is 
evaluated after injection of allergen(s), positive control (histamine) and a negative control 
(PBS or saline) by measuring the wheal diameters at the injection sites after different time 
points (Figure 4) [28]. Intradermal testing using Culicoides or Simulium extracts has been 
reported to have a high sensitivity and specificity and has therefore potential as a 
diagnostic test [115-117, 132]. However, low sensitivity and specificity has been reported 
as well [135] and intradermal testing has some well-known disadvantages. The results can 
be difficult to interpret and repeatability of the test has reported to be poor [136]. 
Furthermore, intradermal tests can be irritating and cause false positive reactions when 
injected to deeply and maybe even lead to sensitisation [137]. Moreover, in vitro testing is 
much more preferable, because it is easier to take a blood sample and more convenient for 
the veterinarian as well as for the horse. 
Figure 4: Intradermal test in a horse. Wheals induced by allergens after 30 min. Upper left wheal is 
histamine positive control. (Picture made by M. Sloet van Oldruitenborgh-Oosterbaan) 
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Basophil degranulation test 
The basophil degranulation test, also called histamine release test (HRT), is performed on 
blood samples and based on mediator release from peripheral blood basophils. Just as the 
intradermal skin test it determines sensitisation with allergen-specific IgE and can thus be 
seen as an alternative for skin testing [38].  
Two HRT’s, the functional in vitro test (FIT) and the Cellular Antigen Stimulation Test 
(CAST), have been tested with Culicoides and Simulium extracts for diagnosis of IBH [75, 
116, 133]. 
The FIT test has been developed at the University of Hannover [138], is performed on 
whole blood and monitors the histamine release by sensitised basophils. A schematic set 
up of this test is shown in Figure 5. The amount of released histamine by horse peripheral 
blood basophils without stimulation (spontaneous release), after stimulation with anti-
horse IgE or IgG (antibody release) or after stimulation with allergen (test release), is 
measured as a percentage of the total histamine content obtained by cooking (maximum 
release) or in some cases obtained by anti-IgG or anti-IgE (Figure 5) Supernatant is 
collected and the histamine content is measured by a competitive Radioimmunoassay 
(RIA). The allergen induced histamine release is set as a percentage of the maximum 
release.  
The CAST determines the release of sulfidoleukotrienes by peripheral blood leucocytes 
Figure 5: Schematic set up of the functional in vitro test, compromising the spontaneous, maxi-
mum, antibody and test histamine release of the basophilic granulocyte for each blood sample 
(modified from Stuke et al. [143]) 
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(PBL) after incubation with allergens and was developed for the diagnosis of IgE-
mediated allergic reactions in human [139]. This test with minor modifications was 
successfully used with horse PBL for the diagnosis of IBH after stimulation with C. 
nubeculosus or S. vittatum extracts. However, when horses were not exposed to insects for 
several months, the sensitivity of the test decreased [75]. Sulfidoleukotriene production 
was shown to be highly correlated with histamine release from basophils [133]. 
Stimulation with C. nubeculosus extract resulted in higher sensitivity and specificity 
compared to S. vittatum stimulation, suggesting that horses with IBH are mainly sensitised 
to Culicoides allergens [75].    
Although sensitisation of basophils and mast cells with IgE is required for clinical allergy, 
sensitisation of mast cells and basophils does not necessarily mean that a horse shows 
clinical symptoms. Clinically healthy horses often show to be clearly sensitised with IgE 
to Culicoides allergens when tested by HRT or intradermal skin testing [117, 118, 135, 
136, 140]. 
 
Serological test 
Serological allergy tests are based on the knowledge that allergic individuals have higher 
allergen-specific IgE levels in their serum than healthy individuals. The detection of 
allergen-specific IgE antibodies in serum is often performed by Enzyme Linked Immuno 
Sorbent Assay (ELISA). Allergen preparations are coated on the plate, serum or purified 
IgE is added and bound equine IgE is detected by polyclonal reagents, monoclonal 
antibodies or the human FcεR1α chain, which is then detected by a secondary antibody 
conjugated with an enzyme, that upon reaction with its substrate can change the colour of 
this substrate  [116, 141, 142]. A schematic set up of such an ELISA is shown in Figure 6. 
The FcεR1α-based ELISA test (ALLERCEPT®, Heska) is used to detect the presence of 
allergen-specific IgE in sera and was evaluated with sera of both IBH-affected and healthy 
horses [141]. In the ALLERCEPT® IgE test an allergen or extract is bound to the wells of 
an ELISA plate, serum is added and afterwards recombinant human alpha chain of the 
high affinity IgE receptor (FcεR1α), known to cross-react with horse IgE, is added that 
will specifically bind to IgE. Specific IgE against insect (including C. nubeculosus 
extract), mould, mite and pollen allergen was measured, but the test results showed that 
the ELISA that uses the high-affinity IgE receptor is not a suitable test for diagnosis of 
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IBH, due to high false positive test results with C. nubeculosus and other extracts. An IgE 
ELISA using C. nubeculosus and C. sonorensis WBE or saliva was reported to have a low 
sensitivity. Purified IgE increased the sensitivity of the ELISA, but the test was less 
accurate than HRT [116]. In addition, intradermal skin tests in horses were also reported 
not to be comparable with results obtained by IgE ELISA using crude allergen extracts 
and serum [143, 144].  
Thus, in conclusion serological testing in horses with IBH with the current available 
assays seems to perform poorly.  
 
 
 
 
 
Figure 6: Schematic set up of an IgE ELISA using an anti-equine IgE antibody  
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Research aim and thesis outline 
Research described in this thesis is part of a bigger project of which the research aim is to 
improve the understanding of immunologic, epidemiologic and genetic aspects involved 
in the development of insect bite hypersensitivity (IBH) in horses that can lead to the 
development of innovative intervention strategies that will effectively decrease the 
prevalence of IBH in a population.  
This thesis focuses on immunological aspects of IBH, with special attention to improving 
diagnosis by the characterization and production of allergens from the causative agent of 
IBH. The recombinant allergens produced were studied in vitro and in vivo, by an IgE 
ELISA and intradermal tests to assess the potential of these allergens for IBH related 
research. An IgE ELISA with high sensitivity and specificity for diagnosis of horses with 
IBH is described.  
Before recombinant allergens can be produced it is necessary to know from which species 
they should be derived. As described in this chapter, C. obsoletus is regularly found to be 
mostly attracted to horses in different countries. However most studies performed on IBH 
used laboratory available C. nubeculosus or C. sonorensis. In chapter 2, WBE of these 
two species were compared with WBE of C. obsoletus for their applicability in different 
in vitro diagnostic tests on Dutch horses, to assess which species we should further use. A 
diagnostic ELISA using C. obsoletus WBE is presented. In addition, in chapter 3 
seasonal differences in C. obsoletus specific IgE levels, cytokine and transcription factor 
mRNA expression were estimated in lesional and non lesional skin of IBH affected and 
healthy horses.  
Since, C. obsoletus was found to be the most important species for diagnosis of IBH in 
The Netherlands as described in chapter 2, mRNA of this Culicoides species was 
sequenced and assembled to create a transcriptome which is presented in chapter 4. The 
transcriptome can be of use for the identification of allergens relevant for IBH. Several 
allergens from C. nubeculosus and C. sonorensis were recently described to be associated 
with IBH (Table 1, [81]). However, allergens from C. obsoletus so far have not been 
described. Using the sequences from described allergens, similarity searches were 
performed on the transcriptome from C. obsoletus. The identification and evaluation of 7 
allergens from C. obsoletus found by similarity searches with sequences from in literature 
described allergens is described in chapter 5.  
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The potential of these individual C. obsoletus derived recombinant allergens compared 
with C. obsoletus WBE in an IgE ELISA using sera of a large number of horses is 
evaluated in chapter 6. Major allergens among the 7 recombinant proteins were identified 
and a diagnostic ELISA using a combination of 3 allergens is presented which can be used 
as a replacement for WBE for robust and large scale testing. In addition, various factors 
associated with the outcome of these ELISA’s were evaluated and quantified in chapter 
7.  
Chapter 8 finalizes this thesis with a summarizing general discussion on the implications 
of the findings of the previous chapters. Additionally, future perspectives for the treatment 
of IBH are discussed.  
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Abstract 
Insect bite hypersensitivity (IBH) is an allergic dermatitis in horses caused by the bites of 
Culicoides species. The aim of the present study was to evaluate the applicability of whole 
body extracts of C. obsoletus (the main species found feeding on horses in the 
Netherlands), C. nubeculosus (rarely found in The Netherlands) and C. sonorensis (typical 
for North America) for diagnosis of IBH in horses in The Netherlands. Blood and serum 
samples of 10 clinically confirmed IBH affected and 10 healthy control horses were used 
to evaluate the IgE titres (ELISA) against the Culicoides whole body extracts of the three 
Culicoides species. Basophil degranulation was assessed by histamine release test (HRT) 
after stimulation with these extracts at 5, 0.5 and 0.05 µg/ml. IBH affected horses had 
significantly higher IgE titres against C. obsoletus than against C. nubeculosus and C. 
sonorensis. Furthermore, C. obsoletus induced significantly higher histamine release in 
whole blood of IBH affected horses compared to the other extracts at 0.5 µg/ml. Western 
blot data revealed IgE-binding to many proteins in C. obsoletus extract. This interaction 
was absent or weak in C. nubeculosus and C. sonorensis extracts for IBH affected horses. 
Results on individual level indicate that the HRT is more sensitive than ELISA in 
diagnosing IBH. However ELISA is more practical as a routine test, therefore the ELISA 
was further evaluated using C. obsoletus extract on 103 IBH affected and 100 healthy 
horses, which resulted in a test sensitivity and specificity of 93.2% and 90.0%, 
respectively. The IgE ELISA readings enabled the analysis of the predicted probability of 
being IBH affected. From an Optical density 450 nm value of 0.33 onwards, the 
probability of IBH affected was more than 0.9. The results presented in this paper show 
that the use of native Culicoides spp that feed on horse, is important for improved 
diagnosis and that the described ELISA based on C. obsoletus can be used routinely to 
diagnose IBH in countries where this species is the main Culicoides feeding on horses. 
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Introduction 
Insect bite hypersensitivity (IBH), also called ‘sweet itch’ or ‘summer eczema’, is a 
seasonal recurrent allergic dermatitis in horses caused by an allergy against the bites of 
midges (Culicoides spp), or sometimes black flies (Simulium spp) and to an even lesser 
extend other insects [1-5]. IBH is found in many countries of the world with a prevalence 
ranging from 3 - 11.6% in areas in the UK [6, 7]; 10 – 60% in areas of Queensland, 
Australia [8] and 0 -71.4% in regions of The Netherlands [9].  
Insect Bite Hypersensitivity is clinically characterized by strong pruritus and irritation, 
leading to alopecia and even secondary lesions due to scratching and rubbing. These 
symptoms are particularly found along the preferred feeding sites of the insect, which is 
the ventral midline, mane and tail region of the horse [3, 10]. Several studies indicate that 
the allergic reaction is predominantly IgE-mediated [11, 12]. However IgG (T) also seems 
to be involved [13] 
Intradermal injections with Culicoides extracts often induce immediate and delayed type 
skin reactions in allergic horses [14, 15]. In Iceland, where Culicoides spp do not occur, 
IBH has never been reported [16, 17]. Several Culicoides species have been associated 
with IBH, including C. sonorensis, C. nubeculosus, C. imicola, C. obsoletus and C. 
pulicaris [4, 15, 18-20]. Intradermal tests on allergic and healthy control horses in 
Northern Germany and British Columbia with extracts and saliva of native and exotic 
Culicoides species, showed no difference between the native and exotic Culicoides 
species, indicating the presence of species-shared allergens [21, 22]. However, 
intradermal skin tests in The Netherlands, with a commercial extract of C. nubeculosus 
and wild-caught C. obsoletus, showed the lack of cross reactivity between these 
Culicoides species [15, 23]. 
The aim of the present study was to evaluate three Culicoides species for their 
applicability in diagnostic tests for IBH of horses in The Netherlands: C. obsoletus which 
is most frequently found on horses in The Netherlands [24, 25], C. nubeculosus, widely 
distributed in Europe, but only occasionally detected in The Netherlands [26] and not 
found to be attracted to horses [24] and C. sonorensis which is only present in North 
America. Currently, C. sonorensis and C. nubeculosus are often used in studies about 
IBH, because they can be successfully maintained in laboratory bred colonies [27]. C. 
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obsoletus however, are not available from laboratory bred colonies and have to be 
collected from the wild. An attempt to breed C. obsoletus has been made, but was not very 
efficient [28]. Results presented in this report show that the use of native Culicoides spp 
that feed on horse, is important for improved diagnosis and possibly, for future 
immunotherapy development. A diagnostic ELISA for IBH based on C. obsoletus is 
described that can be used routinely and has a high specificity and sensitivity.  
 
Material and methods 
Animals 
A total of 223 horses located in different regions of The Netherlands were included in this 
study. Pairs of clinically confirmed IBH affected and healthy control horses kept at the 
same location were formed [29]. Ten clinically confirmed IBH affected and 10 healthy 
control Shetland ponies were used to compare the different Culicoides whole body 
extracts in different in vitro diagnostic tests. The remaining 203 horses (76 Icelandic 
horses and 127 Shetland ponies) were used to evaluate the predictive value and test 
sensitivity and specificity of an ELISA using C. obsoletus whole body extract.    
Blood samples were taken from all horses and serum was frozen in aliquots not later than 
24 hours after blood sampling and stored at -20 o C until use. Blood sampling was 
approved by the Board on Animal Ethics and Experiments from Wageningen University 
and Utrecht University. 
 
Collection of Culicoides insects 
C. obsoletus insects were captured during spring and summer months using a pooter 
(aspirator to collect insects) (Supplementary figure 1) or an “Onderstepoort” suction light 
trap kindly provided by Laboratory of Entomology, Wageningen University. 
Horses wearing an anti-insect blanket were put outside around dawn hours on warm (> 20 
°C), dry and low wind days and Culicoides insects were collected directly from the horses 
using the pooter. The insects were collected and completely frozen alive at -80 °C and 
stored at that temperature until preparation of the extracts. A small fraction (5%) of the 
insects collected with the pooter was checked under a stereo microscope to confirm the 
species. Identification of C. obsoletus was based on size and wing patterns [30] 
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(Supplementary figure 2). The “Onderstepoort” suction light trap was operated from 
before dusk to far after dawn near a horse stable for 19 days at different locations in The 
Netherlands in the summer months of 2009. Insects were captured in 100% alcohol and 
frozen the next day in alcohol at -80 oC until determination. C. obsoletus insects were 
selected and separated from the other captured insects using a stereo microscope as 
described above. Separated C. obsoletus insects were used for the preparation of extracts.  
Three-day-old laboratory bred C. sonorensis were a kind gift from Arthropod Borne 
Animal Diseases Research Unit Centre for Grain and Animal Health, Manhattan, US. C. 
nubeculosus insects were kindly donated by the Institute for Animal Health, Pirbright, 
UK. All insects were kept frozen (without alcohol) at -80 °C until preparation of the 
extracts.  
 
Preparation of Culicoides protein extracts 
Whole body extracts (WBE) were prepared from about 300 insects that were transferred to 
a 2 ml Eppendorf tube with 1 ml of PBS containing a protease inhibitor cocktail (Sigma-
Aldrich, P8849) and crushed with a micro pestle. The insoluble material was removed by 
centrifugation at 13000 x g for 10 min at 4 °C. Supernatant was collected and filtered 
through sterile Millex-GV filters (Millipore) with a pore diameter of 0.22 µm and protein 
content of the filtrate was determined by OD280nm measurement on a Nanodrop 
spectrophotometer (NanoDrop 1000, Thermo Scientific). Samples were aliquoted, directly 
frozen in liquid nitrogen and stored at -80 °C until use. Quality of the protein WBE was 
checked by protein staining with Gelcode Coomassie blue staining (Thermo Scientific) 
after proteins were separated by 15% SDS-PAGE.   
 
 SDS-PAGE and Western blotting 
Whole body protein extract samples, 20 µg/lane (Western blotting) or 60 µg/lane 
(Coomassie staining) were heated at 96 °C for 5 min with sample buffer containing 
dithiotreitol (DTT) and separated by SDS-PAGE (15% gel). These separated proteins 
were transferred to a nitrocellulose membrane (Protrans, Schleicher & Schuell, Bioscience 
GmbH) by means of electrophoresis. Membranes were blocked with 5% non-fat cow’s 
milk in Tris buffered saline (TBS)-Tween (10 mM Tris, 150 mM NaCl, pH 7.5, 0.05% (v/
v) Tween 20) for 1 h at room temperature (RT) and then incubated overnight with horse 
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sera from allergic or control horses diluted 1:10 in 5% non-fat cow’s milk in TBS-
Tween. Membranes were then incubated for 1.5 hour with a mAb against horse IgE 
(αIgE-176) [31] followed by goat anti-mouse IgG horseradish peroxidase (Dako, 
1:1000 in milk powder/TBS-Tween). Between each incubation step, membranes were 
washed three times with TBS-Tween. 
Signal was detected by development with an enhanced chemiluminescence (ECL) 
western blotting detection reagent (Amersham, GE Healthcare) according to the 
manufacturer's protocol and visualized by the use of Lumni-fil chemiluminescent 
Detection Film (Roche, Woerden, The Netherlands). 
 
Histamine release test (HRT) 
The histamine release by basophils was determined by a modified method of Kaul [32]. 
Blood samples were collected in anticoagulant tubes (EDTA) and kept at RT in the dark 
until further use within 24 hours. The total blood cells were washed twice (500 x g for 
10 min) with PBS to remove non-cell bound antibodies. Supernatant was discarded and 
the cell pellet was resuspended in PBS to its original blood sample volume. Endogenous 
histamine from whole body Culicoides extracts was removed by PD-10 Desalting 
columns (GE Healthcare) according to manufacturer’s recommendations. The antigen 
induced histamine release was obtained by incubating 250 µl of washed blood cells 
with 250 µl of PIPES buffer (110 mM NaCl, 5 mM KCl, 40 mM NaOH, 2 mM CaCl2, 
25 mM PIPES, 2 mM MgCl2) containing the histamine depleted Culicoides whole body 
extracts at final concentrations of 5 µg/ml, 0.5 µg/ml and 0.05 µg/ml at 37 °C for 60 
min. Spontaneous release was obtained by incubating 250 µl of PIPES B buffer with 
250 µl of washed blood cells at 37 °C for 60 min. Physical maximum release was 
obtained by boiling 200 µl of washed blood cells with 800 µl of PIPES buffer for 10 
minutes. After incubation, all samples were chilled on ice for 5 min and pelleted by 
spinning down at 700 x g for 10 min. The cell-free supernatants were collected and 
stored at -20 °C. Subsequently, competitive RIA was carried out as per the 
manufacturer’s instructions (LDN Nordhorn, Germany) to determine the histamine 
content of the supernatants.  
The maximum amount of histamine obtained by boiling was set                                                                                                                                                                                                                    
to 100%. The histamine content of each test sample was calculated from this maximum 
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histamine release. The allergen-specific release (ASR) is calculated as: ASR = (sample 
induced release – spontaneous release)/ (maximum release – spontaneous release) x 100%.  
Net-histamine releases that were equal or greater than 10% of the maximum release were 
considered as positive.  
 
Culicoides-specific IgE ELISA 
Specific IgE levels in sera of 10 IBH affected and 10 healthy control Shetland ponies, 
binding the different Culicoides WBE, were measured by ELISA. Optimal coating 
concentration, serum dilution and antibody concentrations were determined prior to the 
experiment by titration of the different components. Costar 96-well microtitre plates were 
coated with 100 µl/well of 10 µg/ml C. obsoletus, C. nubeculosus or C. sonorensis extract, 
diluted in PBS, and incubated overnight at 4 °C and afterwards blocked with 150 µl of a 
1.5% casein buffer (SDT, Germany)  for 1.5 hour at RT. Plates were washed 5 times with 
PBS containing 0.05% Tween20, followed by incubation for 1.5 h at RT with 100 µl of 
horse serum samples diluted 1:5 in a 1.5% casein buffer. After washing, wells were 
incubated for 1 hour at RT with 100 µl of 2.5 µg/ml mouse monoclonal anti-equine IgE-
176 [31] diluted in casein buffer. After washing the plates 5 times with PBS containing 
0.05% Tween20, goat anti-mouse peroxidase conjugate (multispecies adsorbed, Serotec) 
diluted 1000 times in casein buffer, was applied to the wells and incubated for 1 h at RT. 
After 5 washes with PBS/0.05% Tween20, 100 µl tetramethylbenzidine (high sensitivity, 
SDT, Germany) was added to the wells and incubated for 10 min at room temperature. 
The reaction was stopped with 100 µl/well of 1% HCl. Absorbance was measured with a 
multi-mode microplate reader (SpectraMax M5, Molecular Devices) at a wave length of 
450 nm corrected for 650 nm. Based on the preliminary experiments a standard serum 
dilution of 1:5 was selected as suitable for comparison of OD450nm values in the IgE 
ELISA.  The cut off level was assigned as the mean + 3 times the standard deviation (SD) 
of the IgE levels of the healthy control horses. 
An additional 203 horse serum samples, 103 IBH affected and 100 healthy control horses, 
were evaluated for C. obsoletus specific IgE (OD450nm) values in a 384 wells plate to 
determine the sensitivity and specificity of this Culicoides-specific ELISA. The same 
conditions as described for the 96-wells plate were used, with 20 µl volumes per well. 
Distribution plots of the healthy and IBH affected horses were obtained by categorizing  
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horses according to their OD450nm values. The first category ranged from 0 to 0.01, the 
second from 0.01-0.02 and the following categories each increased with 0.02 up to 0.32. 
Then the categories ranged from 0.32-0.35, 0.35-0.4 and subsequent categories each 
increased with 0.2 until the maximum OD450nm of 2.2 was reached.  
Accuracy of diagnostic tests is often determined from so-called receiver-operating 
characteristic (ROC) curves. ROC-curves represent the trade-off between sensitivity (i.e. 
true positive rate) of a test and (1-specificity) (i.e. false positive rate) at all possible 
positivity cut-off points. The area under the curve summarizes the overall diagnostic 
accuracy. It takes values from 0 to 1, where a value of 0 indicates a perfectly inaccurate 
test and a value of 1 reflects a perfectly accurate test. A good first choice for a test cut-off 
value that results in a balanced optimal sensitivity and specificity is that value which 
corresponds to a point on the ROC-curve nearest to the upper left corner of the ROC 
graph. 
 
Statistical analysis 
Analysis of variance was performed on log transformed data obtained by either HRT or 
ELISA to determine influence of Culicoides species on the outcome. Factors included in 
the model were, Culicoides-species (C. nubeculosus, C. sonorensis and C. obsoletus), IBH
-status of the horse (yes/no) and interaction between these two factors. Additionally, WBE 
concentration (0.05, 0.5 and 5 µg/ml) was included in the analysis of HRT results. IBH-
status within individual horses was included as random factor since the same set of horses 
were used in testing the three Culicoides types. Analysis was performed using PROC 
MIXED of SAS (SAS Inc, V9.2).   
The relation of OD450nm value in the IgE ELISA to the IBH-status (negative or positive) 
was analysed with a logistic regression. The analysis was performed with the PROC 
LOGISTIC of SAS (SAS Inc, V9.2).   
 
Results 
Collection of C. obsoletus 
Two different collection methods (“Onderstepoort” light trap and pooter) were used to 
determine the most selective and efficient way of collecting C. obsoletes from the wild.  
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Determination of insects collected with the “Onderstepoort” light trap revealed that many 
different insect species were collected in this manner, from which only a small fraction 
(<1%) belonged to Culicoides species. A total of 766 Culicoides midges were collected 
during these 19 days. The large majority of these Culicoides were identified as C. 
obsoletus (82%), followed by C. dewulfii (6.5%) and C. punctatus (5.0%).  
Using the pooter hundreds of Culicoides insects were easily collected within an hour from 
a horse wearing an anti-insect blanket. A small part (± 5%) of the collected insects was 
used for identification and these were all identified as C. obsoletus based on size and wing 
patterns.  
 
Quality of extracts of Culicoides captures by different methods 
WBE were prepared from C. obsoletus insects collected alive with the pooter system, as 
well as insects collected in alcohol with the Onderstepoort light trap. Insects that were 
stored in alcohol were excluded in the following experiments due to substantial 
degradation of the proteins revealed on SDS-PAGE (Supplementary figure 3). 
The extracts from laboratory bred C. sonorensis and C. nubeculosus and wild-caught C. 
obsoletus prepared in the same manner from freshly frozen insects, showed some  
differences in the lower molecular weight regions (indicated by arrows in Figure 1) on 
SDS-PAGE (15% gel), but overall pattern and intensity of the protein bands were similar, 
with no obvious degradation, indicating similar quality of the different extracts.  
 
IgE-specific antibodies in horse sera specific for Culicoides proteins as determined by 
Western blotting 
Western blotting was performed to evaluate sera of clinically confirmed IBH affected and 
healthy control Shetland ponies for the presence of IgE specific for proteins from C. 
obsoletus, C. sonorensis and C. nubeculosus. Typical examples of 5 allergic (upper panel) 
and 5 healthy horses (lower panel) are shown (Figure 2). 
The IgE in sera of all allergic horses reacted strongly to a number of proteins from C. 
obsoletus extract, but much weaker with proteins from C. sonorensis and C. nubeculosus 
extract despite the similar quality of the extracts. The antigen recognition pattern for each 
individual horse was different, but most IBH affected horses reacted with a protein(s) 
around 20 kDa. IgE from the healthy horses, except for one, hardly recognized any 
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proteins from any of the 3 Culicoides species. Proteins that did bind to the IgE in serum of 
healthy horses all had a Mw of 25 kDa or higher (Figure 2).  
 
Basophil degranulation induced by Culicoides whole body extracts determined by 
histamine release test 
For each of the 3 different Culicoides species the allergen-specific release (ASR) of 
histamine from basophils was tested at 3 WBE concentrations on whole blood samples of 
10 IBH affected and 10 healthy control Shetland ponies (Fig. 3), including the horses that 
were used for the Western blot analysis.  
At the highest WBE concentration of 5 µg/ml 10 out of 10 (100%) of the IBH affected 
horses scored positive on the C. obsoletus WBE, while this was 8 out of 10 (80%) for C. 
nubeculosus and C. sonorensis. However, at this highest WBE concentration some of the 
healthy horses also scored positive on all Culicoides species. At a concentration of 0.5 µg/
ml none of the healthy control horses scored positive on any of the extracts, but at this 
concentration only 20% of the IBH affected horses scored positive with C. nubeculosus 
and C. sonorensis extract. In contrast, 100% of the IBH affected horses scored positive 
when the C. obsoletus extract was used. At this concentration the reactivity towards C. 
obsoletus was significantly higher than to C. nubeculosus (p< 0.01) and C. sonorensis (p< 
Figure 1: Coomassie staining of proteins from C. obsoletus extract (O), C. nubeculosus (N) and C. 
sonorensis (S) whole body extracts demonstrating similar quality of the extracts. M represents the 
molecular weight marker.  
 55 
Chapter 2 
0.001) (Figure 3). At the lowest WBE concentration of 0.05 µg/ml 40% of the IBH 
affected horses were still found to be positive with C. obsoletus, whereas for C. 
nubeculosus and C. sonorensis this was only 10% of the IBH affected horses.  Also at this 
concentration all healthy control horses had a negative test results for all Culicoides 
extracts.  
 
Figure 2: Immunoblot analysis of 5 IBH affected and 5 healthy horses using whole body extracts of 
C. obsoletus (O), C. nubeculosus (N) and C. sonorensis (S). Proteins were separated on 15 % SDS-
PAGE gels and transferred to nitrocellulose membranes. Binding of IgE from horse sera was detect-
ed with an anti-equine IgE mouse mAb and HRP goat anti-mouse IgG. The molecular weight mark-
er (M) is indicated on the left in kDa.  
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IgE measurements in horse sera against Culicoides whole body extracts by ELISA 
Specific IgE serum levels against WBE of the three different Culicoides species were 
determined in an indirect ELISA (Figure 4). 
IgE levels expressed as OD450nm values of the clinically confirmed IBH affected Shetland 
ponies against C. obsoletus extract were significantly higher compared to OD450nm values 
of the same IBH affected horses against the other extracts (both p < 0.0001). With C. 
obsoletus extract only, specific IgE serum levels of IBH affected horses were significantly 
higher than specific IgE levels of healthy control horses (p < 0.0001).  
 
Comparison of ELISA and HRT data for individual horses 
Individual HRT (Figure 5 upper panel) and ELISA (Figure 5 lower panel) responses to the 
WBE of the different Culicoides species were compared for the same Shetland ponies 
Figure 3: Culicoides induced histamine release as percentage of maximum release of 10 IBH af-
fected horses and 10 healthy control horses. Whole blood samples were analysed after stimulation 
with three different Culicoides whole body extracts (O = C. obsoletus, N = C. nubeculosus, S = C. 
sonorensis) tested at three different concentrations (µg/ml, x-axis) by a histamine release test 
(HRT).  Results are presented in box plots. The horizontal line near the middle of the box is the 
median of the measurements. The bottom and top of the box are the 25th and 75th percentile, respec-
tively. The end of the whiskers represent the minimum and maximum value. The stars represent the 
outliers.  Horses with histamine release above the cut off value of 10 % (highlighted in gray) were 
considered positive (Kaul et al., 1998). Statistical analysis was performed on log transformed data. 
The p values account for unequal variance.  
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used in Figure 3 and 4. The values at a concentration of 0.5 µg/ml per extract were chosen 
to analyse the horses on individual level for the HRT, because at this concentration the 
best distinction could be made between IBH affected and healthy control horses. On 
individual level, for the C. obsoletus extract the histamine release of all IBH affected 
horses was higher than 10% and therefore positive [49], whereas the maximum histamine 
release of all healthy control horses was below 10% of the maximum histamine release. 
For the ELISA 6 out of 10 IBH affected horses had OD450nm values against C. obsoletus 
extract above the set cut-off level (mean + 3 times the standard deviation SD of the 
OD450nm values of the healthy control horses). With this cut-off level, all healthy horses 
were negative. In 6 out of 10 IBH cases (horses 2, 3, 4, 5, 6, and 7) the HRT and ELISA 
values against C. obsoletus WBE correlated with each other. Interestingly, the IBH 
affected horses with OD450nm values below the cut-off level in the ELISA (horses 1, 4, 8 
and 10) did have a high positive histamine release with the HRT using C. obsoletus WBE. 
One horse had a higher histamine release after stimulation with C. nubeculosus and C. 
Figure 4: IgE levels presented as OD450nm values against three different Culicoides extracts sera 
diluted 1:5 of 10 IBH affected horses and 10 healthy control horses. Results are presented in box 
plots, for a definition see legend of Fig. 3. Statistical analysis was performed on log transformed 
data. The p values account for unequal variance.  
 2 
58  
Culicoides obsoletus extract relevant for diagnostics 
sonorensis WBE compared to C. obsoletus, but did have a higher IgE level against C. 
obsoletus when measured by ELISA.  
 
ELISA test sensitivity and specificity 
The results described in section 3.6 indicate that the HRT outperforms the ELISA as a 
diagnostic test for IBH, but the ELISA is more practical as a routine test. It is much less 
laborious and can be performed on serum samples, while the HRT requires fresh full 
blood. Therefore the ELISA using C. obsoletus extract was further evaluated with sera of 
103 clinically confirmed IBH affected horses and 100 healthy control horses (76 Icelandic 
horses and 127 Shetland ponies). 
When categorizing the healthy and IBH affected horses according to their OD450nm values 
from the IgE ELISA, two distributions with equal variance were observed which are 
nearly baseline-separated (Figure 6a). Although the distribution curve of healthy and IBH 
affected horses overlapped somewhat, the IBH-affected horses had higher serum IgE 
Figure 5: Comparison between histamine release test (HRT) and ELISA of individual horses. 
Numbers 1-10 represent IBH affected horses; horses 11 – 20 represent healthy control horses. IgE 
levels (ELISA) are presented as OD450nm values; Histamine release after stimulation with whole 
body extract at a concentration of 0.5 µg/ml is presented as percentage of maximum release. The 
cut-off of each test is highlighted in light gray and corresponds to 10 % for the HRT and mean + 3 
times standard deviation of the C. obsoletus values of the healthy control horses for the ELISA.  
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levels against C. obsoletus WBE compared to healthy control horses (p < 0.0001) (Figure 
6b). 
The pattern of the ROC-curve (Figure 6c) indicates that the sensitivity sharply increases 
already at low false positive rates. The sensitivity of the test is therefore high over a large 
range of cut-off points. The accuracy of the test as evaluated by the area under the curve 
(AUC) is high and amounted to 0.97, indicating that high sensitivity is achieved with a 
high specificity. The point on the ROC-curve nearest to the upper left corner of the curve 
corresponds with a sensitivity of 93.2% and a specificity of 90.0% and is obtained at an 
OD450nm cut-off value of 0.2.   
Logistic regression was performed to analyse the relation of IgE OD450nm values to the 
IBH-status. The response IBH-affected or healthy was regressed on OD450nm values.  
Figure 6d shows the predicted probabilities of both IBH-outcomes (i.e. affected or 
healthy) related to OD450nm values. With IgE-values close to zero the probability of being 
healthy is much higher than the probability of having IBH; up to an IgE value (OD450nm  
value) of 0.07 (true for 70% of the healthy horses) the probability of being IBH negative 
is approximately  10 times higher than being IBH positive and 5 times higher for a value 
of 0.12 (true for 85% of the healthy horses). At the inflection point at an OD450nm  value of 
approximately 0.2 the probability being IBH-positive or negative is equal. From an 
OD450nm  value of 0.33 onwards (true for 75% of the IBH affected horses) the probability 
of IBH-positive is more than 0.9.  
 
Discussion 
In this study we evaluated three different Culicoides whole body extracts for their 
applicability for in vitro diagnosis of IBH horses in The Netherlands. We show that C. 
obsoletus (a species found feeding on horses in The Netherlands) whole body extract is 
much better for in vitro diagnosis of IBH by ELISA and HRT, than C. nubeculosus and C. 
sonorensis (not found feeding on horses in the Netherlands) whole body extracts. An IgE 
ELISA with C. obsoletus whole body extract performed with 103 IBH affected horses and 
100 healthy horses located in the Netherlands demonstrated a high sensitivity and 
specificity (93.2% and 90.0%, respectively) and can thus be used as a valuable test to 
diagnose horses for IBH in countries where C. obsoletus is the main species found feeding 
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on horses.  
This study describes an easy and selective method of catching Culicoides spp. attracted to 
horses by using a pooter. Although this method is initially more labour intensive than an 
“Onderstepoort” suction trap, it is a selective way of collecting preferentially those 
Culicoides species attracted to horses. This obviates the need for the labour intensive 
selection of the desired Culicoides species out of a large majority of unwanted insects that 
is required when using a light trap. The biggest advantage of the pooter method is that the 
insects are caught in a gentle way that keeps them alive, preventing substantial protein 
degradation as is observed for insects captured in alcohol by the “Onderstepoort” light 
trap.  
The majority of Culicoides spp that were caught by both capturing methods were found to 
be C. obsoletus: over 80% when using the light trap and nearly 100% when directly 
collected from the horse by the pooter. This is in agreement with earlier studies 
performed in The Netherlands that also found C. obsoletus to be the main Culicoides 
species attracted to horses [24, 25]. In other countries, such as England [5] Ireland [19], 
Japan [33] and United States [4], C. obsoletus was also found to be the most important 
Culicoides species attracted to horses.  
Comparison of three Culicoides extracts demonstrates that in The Netherlands horses with 
IBH have more specific IgE directed against whole body extracts of C. obsoletus than 
against Culicoides species that do not feed on these horses. Although cross-reactivity 
between different Culicoides species has been reported [21, 22] our study shows weaker 
IgE-binding in Western blot and ELISA to proteins of non-indigenous Culicoides species 
compared to native C. obsoletus, which was also observed before [5]. This indicates the 
importance of using extracts from native Culicoides species feeding on horses for reliable 
diagnostics of IBH.  
The binding of IgE from allergic horses with C. sonorensis and C. nubeculosus proteins 
might be due to cross reactivity between these proteins and the C. obsoletus antigens and 
maybe also proteins of other insect species that the horses were exposed to. The horses in 
this study might have been exposed to the native C. nubeculosus, but our as well as 
another study performed in The Netherlands [24] did not find any C. nubeculosus insects 
to be attracted to horses. Although C. sonorensis and C. nubeculosus antigens have 
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previously been successfully used in different diagnostic tests [34-36] our study clearly 
shows the importance of using an extract of a Culicoides species to which horses have 
been actually exposed to for diagnosis. Western blot data revealed many IgE-binding 
proteins in C. obsoletus extract that were absent in C. nubeculosus and C. sonorensis 
extracts. Interestingly, a protein of around 20 kDa from C. obsoletus extract was found to 
be bound by IgE from almost all clinically confirmed IBH affected horses, whereas this 
was not observed for C. nubeculosus and C. sonorensis extracts and also not for IgE from 
healthy horses. This makes this protein an interesting candidate allergen for further 
characterization.  
The C. obsoletus insects collected from the wild using the pooter were all female species, 
since females need blood to reproduce and were trying to feed on the horse when 
captured. Although WBE of laboratory-bred insects were of both sexes, it is unlikely that 
this explains the lower allergen-reactivity by C. nubeculosus and C. sonorensis in this 
study. Other studies found Culicoides extracts made from males only, to be just as 
effective in stimulating horse basophils [37] and non-salivary antigens from the thorax of 
Culicoides spp. have shown IgE reactivity with IBH-affected horses [11]. One of the IBH 
affected horses reacted even slightly stronger in the HRT with C. nubeculosus and C. 
sonorensis than with C. obsoletus WBE, and therefore rules out a lack of antigens of 
lower protein quality in the C. nubeculosus and C. sonorensis WBE. This was also 
demonstrated by the similar pattern and intensity of the protein bands of all three WBE on 
SDS-PAGE.  
Surprisingly, some horses had low IgE-binding in the ELISA but a high histamine release 
in response to Culicoides extract stimulation in the HRT. IgG (T) has also been observed 
to bind to skin mast cells and therefore might play an important role in the histamine 
release reaction in IBH [13]. Therefore, the observation that some horses have low IgE-
binding in ELISA but a high histamine release in response to Culicoides extract 
stimulation, might be due to cross-linking of allergen-specific IgG(T) instead of IgE.   
The results in this study indicate that the histamine release test (HRT) might be more 
sensitive and reliable for diagnosis of IBH than the ELISA. However, this comparison 
was made on a relatively small number of horses (10 IBH affected and 10 healthy control 
horses). When tested with a large number of horses, the IgE ELISA, resulted in a high 
specificity (90.0) and sensitivity (93.2) and proved to be the method of choice for routine 
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screening, because it is more robust, easier to perform and more economical than the 
HRT. The test clearly discriminates between IBH-affected and healthy controls such that 
there is little overlap of distributions. The accuracy of the test as evaluated by the area 
under the curve (AUC) of the ROC-graph is high (0.97), indicating that high sensitivity is 
achieved with a high specificity. At an OD450nm cut-off value for positivity of 0.2 the test 
has a sensitivity of 93.2% and a specificity of 90.0%.  However, this cut-off value does 
not take the actual OD450nm value of an individual horse into account, apart from being 
lower or higher than the determined cut-off value for positivity. Therefore logistic 
regression analysis was performed to determine the relation of the IgE OD450nm values to 
the IBH-status. For most horses the ELISA can determine with 90-100% probability the 
correct IBH-status of the individual tested horse.  For those OD450nm values where 
reliability is less, e.g. around the inflection point at OD450nm value of 0.2, the horse owner 
can choose for an additional HRT to obtain a more conclusive diagnosis.  Western blot 
analysis on C. obsoletus whole body extracts using serum of healthy horses showed some 
IgE reactivity of these horses against proteins with Mw above 25 kDa. Therefore, the use 
of selected recombinant proteins from C. obsoletus might further improve the sensitivity 
of the ELISA described in this study.  
At present, treatment of IBH is based on insect avoidance by stabling, use of anti-midge 
blankets (pyjamas) or insect repellents and suppression of symptoms by the use of 
corticosteroids. Specific immunotherapy might be possible and some immunotherapy 
trials have been carried out with Culicoides whole body extracts, but with varying results  
[38, 39]. The use of purified allergens could further improve diagnostics, but could also be 
a benefit for immunotherapy. Collecting insects is very time consuming and for 
immunotherapy over 10,000 insects were necessary per horse [38], therefore recombinant 
allergens from an infinite source would be a sensible alternative for whole body extracts.  
Currently, allergens have been identified and produced from species that are not present or 
common in The Netherlands, e.g. C. sonorensis and C. nubeculosus [34-36]. 
Implementation of future  immunotherapy in horses will depend on the availability of 
correct allergens and therefore the use of allergens from Culicoides spp to which horses 
have been exposed, which for The Netherlands is mostly C. obsoletus, might be crucial.   
In conclusion, our results show that horses with IBH in the Netherlands have much more 
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IgE antibodies against C. obsoletus proteins compared to C. sonorensis and C. 
nubeculosus proteins which can be routinely detected in different diagnostic tests.  The 
developed ELISA to identify sensitisation against C. obsoletus allergens provides a 
valuable diagnostic test to discriminate IBH affected from healthy control horses in The 
Netherlands, but will also be valuable in other countries were C. obsoletus is mostly found 
feeding on horses.  
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Supplementary data 
Supplementary figure 1 (left): Pooter used to collect Culicoides from horses. Two separate straws 
are inserted in two holes into a 50 ml tube. One straw has a fine mesh covering the end inside of the 
tube. This straw is used to inhale while aiming the other one at the insect to suck it into the tube.  
Supplementary figure 2 (right): Individual example of a female C. obsoletus used in this study 
and identified on size and wing pattern according to Campbell and Pelham-Clinton [30] 
Supplementary figure 3: Coomassie staining of proteins from C. obsoletus extract (50 µg), from 
insects collected alive with the pooter (1) and from insects collected in alcohol with the 
“Onderstepoort” light trap (2). M represents the molecular weight marker. 
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Seasonal differences in cytokine expression in the skin  
Abstract  
Insect bite hypersensitivity (IBH) in horses is a seasonal, IgE-mediated, pruritic skin 
disorder primarily caused by Culicoides spp. We hypothesize that a mixed Th2/Th1-type 
immune status, off season, alters into Th2-dominated immune reactivity in the skin of 
IBH-affected ponies in the IBH season. To study these  immune response patterns 
Culicoides-specific IgE levels, skin histopathology and cytokine and transcription factor 
mRNA expression (IL4, IL10, IL13, IFNγ, FoxP3 and CD3ζ) in lesional and non-lesional 
skin of ponies affected by IBH in the IBH season were compared with those of the same 
animals off season and those in skin of healthy ponies in both seasons. The present study 
revealed a significantly higher histopathology score in lesional skin of affected ponies 
than in non-lesional skin and skin of healthy ponies in the IBH season. C. obsoletus-
specific IgE serum levels of ponies with IBH were significantly higher than those in 
healthy ponies in both seasons. Interestingly, C. obsoletus-specific IgE serum levels 
within each group were the same in the IBH season and off season. The expression of IL4, 
IL13 and IFNγ mRNA in skin biopsies in the IBH season showed a significant 
increase compared to off season in both skin derived from healthy control ponies (n=14) 
as well as in lesional and in non-lesional skin from IBH-affected animals (n=17). This 
apparently general up-regulation of cytokine expression during the IBH season directly 
correlated with an increased CD3ζ mRNA expression in the skin, indicating an overall 
increased T cell influx during the summer months. The only significant 
difference observed between lesional skin from IBH-affected animals as compared to skin 
from healthy control animals in the IBH season was a lower expression of IL13/CD3ζ in 
the affected animals. FoxP3 and IL10 levels were unaffected, except for a lower 
expression of FoxP3 in healthy control skin in the IBH season as compared to off season, 
In addition, the increased level of C. obsoletus-specific IgE did not correlate with higher 
histological scores in LE skin. In summary, our data indicate a general immune activation 
in the skin of both healthy and IBH-affected ponies during the IBH season that potentially 
obscures the Culicoides-specific immune reaction pattern, even in lesional skin of IBH-
affected animals.  
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Introduction  
Equine insect bite hypersensitivity (IBH) is a seasonally recurrent, pruritic skin disorder 
mainly caused by the bites of female Culicoides spp. [1-5]. In Europe all horses are 
exposed to Culicoides bites and develop IgG antibodies to salivary antigens. About 5 
percent of horses develop clinical signs of allergy with elevated Culicoides-specific IgE [6
-8]. Approximately 95 percent of the Culicoides spp. found around IBH horses in the 
Netherlands and other European countries, such as Sweden is C. obsoletus [2, 4, 9]. 
Clinically, at onset IBH is characterized by intense pruritus with papules and wheals, 
which develop into serous crusts, scaling and alopecia on the mane, tail and in some cases 
the ventral midline, when the disease becomes chronic [10-12]. Lesions are only observed 
during the Culicoides season and are absent off season. The diagnosis of IBH is based on 
these characteristic seasonal clinical manifestations as well as skin test reactivity to the 
geographically relevant Culicoides antigen [13]. Histologically, IBH lesions are 
characterized by a mixed perivascular to diffuse cellular infiltrate consisting of mainly 
CD4+ T cells [14] and, especially in acute lesions, eosinophil’s [15, 16].  
Expression levels of IL13 mRNA, but not of IL4 or IL5 mRNA, have been described to be 
significantly elevated in lesional and non-lesional skin of IBH-affected horses [17]. On the 
other hand, IL10 mRNA levels were lower in lesional compared to non-lesional skin, but 
this difference was not statistically significant [17]. An increase in IL4 mRNA production 
with a concomitant decrease in IFNγ mRNA production by cultured equine PBMC was 
observed during the IBH season [18-20].  
No differences in total serum IgE levels were found between healthy horses and animals 
affected by IBH [21]. However, Culicoides-specific IgE serum titres have been reported to 
be higher in horses with IBH as compared to healthy horses [6-8, 17]. Correlations 
between Culicoides-specific IgE titres and histological scores for IBH have not been 
reported so far, nor have differences in these disease parameters between the IBH season 
and off season been investigated. In order to better understand the pathogenesis of IBH we 
investigated the differences in skin pathology and cytokine expression between IBH “on 
and off” season. We hypothesize that the immune balance (a mixed Th2/Th1-type) off 
season alters into a Th2-dominated immune response in the skin of ponies with clinical 
manifestations of IBH, due to exposure to C. obsoletus. Therefore we have compared 
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Culicoides-specific IgE serum levels, parameters of dermatopathology, the mRNA 
expression of cytokines (IL4, IL10, IL13, IFNγ), the transcription factor FoxP3 and the T 
cell receptor linked CD3ζ in lesional and non-lesional skin of ponies affected by IBH 
during the IBH season with those of the same animals off season, as well as of healthy 
control ponies in both seasons.  
Our results show significantly higher histopathology scores in lesional skin of affected 
ponies than in non-lesional skin in the IBH season. The same result was observed when 
comparing lesional skin of IBH ponies and skin from control ponies in the IBH season. 
Culicoides-specific IgE serum levels were higher in IBH-affected ponies compared to 
control animals, but within the group of IBH-affected ponies they were equally high in 
each season. In addition, in both IBH skin and control skin there was an up regulation of 
CD3ζ, IL4, IL13 and IFNγ during the IBH season compared to the situation off season. 
Except for a down regulation of FoxP3 in healthy control skin in the IBH season 
compared to off season, FoxP3 and IL10 levels were unaffected. 
 
Material and Methods 
Animals 
A total of 31 privately-owned Shetland ponies were included in the study.  Ponies with 
IBH (n=17, age range 3-19 years) were selected on the basis of clinical symptoms and 
history, i.e. recurrent, seasonal, pruritic skin lesions located at the mane, tail and ventral 
midline with remission off season. Control ponies (n=14, age range 2-20 years) were 
randomly chosen from the same stables as the ponies with IBH and had no clinical 
symptoms or history of IBH. Ponies in both groups were dewormed and vaccinated at 
regular intervals and did not receive any corticosteroid treatment.  
All animal experiments were approved by the Animal Ethics Committee of the Utrecht 
University. 
 
Collection and processing of blood and skin samples 
To ensure that ponies were not exposed to Culicoides spp. recently, off season samples 
were taken in March 2011 before the start of the IBH season when the average maximum 
temperature was 11.1 °C and midnight temperatures were down to -2.5°C. During the 
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Culicoides season in August 2011 (with an average maximum temperature of 20.2°C) to 
insure maximum exposure to Culicoides the same ponies were sampled again.  
Skin biopsies of 4 mm were taken under local anaesthesia with 2% lidocaine (B. Braun, 
AG Melsungen, Deutschland). Biopsies of healthy and non-lesional skin were collected 
from the dorsolateral neck, whereas chronic lesional skin biopsies were taken from the 
crest. There were no acute lesions present at the time of sampling. Three biopsies were 
taken per sampling site: the first two were snap-frozen in liquid nitrogen and stored at -
70°C until used for RNA isolation. The third biopsy was fixed in 4% neutral buffered 
formaldehyde for 24-48 h and paraffin-embedded for histopathology. Blood samples (20 
ml) were collected from the jugular vein of each pony in off and IBH seasons into heparin 
tubes. Serum was separated after centrifugation and frozen at -20°C until analysed for 
Culicoides-specific IgE levels.  
 
C. obsoletus whole body extract preparation  
Whole body extract (WBE) was prepared from about three hundred female C. obsoletus 
insects, which were frozen at -80 °C without any liquid. They were suspended in a 2ml 
Eppendorf tube with 1ml of PBS containing protease inhibitor cocktail according to the 
manufacturer’s specification (Sigma-Aldrich, St. Louis, MO, USA) and crushed with a 
micro pestle. The sample was centrifuged at 14000 rpm for 10 min at 4°C to remove any 
insoluble material, the supernatant was filtered through a sterile 0.22µm pore diameter 
Millex-GV filter (Millipore, Amsterdam, NL) and the protein content of the filtrate was 
measured at an OD of 280nm with a Nanodrop ND-1000 (Thermo Scientific, Etten-Leur, 
NL). This WBE was snap-frozen in liquid nitrogen en stored at -80°C [22].  
 
Culicoides-specific serum IgE levels 
According to van der Meide et al. [22] a costar 96-well microtitre plate was coated with 
100µl per well of 10µg/ml C. obsoletus WBE in PBS and incubated overnight at 4°C. The 
next day, the plate was washed 3 times with 0.05% Tween20 in PBS and each well was 
incubated with 150µl blocking buffer containing 1.5% casein (SDT, Baesweiler, 
Germany) for 1.5 hours at RT. The wells were washed 5 times with 0.05% Tween20 in 
PBS and subsequently incubated with the serum samples diluted 1:5 in 1.5% casein buffer 
in duplicate. After washing, wells were incubated with 100µl (2.5µg/ml) mouse 
 3 
76  
Seasonal differences in cytokine expression in the skin  
monoclonal anti-equine IgE-176 [21] for 1 hour at RT. Again the wells were washed 5 
times. Subsequently, wells were incubated for 1 hour at RT with 1:1000 goat anti-mouse 
IgG peroxidase conjugate (AbD Serotec, Düsseldorf, Germany) in casein buffer. After 
washing 5 times wells were incubated with 100µl high sensitivity tetramethylbenzidine 
(SDT, Baesweiler, Germany) for 10 min at RT. The reaction was stopped by adding 100µl 
of 1% HCL per well. Absorbance was measured with a SpectraMax M5 multi-mode 
microplate reader (Molecular Devices, Berkshire, UK) at a wavelength of 450nm 
corrected for the OD measured at 650nm.  
 
Histological examination of skin samples 
Paraffin-embedded biopsies were cut in 4 µm sections and stained with haematoxylin-
eosin (HE) for routine histopathology. A semi-quantitative grading system (0 = absent, 1 
= minimal, 2 = mild, 3 = moderate, 4 = severe) was used to assess the degree of epidermal 
(both hyperplasia and hyperkeratosis) and dermal (infiltration of both mononuclear cells 
and eosinophil’s) changes. The overall histological grade, defined as the sum of the grades 
for each of these parameters, was determined for each biopsy. All slides were analysed by 
the same European College of Veterinary Pathologists-certified pathologist, who was 
blind with regard to the group and time assignment of biopsies. 
 
Quantitative Real-time reverse transcription-polymerase chain reactions 
Frozen skin samples were disrupted and homogenized in TRIzol reagent (Invitrogen, 
Breda, NL) using a Biopulverizer (Biospec #59012N, Biospec Inc., Bartlesville, OK) and 
polytron (PT 1200 E, Kinematica AG, Lucerne, CH). TRIzol manufacturer’s instructions 
were followed until the water-phase was obtained after the chloroform step. Subsequently, 
total RNA was extracted using RNeasy columns (Qiagen, Venlo, NL) and eluted with 30 
µl of RNase free water. The RNA was quantified spectrophotometrically using a 
Nanodrop ND-1000 (Thermo Scientific, Etten-Leur, NL). One µg of total RNA was used 
to produce cDNA with an iScript cDNA Synthesis Kit (Bio-Rad laboratories, Veenendaal, 
NL) according to manufacturer’s instructions. A 5′ nuclease assay using TaqMan probes 
was employed for qRT-PCR amplification. Expression of the following genes was 
assessed: IL4, IL10, IL13, IFNγ, FoxP3 and CD3ζ . Reactions were performed in 25 µl 
 77 
Chapter 3 
volumes containing 5 µl cDNA, 12.5 µl TaqMan Universal PCR Mastermix (Applied 
Biosystems, Austin, TX, USA), 0.9 µM relevant primers and 0.25µM fluorescence-
labelled probes and milliQ. The qRT-PCR were performed in an iCycler (Bio-Rad 
laboratories, Veenendaal, NL) with amplification conditions of 2 min at 50 °C, 10 min at 
95 °C, followed by 45 cycles of 15 s at 95 °C and 1 min at 62, 60 or 57 °C (for details see 
Table 1). Each reaction was run in duplicate and a no-template control was included to 
exclude contamination of reagents with cDNA on every plate. PCR efficiencies were 
calculated using a relative standard curve derived from a cDNA pool of equine PBMC 
stimulated with pokeweed mitogen (Sigma–Aldrich, St. Louis, MO, USA) for 24h. 
Relative expression of IL4, IL10, IL13, IFNγ, FoxP3 and CD3ζ was calculated using the 
Pfaffl method [23] using the housekeeping gene 18s ribosomal RNA (18s rRNA) as a 
reference gene. To assess the role of T cells in IBH the ratios of IL4, IL10, IL13, IFNγ, 
FoxP3 with CD3ζ were determined.  
 
Statistical analyses 
Statistical analyses were carried using GraphPad Prism 4.00 (Graphpad Software, San 
Diego, CA). As our data were not normally distributed, correlation between C. obsoletus-
Gene cDNA 
(µl) 
Ta reference  Sequences (5’-3’) 
IL4 2.5 60 (Ainsworth et al., 
2003) 
  
IL10 5 60 Primers: (Swiderski et 
al., 1999) 
Probe: 6FAM-GGCTGAGAACCACGGCCCAG- 
MGBNFQ 
IL13 2.5 60 (Heimann et al., 2011)   
FoxP3 2.5 59 NM_001163272.1 Forward: CCAGCTATGATCAGCCTTCC 
Reverse: GAAGACCTTCTCGCATCCAG 
Probe: 6FAM-GCTGGCAAATGGCGTCTGCA- 
MGBNFQ 
IFNγ 2.5 60 Ec03468605_g1; Ap-
plied Biosytems 
  
CD3ζ 2.5 60 (Debrue et al., 2005)   
18S 0.25 60 4352930E; Applied   
Table 1: Primers and probes and the PCR conditions used for qRT-PCR 
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specific IgE levels and total LE skin histological scores was examined using a non-
parametric correlation (Spearman) test. The Mann–Whitney U test (+) was used to 
compare values from IBH-affected ponies with those from healthy controls. The non-
parametric paired Wilcoxon Signed-Rank Test (WSR Test) (*) was used for comparison 
of paired data (lesional/non-lesional and IBH season/off season). Results were considered 
significant at p ≤ 0.05. 
 
Results 
C. obsoletes-specific IgE levels 
C. obsoletus-specific IgE serum levels of ponies with IBH were significantly higher than 
those in control ponies in both seasons (P=0.0001 and P= 0.0002, respectively) (Figure 
1A). However, within each group there was no significant difference between the levels in 
the IBH season and off season (IBH vs. IBH P=0.2676 and Co vs. Co P=0.0537).  
 
Histopathology 
HE-stained sections of 14 control ponies (Co) and non-lesional skin (NL) of 16 IBH 
ponies, sampled off season, were examined by light microscopy according to the semi-
quantitative grading system. Since some of the ponies were sold during the summer and 
one died of an unrelated cause, 11 of the control and 15 IBH-affected ponies were 
available for examination during the IBH season. Control skin histology scores did not 
differ between the seasons, nor did control skin and NL skin (Tables 2 and 3). The 
average total histological score was significantly higher (P=0.0039) in LE skin compared 
to NL skin from the same ponies as well as compared to that of the control animals 
(P=0.0006) (Figure 1B and D). More specifically, LE skin had higher numbers of 
infiltrating mononuclear cells and eosinophil’s (Tables 2 and 3). In addition, acanthosis 
and hyperkeratosis were found only in LE skin.  
The total histological scores of LE skin of the IBH ponies did not correlate with their 
Culicoides-specific IgE values (P=0.4366) (Figure 1C).  
 
Cytokine expression levels in the skin 
The mRNA expression levels of CD3ζ, a marker for T cells, normalized against 18s 
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(CD3ζ/18s) were significantly increased in the IBH season in healthy control skin 
(P=0.0039) compared to off season; the same observation was made in NL skin of ponies 
with IBH (P=0.0001) (Figure 2). However, there was no difference between NL and LE 
Table 2: Off season semi-quantitative histological scores (average and range between brackets) 
from healthy ponies and ponies with IBH. 
  Healthy (n=14) Non-lesional (n = 16) 
Acanthosis 0 (0-0) 0 (0-1) 
Hyperkeratosis 0 (0-1) 0 (0-1) 
Upper dermis: lymphocytes 1 (1-2) 1 (1-2) 
Upper dermis: eosinophilic granulocytes 1 (1-2) 0 (0-1) 
Middle dermis: lymphocytes 1  (0-2) 1 (0-2) 
Middle dermis: eosinophilic granulocytes 0 (0-0) 0 (0-1) 
Deep dermis: lymphocytes 0 (0-0) 0 (0-0) 
Deep dermis: eosinophilic granulocytes 0 (0-0) 0 (0-0) 
Average total histological score 3 (2-5) 3 (1-5) 
0=absent, 1 = minimal, 2 = mild, 3 = moderate, 4 = severe  
  Healthy 
(n=11) 
Non-lesional  
(n = 15) 
Lesional  
(n = 10) 
Acanthosis 0 (0-0) 0 (0-1) 2 (1-2) 
Hyperkeratosis 0 (0-0) 0 (0-0) 1 (0-3) 
Upper dermis: lymphocytes 1 (1-2) 1 (1-2) 2 (1-4) 
Upper dermis: eosinophilic granulocytes 0 (0-1) 0 (0-1) 1 (0-3) 
Middle dermis: lymphocytes 1 (0-2) 1 (0-1) 2 (0-3) 
Middle dermis: eosinophilic granulo-
cytes 
0 (0-1) 0 (0-1) 1 (0-3) 
Deep dermis: lymphocytes 0 (0-1) 0 (0-1) 2 (0-3) 
Deep dermis: eosinophilic granulocytes 0 (0-1) 0 (0-1) 1 (0-2) 
Average total histological score 3 (1-6) 3 (1-6) 14 (2-18) 
0=absent, 1 = minimal, 2 = mild, 3 = moderate, 4 = severe    
Table 3: IBH season semi-quantitative histological scores (average and range between brackets) 
from healthy ponies and ponies with IBH. 
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skin in the IBH season or between Co and NL skin in the off season (Figure 2).  
The ratio IL4/CD3ζ, as determined by IL4/18s divided by its corresponding CD3ζ/18s 
value, both in control and affected ponies showed no difference between seasons (Figure 
3). There was also no difference between Co and NL skin in the off season and Co, NL 
Figure 1: C. obsoletus-specific IgE serum levels and histology in the off season and in the IBH 
season. IgE serum levels and histological scores of skin of 14 control and 16 IBH ponies (off sea-
son) and 11 control and 15 IBH ponies (IBH season) were examined. Histology scores of lesional 
skin of 9/15 IBH ponies were determined. (A) C. obsoletus-specific IgE serum levels as determined 
by ELISA assay. The bars represent the mean of all samples in the group. (B) Mean histological 
scores were determined according to a semi-quantitative grading system (0-4) for acanthosis, hyper-
keratosis, lymphocyte infiltration and eosinophilic granulocytes (C) C. obsoletus-specific IgE serum 
levels plotted against the lesional skin’s total histological sores (P=0.4366). (D) Representative 
examples of HE stained section of: a) Off season control skin with few perivascular mononuclear 
cells in the superficial dermis (average total histological grade 3). b) Off season non-lesional (NL) 
skin with mild perivascular inflammation (average total histological grade 3). c) IBH season control 
skin (Co) with minimal perivascular inflammation of the superficial dermis (average total histologi-
cal grade 3). d) IBH season non-lesional skin (NL) with mild perivascular inflammation (average 
total histological grade 3). e) IBH season non-lesional skin (NL) with pronounced dermal inflam-
mation and moderate numbers of eosinophil’s (arrow) (average total histological grade 14). Original 
magnification 400x. The bar corresponds to 50 µm.  
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and LE skin in the IBH season. When comparing only IL4/18s expression an increase was 
observed when comparing NL skin as well as control skin off season and during the IBH 
season (respectively P=0.004 and P=0.0273). In the IBH season no difference was found 
between healthy, NL and LE skin (Supplementary figure 1). IL13 mRNA expression off 
season was not detectable, whereas in the IBH season IL13/CD3ζ was lower in LE skin 
compared to healthy control skin (P=0.0239), but not compared to NL skin (Figure 4). 
The same results were obtained when only 18s was used for normalization 
(Supplementary figure 2).  
The IFNγ/CD3ζ analysis showed a significant increase when comparing Co off season and 
Co IBH season (P=0.002), NL off season versus NL IBH season (P=0.0002). However, 
there was no difference between Co and NL skin in the off season and Co, NL and LE 
Figure 2 (Left): Expression of CD3ζ mRNA, a T cell receptor marker. Off season 13 control and 14 
IBH ponies were used. In the IBH season 11 of the 13 control ponies were examined and all 14 IBH 
ponies were examined of which 13 had lesional skin 1 IBH ponies was added in the course of the 
experiment. The mRNA expression of CD3ζ was determined with qRT-PCR and normalized against 
the housekeeping gene 18s using the Pfaffl method [23]. The bars represent the mean of all samples 
in the group.  
Figure 3 (Right): Expression of IL4/CD3ζ mRNA, a Th 2 cytokine. The skin of 13 control and 13 
IBH ponies were used during off season. In the IBH season 11 of the 13 control ponies were exam-
ined and all 13 plus 2 extra IBH ponies were examined of which 13 had lesional skin. The mRNA 
expression of IL4 was determined with qRT-PCR and normalized against the housekeeping gene 
18s using the Pfaffl method [23] and subsequently divided by the CD3ζ/18s value of the same sam-
ple. The bars represent the mean of all samples in the group.  
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skin in the IBH season (Figure 5). The same results were observed when IFNγ/18s levels 
were compared (Supplementary figure 3).  
IL10/CD3ζ mRNA expression levels did not differ between off season and the IBH season 
(Figure 6). Moreover, there was no difference between Co and NL skin in the off season 
and Co, NL and LE skin in the IBH season. Analysis of IL10/18s shows a tendency for 
increased IL10 expression in the IBH season (Supplementary figure 4). 
Analysis of FoxP3/CD3ζ mRNA expression showed a significant down regulation 
between Co off season and Co skin in the IBH season (P=0.0078) (Figure 7). However, 
there was no difference between NL off season and NL skin in the IBH season. The same 
was observed for NL and LE skin in the IBH season. Finally, there was no difference in 
FoxP3 expression levels between on and off season normalized against only 18s. There 
Figure 4 (Left): Expression of IL13/CD3ζ mRNA, a Th 2 cytokine. The skin of 13 control and 13 
IBH ponies were used during off season. In the IBH season 11 of the 13 control ponies were exam-
ined and all 13 plus 2 extra IBH ponies were examined of which 13 had lesional skin. The mRNA 
expression of IL13 was determined with qRT-PCR and normalized against the housekeeping gene 
18s using the Pfaffl method [23] and subsequently divided by the CD3ζ/18s value of the same sam-
ple. The bars represent the mean of all samples in the group.  
Figure 5 (Right): Expression of IFNγ/CD3ζ mRNA, a Th 1 cytokine. The skin of 10 control and 13 
IBH ponies were used during off season. In the IBH season all 10 control ponies plus 1 extra were 
examined and all 13 plus 2 extra IBH ponies were examined of which 13 had lesional skin. The 
mRNA expression of IFNγ was determined with qRT-PCR and normalized against the housekeep-
ing gene 18s using the Pfaffl method [23] and subsequently divided by the CD3ζ/18s value of the 
same sample. The bars represent the mean of all samples in the group.  
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was also no difference between Co and NL skin in the off season and Co, NL and LE skin 
in the IBH season (Supplementary figure 5).  
 
Discussion 
IBH is an IgE-mediated, pruritic skin disorder caused primarily by Culicoides spp. 
Differences in cell types present in the skin and as a potential consequence in functional 
immunological aspects between IBH “on and off” season may be indicative for processes 
underlying the disease. In general, IBH is thought to be a Type-1 hypersensitivity with a 
potential Th2 skewed immune responsiveness  [17, 18].  
In the present study, we examined the skin-infiltrating cells by histopathological analysis 
as well as cytokine expression by PCR in the off and IBH season in the same pony to 
determine Th1 versus Th2 immune responsiveness. Additionally, specific IgE serum 
Figure 6 (Left): Expression of IL10/CD3ζ mRNA, an immune suppression cytokine. The skin of 11 
control and 7 IBH ponies were used during off season. In the IBH season all control ponies were 
examined and all 7 plus 6 extra IBH ponies were examined, all having lesional skin. The mRNA 
expression of IL10 was determined with qRT-PCR and normalized against the housekeeping gene 
18s using the Pfaffl method [23] and subsequently divided by the CD3ζ/18s value of the same sam-
ple. The bars represent the mean of all samples in that group.  
Figure 7 (Right): Expression of FoxP3/CD3ζ mRNA, a Treg cell marker. The skin of 11 control 
and 7 IBH ponies were used during off season. In the IBH season all control ponies were examined 
and all 7 plus 6 extra IBH ponies were examined, all having lesional skin. The mRNA expression of 
FoxP3 was determined with qRT-PCR and normalized against the housekeeping gene 18s using the 
Pfaffl method [23] and subsequently divided by the CD3ζ/18s value of the same sample. The bars 
represent the mean of all samples in the group.  
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levels were measured to determine correlation between allergen-specific IgE levels and 
the presence of histological manifestations.  
A study by Wagner et al. [7] provided the first direct evidence that IgE mediates classical 
Type-I hypersensitivity in horses and plays a major role in the pathogenesis of IBH. In 
addition, C. nubeculosus-specific IgE serum levels were found in IBH-affected horses 
[17]. Such a finding is comparable with the situation in other animals such as the dog, 
where significantly higher flea-specific IgE levels where found in cases of flea allergy 
dermatitis (FAD) than in healthy dogs [24, 25].  
The C. obsoletus WBE-specific IgE titres in IBH ponies are higher than those in the 
control ponies in the off season as well as in the IBH season, suggesting that in IBH there 
is a Th2 skewing of the immune system. There was no difference between the specific IgE 
serum titres off season and in the IBH season within each group. IgE titres being stable 
throughout the year indicate continuous production of IgE by plasma cells, which instead 
of memory B cells do not need to be reactivated to produce IgE.  
Next to clinical symptoms, there are currently two major tests to diagnose IBH in ponies 
and horses i) the intradermal skin test using WBE, ii) a Culicoides-specific serum IgE 
ELISA. The intradermal skin allergy test is based on degranulation of mast cells in vivo, 
causing tissue swelling, due to cross-linking of Culicoides-specific IgE by the allergen 
and the ELISA assay is based on the binding of Culicoides specific serum IgE to 
Culicoides extract coated plates. Since Culicoides-specific IgE is the most important 
factor in both these tests and IgE titres seem to stay stable between seasons it is likely that 
these tests can be done off season as well as in the IBH season.  
The higher histological scores for LE skin suggests a Th2 response of the immune system. 
There was however, no difference between healthy control skin and NL skin of IBH 
ponies in the IBH season. This might be explained by the fact that only mild clinical 
symptoms were found in all IBH ponies potentially due to the relatively cold IBH season, 
and consequently less active C. obsoletus midges than in an average season.  
Remarkably, there was no correlation between the allergen specific IgE titre and the total 
histological score of LE skin from the same pony. This indicates that levels of free serum 
IgE cannot be used as markers for the severity of IBH. An explanation for the discrepancy 
may be that circulating allergen-specific IgE levels do not reflect the amount of mast cell- 
or eosinophil-bound IgE, which more likely contributes to the inflammatory response. In 
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addition, Wagner et al. [7] suggest that IgG(T), which can also activate skin mast cells,  
may play a role in IBH. Also in dogs with FAD, flea-specific IgG levels are higher than in 
healthy dogs [24].  
To further assess our hypothesis that a mixed Th2/Th1-type immune status, off season, 
alters to a Th2-dominated immune response in the skin of IBH-affected ponies, hence 
local immune response parameters, skin mRNA expression levels of IL4, IL10, IL13, 
CD3ζ, FoxP3 and IFNγ were determined. 
The CD3ζ mRNA expression in skin of IBH-affected and control ponies was determined 
to assess differential T cells presence. A significant increase in T cells was observed in Co 
skin in the IBH season as compared to off season. The same was seen in NL skin. 
However, there was no significant difference between Co and NL skin in the off season, 
or in all types of skin in the IBH season, which suggests that the immune system in the 
skin is activated. This activation might be due to other seasonal factors such as bites of 
mosquitoes and warble flies. It might even be preferential to perform experiments during 
the off season to exclude additional effects from other insect bites, which might interfere 
with the assays.  
To address Th2 skewing of the immune response in IBH, we examined mRNA expression 
of the Th1 type cytokine IFNγ and of the Th2 type cytokines IL4 and IL13. These mRNA 
levels were subsequently assessed relative to the corresponding CD3ζ mRNA levels since 
these cytokines are mainly secreted by T cells. There was no difference between NL and 
LE skin in the IBH season in expression of IL4, which was increased in the IBH season in 
both controls and ponies with IBH when only normalised with 18s (Supplementary figure 
1). Correcting for the number of T cells (IL4/CD3ζ) abolished the significant increase of 
IL4 in Co and IBH skin (Figure 2). This indicates that the increase in IL4 mRNA 
expression is due to increased numbers of T cells, which is in line with the study of 
Heimann et al. [17] where difference in IL4/18s expression between healthy horses and 
horses with IBH were observed neither. Similar observations have been reported for 
example in healthy dogs and dogs with FAD [26]. The lack of altered IL4 expression by T 
cells and the general increase of IL4/18s suggests that other factors may contribute to the 
development of clinical manifestations.  
In the present study, a substantial expression of IL13 mRNA was observed during the 
IBH season suggesting again a general immune activation in all types of skin. In the IBH 
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season a significant lower expression of IL13/CD3ζ was observed in chronic lesional skin 
as compared to control skin. IL13 as a Th2 cytokine plays a role in the effector phase of 
allergic reactions [27]. Hence, IL13 mRNA levels are expected to increase in acute 
lesional skin as shown by [17], but maybe not in chronic lesional skin, which was 
confirmed by our results. A similar situation has been described for FAD dogs [26]. A 
down regulation of IL13 was observed  after in vitro stimulation of allergic skin exposed 
to fleas for 4 days with flea antigen [26] which is coherent with our observation in vivo. 
Hence, T cells do not seem to alter IL13 production in our study. However, we do need to 
take into account that chronic lesional skin was examined and that Heimann et al. (2011) 
[17] did find a significant increase in IL13 in more acute lesional skin indicating a Th2 
skewing of the immune response.  
Our study showed an overall significant elevation of IFNγ in the IBH season as compared 
to off season confirming a general activation of the immune system in the skin. Contrary 
to elevated IFNγ levels in human chronic AD lesions [28], there were no differences 
observed in IFNγ mRNA expression between control, non-lesional and chronic lesional 
skin of ponies in the IBH season (Figure 5), which is in line with earlier reports by 
Heimann et al. [17]. Our combined results indicated a mixed Th2/Th1 cytokine expression 
in both seasons, but at a higher level during the IBH season. 
In addition, to the Th1 and Th2 cytokines, Treg cells have been suggested to play a major 
role in allergies in humans [29]. We therefore decided to examine FoxP3 and IL10 mRNA 
expression. FoxP3 expression relative to that of CD3ζ only showed a significant decrease 
in healthy skin in IBH season compared to the off season. This suggests that there is a 
decrease of Treg cells in the skin of healthy ponies in the IBH season. This yet remains to 
be explained. There was no difference in FoxP3 expression between healthy and NL skin 
off season. Furthermore, there was no difference between healthy, NL and LE skin in the 
IBH season (Figure 7). When examining the FoxP3/18s data no significant differences 
could be found. This suggests that numbers of FoxP3 positive cells in the skin do not 
differ between healthy and IBH-affected ponies. This is in contrast with the study of 
Heimann et al. [17], which reported a significant decrease in FoxP3 in NL and LE skin 
compared to healthy skin suggesting a decrease in Tregs. The reason for these differences 
might be that they have omitted horses with low histological scores from further analysis. 
In line with our results a study by Hamza et al. [30] showed that the number of CD4+ 
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CD25+hi FoxP3+ T cells levels in PBMC of healthy horses was similar to that in IBH-
affected horses. In addition, when CD4+ CD25+ T cells were stimulated with C. 
nubeculosus extract, expression of FoxP3 was significantly higher in healthy controls 
compared to IBH-affected horses [30]. Our results do not address the reactivity of Treg 
cells in the skin of IBH-affected ponies compared to healthy ponies.  
There was no difference in IL10/CD3ζ between seasons. Moreover, there was also no 
difference between control, non-lesional and chronic lesional skin in the IBH season 
(Figure 6), which is similar to the observations of Heimann et al. [17]. Our current 
approach does not confirm a regulatory role for IL10, a longitudinal study may give more 
inside into the kinetics.   
In summary, our data of the same ponies in the off season versus the IBH season showed a 
general increase of CD3ζ expression in the IBH season. IL4/18s, IL13 and IFNγ levels 
were also higher in the IBH season compared to the off season. The increased level of C. 
obsoletus-specific IgE and numbers of cutaneous eosinophils, although not correlated in 
LE skin, both suggest a Th2 type reactivity of the immune system of IBH-affected ponies. 
However, based on the IL4, IL13 and IFNγ parameters the Th2/Th1 balance seems to be 
maintained. Moreover, the role of regulatory T cells (FoxP3 and IL10) could not be 
confirmed in the present study. These overall results suggest that the immune system in 
the skin for healthy and IBH-affected ponies is activated in the IBH season in general.  
Our data warrant a careful re-evaluation of studies describing the immune status of the 
skin, taking general seasonal influences in account. 
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Supplementary data 
 
 
 
 
 
 
 
Supplementary figure 1 (Left): Expression of 
IL4 mRNA, a Th2 cytokine. The skin of 13 control and 13 IBH ponies were used during off season. 
In the IBH season 11 of the 13 control ponies were examined and all 13 plus 2 extra IBH ponies 
were examined of which 13 had lesional skin. The mRNA expression of IL4 was determined with 
qRT-PCR and normalized against the housekeeping gene 18s using the Pfaffl method [23]. The bars 
represent the mean of all samples in the group.  
Supplementary figure 2 (Right): Expression of IL13 mRNA, a Th2 cytokine. The skin of 13 con-
trol and 13 IBH ponies were used during off season. In the IBH season 11 of the 13 control ponies 
were examined and all 13 plus 2 extra IBH ponies were examined of which 13 had lesional skin. 
The mRNA expression of IL13 was determined with qRT-PCR and normalized against the house-
keeping gene 18s using the Pfaffl method [23]. The bars represent the mean of all samples in the 
group. 
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Supplementary figure 5: Expression of FoxP3/CD3ζ mRNA, a Treg cell marker. The skin of 11 
control and 7 IBH ponies were used during off season. In the IBH season all control ponies were 
examined and all 7 plus 6 extra IBH ponies were examined, all having lesional skin. The mRNA 
expression of FoxP3 was determined with qRT-PCR and normalized against the housekeeping gene 
18s using the Pfaffl method [23]. The bars represent the mean of all samples in the group.  
Supplementary figure 3 (Left): Expression of IFNγ mRNA, a Th 1 cytokine. The skin of 10 con-
trol and 13 IBH ponies were used during off season. In the IBH season all 10 control ponies plus 1 
extra were examined and all 13 plus 2 extra IBH ponies were examined of which 13 had lesional 
skin. The mRNA expression of IFNγ was determined with qRT-PCR and normalized against the 
housekeeping gene 18s using the Pfaffl method [23]. The bars represent the mean of all samples in 
the group.  
Supplementary figure 4 (Right): Expression of IL10 mRNA, an immune suppression cytokine. 
The skin of 11 control and 7 IBH ponies were used during off season. In the IBH season all control 
ponies were examined and all 7 plus 6 extra IBH ponies were examined, all having lesional skin. 
The mRNA expression of IL10 was determined with qRT-PCR and normalized against the house-
keeping gene 18s using the Pfaffl method [23]. The bars represent the mean of all samples in the 
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Abstract 
Culicoides midges are vectors for numerous important viruses, including African horse 
sickness virus (AHSV) and bluetongue virus (BTV). Furthermore, they are the primary 
cause of Insect Bite Hypersensitivity (IBH), a skin allergy in horses. Only limited 
sequence data of Culicoides species is publicly available. In this study, a transcriptome 
database was constructed of female Culicoides Obsoletus complex insects.  
Approximately 91 million raw reads were generated by Illumina paired-end RNA 
sequencing technology. These reads were assembled de novo into 41,223 contigs using the 
assembler IDBA-UD. The estimated open reading frames (ORFs) were extracted from the 
contigs using QUAST, which resulted in 28,519 unique candidate genes. Contigs were 
compared with Nematocera proteome by BLAST-X searches and resulted in the highest 
number of matches with proteins from Aedes aegypti. Functional annotation using gene 
ontology (GO) resulted in similar distribution of the functions between Obsoletus complex 
and the top 4 matching species, indicating that Obsoletus complex transciptome is 
complete. In addition, contigs were compared with publically available transcriptome 
sequences of C. nubeculosus (salivary gland) and C. sonorensis (midgut and salivary 
gland). Only a quarter of salivary gland proteins of C. nubeculosus and C. sonorensis was 
found to match with contigs of Obsoletus complex insects. Thus, there appears to be a lot 
sequence differences between salivary proteins of the different Culicoides species. 
This is the first report of a transcriptome database for insect of the Obsoletus complex. 
This transcriptome provides a valuable tool for vector biology studies and identification of 
allergens relevant for IBH in horses. 
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Introduction 
Culicoides midges belong to the family Ceratopogonidae (Diptera) and comprise over 
1400 different species from which about 96 % are blood suckers feeding on mammals and 
birds. With only 1-3 mm in size they are among the world’s smallest haematophagous 
flies and can be found in almost all parts of the world with some exceptions like 
Antarctica, New Zealand and Iceland [1]. Culicoides midges are vectors for numerous 
important viruses affecting both domestic and wild animals, of which African horses 
sickness virus (AHSV) and bluetongue virus (BTV) are of most international and 
economical significance and therefore formally classified by the World Organisation for 
Animal Health (OIE) on the list of notifiable diseases [2]. Furthermore, a recently 
discovered animal virus emerging in Europe, named “Schmallenberg Virus (SBV)”, also 
appears to be transmitted by Culicoides insects [3]. Moreover, Culicoides insects can 
transmit protozoa and filarial worms affecting birds and mammals and are the primary 
cause of a skin allergy in horses,  known as Insect Bite Hypersensitivity (IBH) [4-6]. IBH 
is a serious welfare problem for affected horses and results in economic losses, because 
horses can become unsuitable for riding or showing purposes. Severely affected horses 
might even be euthanized [7]. 
Within the different Culicoides species, members of the Obsoletus complex (subgenus 
Avaritia Fox) are among the most important species associated with BTV in different 
parts of Europe [8-12]. Members of this complex are also suspected of being vector of 
AHSV and SBV [13, 14]. The Obsoletus complex comprises about 30 species in the 
Palearctic region [15]. In central and northern Europe the Obsoletus complex is composed 
of three species:  C. obsoletus, C. scoticus and C. chiopterus [16]. Females midges of the 
Obsoletus complex are morphologically very difficult to distinguish from each other. 
Furthermore, C. dewulfi is morphologically similar as the members of the Obsoletus 
complex, but was recently reported to be treated as a separate group [17].  Several PCR 
based methods have been described for the identification of species from the Obsoletus 
complex and C. dewulfi [16, 18, 19]. 
No genome of any Culicoides species, including members of the Obsoletus complex, is 
available in the Genbank database. However, salivary gland cDNA libraries of C. 
sonorensis and C. nubeculosus are available [20, 21]. These libraries have been useful for 
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the characterisation of allergens from these species relevant for IBH in horses [22, 23].  
However, C. sonorensis and C. nubeculosus are less relevant for IBH than C. obsoletus, at 
least in countries were C. obsoletus is the main species attracted to horses [24]. Genomic 
or transcriptome sequence data of Obsoletus complex Culicoides insects will provide a 
valuable source of information for research on IBH and on the transmission of important 
viruses, like BTV, AHSV and SBV. 
Next generation sequencing technologies, such as the the Roche 454 platform and 
Illumina platform resulting in short read sequences, have made it possible to gather large 
amount of sequence data of an organism at affordable costs [25]. The Roche 454 platform 
results in longer reads than Illumina platform and is therefore easier for de novo assembly, 
but is also much more expensive. Illumina sequencing is thus an interesting choice and 
has lately been successfully used for de novo transcriptome assembly of different 
organisms [26-28].  
The aim of this work was to sequence RNA from adult female Obsoletus complex insects, 
using Illumina paired-end sequencing and to assemble a reliable transcriptome database of 
these species. This database will be a valuable tool for gene expression analyses, gene 
discovery and for future genome projects of Obsoletus complex and other Culicoides 
species.  
Additionally we analysed salivary proteins and compared their similarity with the salivary 
proteins of C. sonorensis and C. nubeculosus. These salivary protein sequences will be 
valuable for the identification of candidate allergens relevant for IBH.  
 
Material and methods 
Collection of Obsoletus complex insects 
Female Culicoides insects of the Obsoletus complex were collected alive directly from a 
horse wearing a protective blanket in the east of the Netherlands using a pooter system as 
previously described [24]. About 5% was separated for morphologically determination 
and all were determined to be insects of the Obsoletus complex by an experienced 
entomologist.  Because C. dewulfi is hard to distinguish from insects of the Obsoletus 
complex, C. dewulfi is considered part of the Obsoletus complex in this paper. The 
remaining Culicoides insects were frozen alive at -80 °C until use.  
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RNA extraction 
RNA was isolated from the wild-caught female Obsoletus complex insects by 
homogenization in TRIzol® (Invitrogen, Paisley, UK) according to the instructions of the 
manufacturer. The concentration was measured on a spectrophotometer (Nanodrop 
Technologies) at OD260nm. The integrity of RNA was analysed by electrophoresis on a 1% 
agarose gel. Total RNA was stored at -80 °C until use.  
 
RNA sequencing and assembly 
RNA sequencing was performed at the Genome Analysis Facility of the Universitair 
Medical Center Groningen (UMCG), The Netherlands. The method used was deep 
sequencing RNA with the Illumina HiSeq2000, 2x100 bp paired-end technology. The 
RNA-sequence data were treated with IDBA-UD [29] for a de novo assembly without 
genome of reference. The quality of the assembly was evaluated by the ‘quality 
assessment tool for genome assemblies’ (QUAST) [30].  
 
Functional annotation of C. obsoletus transcriptome 
Contigs generated by the assembly were compared with Nematocera proteome by Blast-X 
search using NCBI Genome Workbench version 2.6.0. Protein sequences minimum 
alignment sequence of at least 75 amino acids  and identical for at least 40 % were 
considered as a significant match.  
From the alignment results, proteins were linked to Uniprot and each protein’s associated 
Gene Ontology (GO) terms were retrieved in order to observe the functional categories 
within the biological process, cellular component and molecular function. To gain more 
information about the completeness of the transcriptome, the functional annotated 
transcriptome of the Obsoletus complex was compared with the functional annotation of 
the genomes from the four best matching Nematocera species. 
 
Detection of other species sequences 
Because we performed the transcriptome assembly with whole female Obsoletus complex 
insects collected from the wild, there might be some unwanted transcribed sequences 
present. Therefore we performed BLAST-n alignment with our contigs over different 
organisms likely to be present. To perform this analysis, we retrieved gene sequences 
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from horse (Equus caballus) and viruses from the NCBI website (using respectively the 
taxonomy Ids :txid9796, txid10239). We also specifically looked for the presence of 
sequences from BTV, AHSV and SVBV. 
 
Relation of Obsoletus complex contigs with C. sonorensis and C. nubeculosus salivary 
proteins 
A possible relation between salivary proteins of C. nubeculosus and salivary and proteins 
of C. sonorensis with contigs within the Obsoletus complex transcriptome was analysed 
by inhouse programs. Sequences of at least 75 amino acid matching length and an identity 
of at least 40 % were considered a match.  
 
Results and discussion 
Illumina paired-end sequencing and de novo assembly 
A total of 91,462,723 raw reads were generated from the paired-end Illumina HiSeq2000 
sequencing. The assembler IDBA-UD was used for de novo assembly of the full dataset of 
short-read sequences of Obsoletus complex. A total of 41,223 contigs were assembled 
with a total length of 64,668,537 nucleotides. The maximum contig length was 15,641 bp 
(data not shown).   
The estimated open reading frames (ORFs) were extracted from the contigs using 
QUAST. This de novo assembly and ORFs estimation yielded 28,519 unique candidate 
genes of which more than 70 % had a length of >1000 bp (Figure 1). No genome or full 
transcriptome of any other Culicoides species is available to compare the number of 
candidate genes. As it has been estimated for Drosophila melanogaster that the overall 
transcriptome represents a coverage of nearly 75 % of the genome [31]. The whole 
assembly of the Obsoletus complex transcriptome counts 64,668,537 nucleotides. From 
this basis and considering that Obsoletus complex and D. melanogaster are close enough 
to be compared in that matter, we can assume that the genome size of Obsoletus complex 
insects is larger than 85 million nucleotides. On the other hand, the ORFs (representing 
candidate proteins) extracted from QUAST counts 27,952,064 nucleotides representing 
about half of the assembled transcriptome. 
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Detection of other species sequences 
The whole assembly of the Obsoletus complex transcriptome includes all mRNA present 
in the entire organism. Therefore we also checked for viral and horse sequences, because 
the insects might have sucked blood. However, the contribution of virus sequences in the 
obtained ORFs sequences were limited. With low filtering (≥ 80 % identity and ≥ 100 
nucleotides), only 581 genes were found to match virus gene sequences, representing 
2.2% of the transcriptome. Two ORFs were found to match one untranslated region 
(UTR) from the BTV, but no other significant alignments were found for AHSV and 
SBV. 
The presence of horse sequences is very low, as only 12 ORFs have been found 
significantly (95 % of identity and minimum size of 100 nucleotides) similar to 11 horse 
genes (data not shown). This suggests that most Obsoletus complex insects did not feed 
on the horses, which were protected by an anti-insect blanket, when they were caught. 
 
 
 4 Figure 1: Distribution of the candidate genes over their length. The y-axis refers to the length of the 
candidate genes (contigs) in kbp and the x-axis the percentage of candidate genes corresponding to 
that length.  
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Functional annotation of Obsoletus complex transcriptome 
Contigs generated by the assembly were compared with Nematocera proteome by Blast-X 
search using NCBI Genome Workbench version 2.6.0. The Nematocera proteome was 
retrieved directly from the NCBI website (using the taxonomy ID : txid7148).  
The top eight organisms having the highest number of identified proteins best matching 
with Obsoletus complex contigs are presented in Figure 2. The organism with most 
matching proteins was found to be Aedes aegypti, followed by three other mosquito 
species. A whole genome is available for these four organisms. For C. sonorensis only 
limited sequence data is publicly available and the number of matches therefore only 
account for a relatively small number of genes [20]. It is for this reason why C. sonorensis 
is not located at the first position in spite of its much closer phylogenetic relationship with 
insects from the Obsoletus complex than Aedes aegypti.  
The distribution of proteins to the GO terms indicates that Obsoletus complex 
transcriptome contains proteins from a diverse range of functional classes (Figure 3). 
The functional annotation of the four best matching Nematocera organisms was compared 
with the functional annotation of the transcriptome to evaluate the completeness of the 
transcriptome. The GO terms showed a similar distribution of the functions between 
Obsoletus complex and the top four  species (indicated by similar colour pattern, Figure 
4). Furthermore, no class is missing within the transcriptome which indicates that all 
Figure 2: Top eight organisms having the highest number of identified proteins matching with 
Obsoletus complex contigs.  
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Figure 3: Distribution of Gene Ontology (GO) for the Obsoletus complex transcriptome. Main 
functional categories in the biological molecular functions, cellular functions and biological process 
found in the transcriptome of the Obsoletus complex.    
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Figure 4: Functional annotation and divergence between the  C. obsoletus complex genes and 
genes from 4 other species of Nematocera.  The transcriptome of the Obsoletus complex and 
genes from the genome of 4 closely related species underwent functional annotation using Gene 
Ontology (GO). Colours indicate gene abundance per  GO term from white (high abundance) to red 
(low abundance).  
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functions are present in the transcriptome. 
 
Sequence comparisons of C. obsoletus with C. nubeculosus and C. sonorensis.  
We were interested in differences between sequences of Obsoletus complex insects, C. 
nubeculosus and C. sonorensis. Limited sequences are available for C. sonorensis (midgut 
and salivary gland) and C. nubeculosus (salivary gland) [20, 21]. These Culicoides 
species have all been reported to be associated with Insect Bite Hypersensitivity (IBH) in 
horses. IBH is an IgE mediated allergy and symptoms occur when mast cells in the skin 
degranulate due to the bite of a Culicoides insect. For degranulation of mast cells to occur, 
(salivary) proteins need to have at least two IgE binding epitopes to cause cross-linking of 
mast cell bound IgE. Horses in Europe are not (or hardly) exposed to C. nubeculosus and 
C. sonorensis, in contrast to C. obsoletus [32]. However, allergens from C. nubeculosus 
and C. sonorensis showing reactivity with horses in Europe have recently been identified, 
suggesting cross-reactivity between Culicoides species [22, 23]. Nevertheless, we 
previously reported much better in vitro reactivity by IBH affected horses with C. 
obsoletus compared to C. nubeculosus and C. sonorensis, suggesting low cross reactivity 
between these species [24].  
In this study, we were therefore interested in the amount of sequence similarity between 
these species to see if this might be an explanation for the low cross reactivity between 
these species. Contigs were compared with sequences from C. nubeculosus and C. 
sonorensis, publically available at NCBI using BLAST-x alignments. Proteins which 
showed more than 40% identity and are larger than 75 Amino acids were considered a 
match. Results are presented in a Venn diagram created in “R” [33] using the package 
‘VennDiagram’ [34] (Figure 5A).  
C. sonorensis has more publicly available sequences, including both whole midgut and 
salivary gland genes, whereas for C. nubeculosus only genes from salivary glands are 
available. Only about a quarter of the C. nubeculosus salivary gland proteins seem to have 
an identity of at least 40 % with candidate proteins from the Obsoletus complex 
transcriptome. The percentage of publically available proteins of C. sonorensis that match 
with candidate proteins from Obsoletus complex is higher, more than half of the proteins 
match.  
An explanation might be that non-salivary gland proteins, that are available for C. 
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sonorensis, but not for C. nubeculosus, contain more conserved proteins than the salivary 
gland proteins. This explanation is supported by Calvo et al. (2004) [35], who found that 
salivary proteins of Anopheles species are less conserved than the housekeeping proteins 
within the salivary glands, which suggests that salivary proteins are changing at a faster 
evolutionary rate. The non-salivary gland part of C. sonorensis probably contains more 
housekeeping genes. To enforce this assumption, we selected the salivary proteins from 
C. sonorensis. Proteins were considered salivary proteins if ‘salivary protein’ was part of 
the protein description. This resulted in sixty two proteins which were compared with 
Obsoletus complex  and C. nubeculosus sequences (Figure 5B).    
Only about a quarter of the salivary proteins of C. sonorensis was found to match 
Obsoletus complex contigs which is similar as with C. nubeculosus.  Thus, there appears 
to be a lot of sequence differences between salivary proteins of the different Culicoides 
species, by showing very low similarity. Low similarity was previously reported between 
genes coding for similar allergens of C. obsoletus and C. nubeculosus relevant for IBH in 
horses [36]. The presence of species shared-proteins, and consequently cross-reactivity of 
antibodies induced by salivary proteins is therefore likely to be low between the different 
Culicoides species. 
 
Conclusions 
Prior to this work, no transcriptome has been available for Obsoletus complex insects in 
public databases. The transcriptome described here provides a first and reliable tool for 
vector biology studies and identification of allergens relevant for Insect Bite 
Hypersensitivity in horses. 
 
 
 
 
 
 
 
  
Chapter 4 
 105
 4 
Figure 5: Venn diagram of three Culicoides species. The Obsoletus complex transcriptome  was 
compared with sequences from C. nubeculosus and C. sonorensis , publically available at NCBI , 
using BLAST-x alignments.  Aligned (sequence-based) protein sequences identical for at least 40% 
and a minimum alignment sequence of at least 75 amino acids are considered a match. A. 
Comparison with C. sonorensis salivary gland plus whole midgut. B. Comparison with salivary 
gland sequences of C. sonorensis 
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Abstract 
Insect bite hypersensitivity (IBH) is an IgE-mediated (Type I) hypersensitivity reaction 
induced by allergens from biting midges of the Culicoides spp. The aim of the present 
study was to identify, clone and express recombinant allergens from C. obsoletus, the 
main species found feeding on horses in the Netherlands, by sequence similarity searches 
on the C. obsoletus specific RNA database, with previously described allergens from C. 
nubeculosus and C. sonorensis. BLAST searches with these described allergens resulted 
in similarity hits with 7 genes coding for C. obsoletus allergens. These allergens were 
expressed as hexahistidine tagged recombinant proteins in E. coli. Allergens were termed 
Cul  o 1 – Cul o 7. A maltase (Cul o 1) plus Cul s 1 (maltase of C. sonorensis) were 
additionally expressed in insect cells using the baculovirus expression system to compare 
similar allergens from different species produced with different expression systems in 
diagnostic in vitro and in vivo tests. We demonstrate that IBH affected horses in the 
Netherlands show higher IgE levels to Cul o 1 than to Cul s 1, as determined by an IgE 
ELISA. Furthermore, we show that Cul o 1 produced in E. coli is at least as suitable for in 
vitro diagnosis of IBH affected horses as Cul o 1 produced in the baculovirus/insect cell 
expression system.  
The resulting proteins were evaluated for their ability to discriminate IBH affected and 
healthy horses by ELISA and intradermal testing. The frequency of positive test results by 
ELISA within IBH affected horses ranged from 38 % to 67 % for the different allergens. 
When results of IgE-binding to Cul o 1 – Cul o 7 were combined the test had a sensitivity 
of 92 % and specificity of 85 %. The capability of the allergens to induce Type I 
hypersensitivity reaction in IBH affected horses was demonstrated by an intradermal test.  
The results show that E. coli expressed recombinant allergens from C. obsoletus are 
valuable tools to determine the allergen specific sensitisation profile (component resolved 
diagnosis) in horses with IBH in countries were C. obsoletus is the most abundant species 
and may facilitate in the development of future immunotherapy.  
 
 
 
 
 
 111 
Chapter 5 
Introduction 
Insect bite hypersensitivity (IBH) is an IgE-mediated (Type I) hypersensitivity reaction 
found worldwide and is believed to be mainly induced by allergens from biting midges of 
the Culicoides spp., although other insect species, such as Simulium and Stomoxys spp. 
were also described to be of importance [1-4]. Although IBH is not life threatening, it 
causes a lot of discomfort to affected horses, due to the self-mutilation to alleviate the 
symptoms of pruritus.  
Current methods to prevent IBH include insect avoidance by stabling the horses during 
dusk and dawn when midges are most active, use of blankets to cover the horse, and 
insect repellents. Skin-related symptoms are sometimes suppressed by the use of topically 
applied corticosteroids. Some treatment options, like anti-histamines, dietary supplements 
and ointments are available on the market, but studies on horses using these treatments 
have shown inconsistent results [5-7].  
Immunotherapy could alleviate the symptoms for horses suffering from IBH and some 
trials have already been carried out with Culicoides whole body extracts, but with varying 
results [8, 9]. Anderson et al. [9], however did see a clear reduction of clinical signs in 
most and even a complete disappearance in some horses after immunotherapy with C. 
variipenis extract. The quantity of insects required to obtain these results though was very 
high, being more than 10.000 insects per horse. The use of purified allergens from 
Culicoides insects could simplify and improve future immunotherapeutic approaches.  
Several studies have shown that many proteins from Culicoides can bind IgE in IBH-
affected horses and are therefore potential allergens [10, 11]. 
Several allergens have now been identified and produced as recombinant proteins. These 
allergens were derived from the laboratory bred Culicoides species, C. sonorensis and C. 
nubeculosus [12-14].  
The first allergen associated with IBH was identified to be a 66 kDa maltase from C. 
sonorensis and was expressed as recombinant protein (Cul s 1) via the baculovirus 
expression system [14]. This recombinant protein was found to be highly allergenic in 
both in vivo and in vitro tests.  
Later, a gene encoding an antigen 5-like allergen was cloned, sequenced and expressed as 
recombinant protein. This was the first described allergen from C. nubeculosus and was 
therefore designated Cul n 1 [13]. In addition, using phage display technology, a set of 10 
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recombinant salivary gland allergens from C. nubeculosus was produced and named Cul n 
2 to Cul n 11. These allergens were recognized by IgE of 13 % to 56.5 % of IBH-affected 
horses, depending on the allergen [12].  
Although many Culicoides species have been described to be associated with IBH, 
apparently C. obsoletus is the most important species in the Netherlands in relation to 
IBH, as this is by far the most abundant Culicoides species found feeding on horses in this 
country [15]. Furthermore, a comparison for in vitro diagnosis of IBH using whole body 
extracts of C. sonorensis, C. nubeculosus and C. obsoletus, showed the importance of 
using C. obsoletus for sensitive and specific diagnostics for horses in the Netherlands. An 
ELISA with C. obsoletus WBE was developed with high sensitivity and specificity that 
can be used both with sera collected in the Culicoides active season as well as with sera 
collected in the off season [16, 17].  
C. obsoletus insects still need to be collected from the wild, because they are not available 
from laboratory bred colonies and are difficult to rear [18]. Therefore recombinant 
allergens would be an attractive alternative for whole body extracts for diagnostic assays.  
The aim of this study was to develop recombinant allergens from C. obsoletus that can be 
used to improve diagnosis and may be applied in immunotherapy for horses that are 
exposed to C. obsoletus. Furthermore, we compared the reactivity of recombinant maltase 
from C. obsoletus (Cul o 1) with that of C. sonorensis (Cul s 1) [14]. These allergens were 
expressed both in an E. coli as well as a baculovirus expression system, to evaluate 
whether these allergens are more allergenic when expressed in an eukaryotic system, due 
to possible post translational modifications. Additional C. obsoletus genes with sequence 
similarity to previous described allergens from C. nubeculosus were cloned and expressed 
as recombinant proteins in E.coli. These proteins were evaluated for their ability to 
discriminate IBH and healthy horses in vitro by ELISA and their ability to induce 
immediate and delayed type skin reactions in vivo.  
 
Material and methods 
Insects 
Wild C. obsoletus insects were collected in the Netherlands and whole body extracts 
(WBE) were prepared as previously described [16]. A small fraction (± 5%) of the insects 
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was checked under a stereo microscope and indeed only contained C. obsoletus. 
Identification of C. obsoletus was based on size and wing patterns [19]. 
 
Horses 
A total of 217 Shetland ponies and Icelandic horses located in different regions of The 
Netherlands were included in this study. Pairs of clinically confirmed IBH affected and 
healthy control horses kept at the same location were formed [20]. Seven IBH affected 
Icelandic horses that showed recurrent symptoms for at least several years and 7 healthy 
controls from the same pasture were selected for the intradermal test. The remaining 203 
horses (76 Icelandic horses and 127 Shetland ponies) were used to evaluate E. coli 
expressed Cul o 1 to Cul o 7 and Cul s 1 in a diagnostic ELISA.  
Blood samples were taken from all horses and serum was frozen in aliquots not later than 
24 hours after blood sampling and stored at -20 oC until use. The experimental procedures 
were approved by the Board on Animal Ethics and Experiments from Wageningen 
University. 
 
cDNA synthesis 
RNA was isolated from ± 200 wild-caught C. obsoletus insects by homogenization in 
TRIzol® (Invitrogen, Paisley, UK) according to the instructions of the manufacturer. The 
concentration was measured on a spectrophotometer (Nanodrop Technologies) at 
OD260nm. The integrity of RNA was analysed by electrophoresis on a 1% agarose gel. 
Total RNA was stored at -80 °C until use.  
Prior to cDNA synthesis, a DNase treatment was performed by mixing 2 µg RNA with 1 
µl 10x DNAse I Reaction buffer, DNAse I (1 U/µl) and DEPC-treated water up to a final 
volume of 10 µl. The mixture was incubated for 15 minutes at room temperature (RT), 
followed by the inactivation of DNAse I by adding 25 mM EDTA (Merck, Darmstadt, 
Germany) and heating for 10 minutes at 65 °C. Synthesis of cDNA was performed using 
the Superscript III First Strand Synthesis system (Invitrogen, Paisley, UK), according to 
manufacturer instructions. Briefly, 300 ng random primers (Invitrogen, Cat. no. 48190-
011, 300 ng/µl) and 10 mM dNTPs were added to the DNase I-treated RNA sample. The 
mixture was heated at 65 °C for 5 minutes and held on ice for a minimum of one minute. 
5x First strand buffer (Invitrogen), 0.1 M DTT (Invitrogen), RNase OUT Inhibitor 
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(Invitrogen, Cat. no. 10777-019, 40 U/µl), and SuperScript III (Invitrogen, 200 U/µl) was 
added to the mixture and incubated for 10 minutes at RT, followed by incubation for 50-
60 minutes at 50 °C. The reaction was terminated by heating at 70 °C for 15 minutes. 
 
Cloning of C. obsoletus cDNA’s encoding potential allergens 
cDNA of C. obsoletus was synthesized using random primers, modified and enriched for 
attachment to the Illumina flowcell (HiSeq2000, Illumina) at the Genome Analysis 
Facility of the Universitair Medisch Centrum Groningen (UMCG), The Netherlands. One 
100-cycle paired-end lane was sequenced. De novo  sequence assembly was done with 
Velvet (version 1.1.04) [21] using a coverage cut-off of 5 and a minimum contig length of 
200 yielding 26936 cDNA contigs (manuscript in preparation). The cDNA contigs were 
used as an input to create a C. obsoletus specific RNA blast database. A protein BLAST 
with the sequence coding for Cul s 1 was performed on this RNA database to find a 
similar gene for C. obsoletus and specific primers were designed.  
Meanwhile, new allergens from C. nubeculosus were identified [12, 13] and similarity 
searches with the sequences coding for these genes were performed as well using BLAST 
on the C. obsoletus RNA database. Six complete sequences coding for genes similar to, 
respectively, Cul n 1 (antigen 5 like protein), Cul n 2 (hyaluronidase), Cul n 4 (secreted 
salivary protein), Cul n 7 (unknown salivary protein), Cul n 9 (D7-related salivary protein) 
and Cul n 11 (trypsin) were found and specific primers for these allergens from C. 
obsoletus were designed. The primers are listed in Table 1, set 1. The 7 allergens were 
termed according to the recommendation of the allergen nomenclature sub-committee 
(www.allergen.org) and according to their MW; Cul o 1 (similarity to Cul s 1), Cul o 2 
(similarity to Cul n 2), Cul o 3 (similarity to Cul n 1), Cul o 4 (similarity to Cul n 11), Cul 
o 5 (similarity to Cul n 7), Cul o 6 (similarity to Cul n 9) and Cul o 7 (similarity to Cul n 
4). The recombinant proteins with their characteristics are listed in Table 2.   
Signal peptides for each allergen were predicted by submitting the sequences to SignalP 
4.0 server (http://www.cbs.dtu.dk/services/SignalP). To clone the C. obsoletus allergens in 
expression vectors, the sequence corresponding to the mature part of the allergens was 
amplified from C. obsoletus cDNA by nested PCR (for primers see Table 1) using KOD 
hot start DNA polymerase according to manufacturer’s instructions (Novagen, 
Nottingham, UK). The inner primer pairs contained additional restriction sites (Table 1, 
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 Cul o 1 
 
Set 1 
Fw 5’-GAAGAATGATAATTTTCAAAACATT-3’ 
Rv 5’-TTATTGTTCATATTGTCCGGGA-3’ 
Set 2 Fw 5’-CGCGGATCCCCTCAGGGAGCTCGTGAA-3’ 
Rv 5’-GCGCTCGAGTTATTGTTCATATTGTCCGGGATC-3’ 
  
 Cul o 2 
  
  
Set 1 
Fw 5’-TACACTTGTTGTGTGTTTCTG-3’ 
Rv 5’-CTCTACATCATAACATAGATAATAATG-3' 
Set 2 Fw 5’-CGCGGATCCCAACATCTGATTCAGGCAGA-3’ 
Rv 5’-GCGCTCGAGTACATCATAACATAGATAATAATG-3’ 
  
 Cul o 3 
  
  
Set 1 
Fw 5’-GAAAATGTTTCGTATTTGTTTATTTAC-3’ 
Rv 5’-TATTTGATGGCAAAACTCTGTT-3' 
Set 2 Fw 5’-CGCGGATCCACAGATTTTTGTGACCGAAAGC-3’ 
Rv 5’-GCGAAGCTTCCAATTACGGTAAAAATGGCA-3’ 
  
 Cul o 4 
 
  
Set 1 
Fw 5’-GCAATAATATCGGCTGTTTATGC-3’ 
Rv 5’-TTAGTTCATGTTTTGCGTTATCC-3’ 
Set 2 Fw 5’-CGCGGATCCGCTGATCATCAATCGC-3’ 
Rv 5’-GCGAAGCTTTTAGTTCATGTTTTGCG-3’ 
  
 Cul o 5 
 
  
Set 1 
Fw 5’-GCGTAATCTTAGGAGGAAT-3’ 
Rv 5’-TGAATAGATCATCATTTCT-3’ 
Set 2 Fw 5’-CGCGGATCCTTTGATTTAAGTGATG-3’ 
Rv 5’-GCGCTCGAGTCATCATTTCTTTATTT-3’ 
  
 Cul o 6 
  
Set 1 
Fw 5’-CCGTTACTTGCCGTTATTGG-3’ 
Rv 5’-TCATTATAGACCTTCGTCAAC-3' 
Set 2 Fw 5’-CGCGGATCCTCATTCGTTCCAAAGGAGAG-3’ 
Rv 5'-GCGAAGCTTTTATATTGTATTCGGTTTTCCATC-3’ 
  
 Cul o 7 
  
  
Set 1 
Fw 5’-GTTCTCCGTGTCTAAGCTATC-3’ 
Rv 5’-TTAATGAAGAGCTGCGAGTG-3’ 
Set 2 Fw 5’-CGCGGATCCTGCTCCTCAATGGCAAATAAG-3’ 
Rv 5’-GCGAAGCTTTTAATGAAGAGCTGCG-3’ 
Table 1: Primers used to amplify cDNA’s coding for allergens Cul o 1 - Cul o 7. Set 2 includes 
primers to amplify the mature part of the protein including restriction sites (underlined).  
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set 2) for cloning of the PCR products into the corresponding sites of the used expression 
vectors. For expression by E. coli the obtained PCR products were ligated into a pET15b 
(Novagen) derived vector, pET15bNew, restricted by BamHI and XhoI or HindIII, 
downstream of the sequence coding for a hexahistidine tag. The mature part of Cul s 1 
was ordered as a synthetic gene (Mr. Gene, Regensburg, Germany) codon optimized for 
E.coli expression and directly cloned between the BamHI- and HindIII-sites of 
pET15bNew. 
Searches for sequence similarity within the database were performed using the BLAST 
method (http://blast.ncbi.nlm.nih.gov/Blast.) Nucleotide sequences were translated using 
the BCM search launcher translation tool (http://searchlauncher.bcm.tmc.edu/seq-util/seq-
util.html) and aligned with Clustal W (http://www.ebi.ac.uk/Tools/clustalw2/index.html). 
The cloned cDNAs encoding for Cul s 1 or Cul o 1 including the N-terminal  
hexahistidine tag, were sub-cloned into pFB-HBM, a derivative of the pFastBac1vector 
(Invitrogen) downstream of a honey bee mellitin (HBM) signal sequence [22], kindly 
provided by Dr. P. Sondermeyer, MSD Animal Health, Boxmeer, NL, for subsequent 
expression in the baculovirus/insect cell expression system.  
 
Allergen Genbank 
Accession nr 
MW Sequence similarity to % aa identity 
Cul o 1 KC339671 66.8 Maltase (Cul s 1) 
AY 603565 
78 % 
Cul o 2 KC339672 42.3 Hyaluronidase (Cul n 2) 
HM 145950 
75 % 
Cul o 3 KC339673 27.9 Antigen 5 like protein (Cul n 1) 
EU 978899 
70 % 
Cul o 4 KC339674 27.1 Trypsin (Cul n 11) 
HM 145959 
51 % 
Cul o 5 KC339675 17.9 Unknown salivary protein (Cul n 7) 
HM 145955 
41 % 
Cul o 6 KC339676 15.2 D7-related salivary protein (Cul n 9) 
HM 145957 
40 % 
Cul o 7 KC339677 15.0 Secreted salivary protein (Cul n 4) 
HM 145952 
33 % 
Table 2: Characteristics of the C. obsoletus allergens.  
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E. coli expression and purification  
The isolated pET15bNew plasmids encoding the different Culicoides antigens were used 
to transform E. coli BL21_CodonPLus (DE3) (Agilent Technologies, Amsterdam, The 
Netherlands). Proteins were expressed similarly as described by van der Aa et al. (2010) 
[23].  
 
Baculovirus expression and purification of Cul o 1 and Cul s 1 
Recombinant Autographa californica nucelopolyedrovirus (AcMNPV) encoding Cul o 1 
and Cul s 1 with N-terminal hexahistidine tag were generated using the Bac-to-Bac system 
(Invitrogen). Briefly, the pFB-HBM recombinant plasmids containing either Cul o 1 or 
Cul s 1 cDNA were used to transform DH10ß competent cells containing an AcMNPV 
bacmid with a chitinase and cathepsin deletion [22] followed by isolation of the 
recombinant bacmid DNA. Screening of transposition-positive constructs was done by 
PCR with bacmid and gene specific primers. 
Preliminary experiments revealed that an optimal production was obtained with a 
multiplicity of infection (MOI) of 10 TCID50 units/cell 72 hours after infection. 
The recombinant bacmid DNAs were used to transfect Sf9 cells with CELL FECTIN 
reagent (Invitrogen) using standard protocols and the virus was harvested 72 h later, 
followed by amplification of the viral stock on Sf9 cells in suspension cultures with a cell 
density of 2 x 106 viable cells/ml in serum free medium (Sf-900 II SFM, Invitrogen) to 
produce working viral stocks without serum. The titre of the viral stocks was determined 
by an End-Point Dilution Assay using the Sf-9 Easy Titre cell line, encoding EGFP under 
control of the polyhedrin promoter [24]. Immediately after titre determination, Sf9 cells in 
suspension cultures (5 x 60 ml) were infected at a density of 2 x 106 cells/ml with a 
multiplicity of infection (MOI) of 10 50% Tissue Culture Infective Dose (TCID50) units/
cell. At 72 hours post infection, the cell suspensions were centrifuged at 1000g for 10 min 
at RT and supernatant and cells were collected. The cell-free supernatants were 
concentrated using Centricon Plus-70 centrifugal Filter Devices (Merck Millipore, 
Billerica, Massachusetts, US) and subsequently Cul o 1 and Cul s 1 were purified on 
Ni2+charged chelating sepharose (Fast Flow, GE Healthcare, Uppsala, Sweden) columns. 
Proteins were eluted with 500 mM imidazole and afterwards dialysed against PBS.  
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SDS-Page and Western blot analysis of recombinant proteins 
To confirm localization and to analyze the purification of the baculovirus expressed 
recombinant proteins, samples were analysed by SDS-PAGE (12.5 % gel) and 
immunoblotting. To analyze the purity of the recombinant proteins, dialyzed eluted 
fractions were loaded on a 12.5 % SDS-PAGE and the gel was stained with Pierce Silver 
Stain Kit (Pierce, Rockford, USA) for the baculovirus recombinant proteins or stained 
with Gelcode Blue Stain Reagent (Pierce) for the E. coli recombinant proteins. 
For immunoblotting, nitrocellulose membranes (Protran, Schleicher & Schuell Bioscience 
GmbH, Dassel, Germany) were blocked in 5% non-fat cow’s milk in Tris buffered saline 
(TBS)-Tween (10 mM Tris/HCL, pH 7.5, 150 mM NaCl, 0.05% (v/v) Tween-20) for 1 h 
at RT and then incubated for 1.5 hour with an anti-His6 tag specific monoclonal antibody 
that was earlier developed in house. Membranes were then incubated for 1 hour with goat 
anti-mouse IgG horseradish peroxidase (Dako, 1:1000 in milk powder/TBS-Tween). 
Between each incubation step, membranes were washed three times with TBS-Tween. 
Signal was detected by development with an enhanced chemiluminescence (ECL) western 
blotting detection reagent (GE Healthcare) according to the manufacturer's protocol and 
visualized by the use of Lumni-fil chemiluminescent Detection Film (Roche, Woerden, 
The Netherlands). 
 
ELISA 
Specific IgE serum levels against the recombinant C. obsoletus allergens (Cul o 1 to Cul o 
7) and Cul s 1 were determined in an indirect ELISA as previously described [16]. 
Briefly, wells (384 wells plates) were coated with 20 µl/well of 10 µg/ml of recombinant 
protein overnight at 4°C, followed by incubation with horse serum samples diluted 1:5 in 
a 1.5% casein buffer (SDT GmbH, Baesweiler, Germany). IgE binding was detected by 
mouse monoclonal anti-equine IgE-176 [25], followed by goat anti-mouse peroxidase 
conjugate (multispecies adsorbed, AbD Serotec, Oxford, UK). High sensitivity 
tetramethylbenzidine (SDT GmbH) was used as a substrate. The reaction was stopped 
with 1% HCL. Absorbance was measured with a multi-mode microplate reader 
(SpectraMax M5, Molecular Devices, Sunnyvale, US) at a wave length of 450 nm 
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corrected for 650 nm. For each allergen, sera of all the IBH affected and healthy horses 
were tested on the same 384-wells plate to avoid “between plate” OD value differences. 
Wells without horse serum, but all the other components showed background OD450nm 
values < 0.07.  
The cut-off for positive IgE-binding was set at the mean + 3 times the standard deviation 
of the OD450nm reading of the healthy horses. The OD450nm values of the healthy horses that 
were evidently positive (> 1.0, arbitrarily decided) were left out to determine this cut-off, 
but were taken into consideration to determine false positives. 
 
Intradermal test 
An intradermal test was performed on seven clinically confirmed IBH affected and seven 
healthy control Icelandic horses to test the capability of the Culicoides recombinant 
allergens to induce Type I (IgE mediated) hypersensitivity reactions. All horses were 
living under the same circumstances (bedding, feeding, pasture) for at least one year. The 
middle region of the neck of the horses was clipped. The injection sites were indicated 
with a permanent marker and were placed about 5 cm apart. One concentration (10 µg/ml) 
per recombinant allergen or C. obsoletus WBE were injected intradermal in a volume of 
0.1 ml [26]. Histamine phosphate was used as a positive control (10 mg/ml) for a positive 
wheal reaction and a phosphate buffer as a negative control (Artuvetrin, Artu Biologicals, 
Almere, The Netherlands). The wheal diameter was measured in millimeters at 30 min and 
1 h (immediate phase reaction) and 4 h and 24 h (late phase cell-mediated reaction).  
Skin reactions were considered positive when the absolute wheal diameter was larger than 
the highest wheal diameter provoked by the negative control at the same time point.  
 
Statistical analysis 
IBM SPSS statistics, version 19, software program was used for statistical analysis. The 
non-parametric Mann–Whitney U test was used to compare OD450nm values from IBH-
affected horses with those from healthy controls against Cul o 1 and Cul s 1 and to 
compare wheal diameters from IBH affected horses and healthy horses after the 
intradermal test. Results were considered significant at p ≤ 0.05.  
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Results 
Cloning of Cul o 1 cDNA 
A C. obsoletus specific RNA blast database was used to identify the gene encoding for 
maltase with the sequence encoding for the maltase of C. sonorensis (Cul s 1). Specific 
primers were designed and used to amplify the gene encoding for the maltase (Cul o 1).  
To detect a putative polymorphism in the gene encoding for Cul o 1 in a C. obsoletus 
population, ten independent PCRs were performed on the cDNA from a pool of 
Culicoides obsoletus insects. Three isoforms were found with only minor differences on 
the amino acid level. Alignment of the most detected Cul o 1 isoform with the published 
Cul s 1 maltase revealed an identity of 78 % on amino acid level (Supplementary figure 
1). 
 
E. coli expression and purification of Cul o 1 and Cul s 1  
Cul o 1 and Cul s 1, expressed in E. coli, were found to be in the insoluble fractions 
(inclusion bodies) and their molecular masses were in agreement with the expected size 
(69 kDa). After purification and refolding, a yield of 10.6 mg/L bacterial culture was 
obtained for Cul o 1 and 11.2 mg/L bacterial culture for Cul s 1. The proteins were found 
to be >95 % (Figure 1).  
Figure 1: Purification of E. coli expressed Cul s 1 and Cul o 1. M = marker, IB = solved inclusion 
bodies, FT = flow through (unbound proteins), E = refolded and dialysed eluted fraction. Proteins 
were separated by SDS-PAGE (12,5 % gel) and stained with Gelcode coomassie blue-stain.  
 121 
Chapter 5 
Baculovirus expression and purification of Cul o 1 and Cul s 1 
The Bac-to-Bac system was used for the production of recombinant Cul o 1 and Cul s 1 in 
a baculovirus expression system. Immunoblot analysis with an anti-6X His tag specific 
antibody showed that the recombinant Cul o 1 and Cul s 1 were mainly found in the cell-
free supernatant (Figure 2A). After purification, a substantial reduction of recombinant 
protein was observed in the flow through and bound proteins were recovered by elution 
with 500 mM imidazole (Figure 2B). Eluted Cul o 1 and Cul s 1 were found to be > 95% 
pure (Figure 2C). A yield of approximately 100 µg/109 cells was obtained for both Cul s 1 
and Cul o 1.  
 
Determination of IgE antibodies against E. coli expressed Cul o 1 and Cul s 1 
An initial IgE and IgG ELISA with 10 IBH affected and 10 healthy control horses with all 
three Cul o 1 isoforms did not show any clear differences in OD450nm values (data not 
shown). and therefore the isoform that was most abundant (isoform 3) was chosen as the 
antigen in further experiments. 
Sera of 103 IBH affected and 100 healthy horses were evaluated for IgE levels (OD450nm 
values) against Cul o 1 and Cul s 1 in an indirect ELISA. Test results were considered 
positive when above the cut-off level (mean + 3 times the standard deviation of IgE levels 
of healthy horses).  
Almost double the percentage of positive tested IBH affected horses was obtained with 
Cul o 1 (43 %) compared to Cul s 1 (22 %). A significant difference between the OD450nm 
values of IBH affected and healthy horses was observed for both Cul o 1 and Cul s 1 (p < 
0.001), however OD450nm values obtained with Cul o 1 for IBH affected horses were 
significantly higher compared to OD450nm values obtained with Cul s 1 (p < 0.001, Figure 
3).  
 
Determination of IgE antibodies against baculovirus expressed Cul o 1 and Cul s 1 
versus E. coli expressed Cul o 1 and Cul s 1 
To compare the IgE levels (OD450nm values) against baculovirus expressed Cul o 1 and Cul 
s 1 with IgE levels against E. coli expressed Cul o 1 and Cul s 1, an additional IgE ELISA 
was performed. Because of the low yield of baculovirus expressed Cul o 1 and Cul s 1, 
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Figure 2 a) Western blot analysis of cell-free supernatants (1) and cell lysates (2) of 72h post infec-
tion with recombinant baculovirus expressing Cul o1 or Cul s1. The presence of Cul o 1 (O) and 
Cul s 1 (S) was detected by an anti-[His]6 antibody, followed by horseradish peroxidase-labelled 
detection antibody. b) Western blot analysis of purified baculovirus expressed Cul o 1 and Cul s 1 
from the cell-free supernatants. S: Concentrated supernatant prior to purification; FT: flow-through 
(unbound proteins); E: Eluted fraction after dialysis. c) Silverstaining of purified baculovirus ex-
pressed Cul s 1 (S) and Cul o 1 (O)  
only a small number of horses could be tested by ELISA. These horses were selected to 
(a)
(b)
(c)
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belong to one of the following groups: Group A) Seven horses that were clinically IBH 
affected and previously tested positive in ELISA with WBE as well as with  E. coli Cul o 
1; Group B) Seven horses that were clinically IBH affected and previously tested positive 
in ELISA with WBE, but negative with E. coli Cul o 1; Group C) Ten horses that were 
clinically healthy and previously tested negative ELISA with WBE as well as with E. coli 
Cul o 1  (Figure 4).   
Horses from group A on average showed similar IgE levels (OD450nm values) against E. 
coli expressed Cul o 1 as against baculovirus expressed Cul o 1. However, IgE levels 
against baculovirus expressed Cul s 1 were higher compared to E. coli expressed Cul s 1. 
Figure 3: IgE levels presented as OD450 values against E. coli expressed Cul s 1 and Cul o 1 in sera 
diluted 1:5 of 103 IBH affected horses and 100 healthy control horses. Results are presented in box 
plots. The horizontal lines inside of the box is the median of the measurements. The horizontal lines 
crossing the box plots are the cut-off values determined by the mean OD450 values of the healthy 
horses + 3 x Standard deviation. The bottom and top of the box are the 25 th and 75th percentile, 
respectively. The end of the whiskers represent the minimum and maximum value. The dots repre-
sent the outliers. Lines connecting two box plots denote a statistically significant difference with the 
p value on top. The percentage of positive tested horses for each allergen is indicated on the top. 
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All horses in group A, except for 1 horse with Cul s 1, had a positive test result with both 
recombinant proteins regardless of the used expression system.  
Horses from group B that were previously tested positive on WBE but negative on E. coli 
expressed Cul o 1, on average had higher IgE levels against the baculovirus expressed Cul 
o 1 and Cul s 1 and the OD values of all these horses were above the cut-off level. 
However, clinically healthy horses (group C) showed similar IgE levels against these 
baculovirus expressed proteins. In contrast, IgE levels against the E.coli expressed 
proteins were not above the cut-off level, suggesting non-specific reaction with 
baculovirus expressed recombinant Cul o 1 and Cul s 1 (Figure 4).   
 
Amplification of Cul o 2 – Cul o 7 cDNA 
Six complete genes coding for  C. obsoletus allergens with sequence similarity to Cul n 1, 
Cul n 2, Cul n 4, Cul n 7, Cul n 9 and Cul n 11 [12, 13] were found in a C. obsoletus RNA 
database. Specific primers were designed and used to amplify these genes from C. 
obsoletus cDNA.   
Alignments of the allergens Cul o 2 – Cul o 7 with their similar C. nubeculosus allergens 
showed global similarity with amino acid identities ranging from 33 – 75 %, depending on 
the alignment (Supplementary figure 2-7). 
 
E. coli expression and purification of Cul o 2 – Cul o 7  
Cul o 2 – Cul o 7 were successfully expressed in E. coli. The recombinant proteins were 
found to be in the insoluble fractions and were dissolved, purified, refolded and dialysed 
(Figure 5A). All E. coli expressed proteins were found to be > 95 % pure (Figure 5B). The 
sizes of the proteins that were purified were in good agreement with the expected sizes 
based on the calculation from the amino acid sequences including the hexahistidine tag.   
 
Determination of IgE antibodies against E. coli expressed Cul o 2 – Cul o 7 
Sera of 103 IBH affected and 100 healthy horses were evaluated for IgE levels (OD450nm 
values) against E. coli expressed Cul o 2- Cul o 7. Test results were considered positive 
when above the cut-off level (i.e. mean + 3 times the standard deviation of IgE levels of 
healthy horses). The frequency of positive test results varied between the allergens, with 
Cul o 6 resulting in the lowest percentage of positive tested IBH affected horses (38 %)  
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Figure 4: IgE levels presented as OD450 values against Cul o 1 (upper graph) and Cul s 1 (lower 
graph) expressed in baculovirus or E. coli of A. Seven clinically IBH affected horses, tested posi-
tive with C. obsoletus WBE as well as for E. coli Cul o 1; B: Seven clinically IBH affected horses, 
tested positive with C. obsoletus WBE, but negative for E. coli Cul o 1 C. Ten clinically healthy 
horses, tested negative with C. obsoletus WBE as well as for E. coli Cul o 1.  The cut-off level is 
highlighted in light gray and determined by the mean OD450 values of the healthy horses + 3 x 
standard deviation. The triangles represent the individual values. The horizontal lines are the means 
of the IgE levels. 
and Cul o 5 the highest percentage of positive tested IBH affected horses (67 %). 
Percentages of positive tested clinically healthy horses were between 2 – 6%, depending 
on the allergen (Figure 6).  
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From the 103 IBH affected horses, 95 reacted with at least one of the E. coli recombinant 
allergens (Cul o 1 – Cul o 7) while 15 out of 100 healthy horses showed IgE reactivity, 
resulting in a test sensitivity of 92 % and specificity of 85 %. The eight horses that were 
(a)
(b)
Figure 5: a) Typical example of induction and purification of E. coli expressed protein (Cul o 2). 1: 
Uninduced protein; 2: Induced with IPTG; 3: soluble fraction; 4: insoluble fraction (inclusion bod-
ies); 5: solved inclusion bodies; 6: Flow through (unbound proteins); 7: refolded and dialysed eluted 
fraction. Proteins were separated by SDS-PAGE (12,5 % gel) and stained with Gelcode coomassie 
blue-stain. b) SDS-PAGE (12,5 % gel) and Gelcode coomassie blue-stain of the E. coli expressed 
proteins Cul o 2 t/m Cul o 7.  
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Figure 6: IgE levels presented as OD450 values against Cul o 2 – Cul o 7 in sera diluted 1:5 of 103 
IBH affected horses and 100 healthy control horses. Results are presented in box plots. The hori-
zontal lines inside of the box are the median of the measurements. The horizontal lines crossing the 
box plots are the cut-off values determined by the mean OD450 values of the healthy horses + three 
times the standard deviation (excluding OD values above 1.0). The bottom and top of the box are 
the 25th and 75th percentile, respectively. The ends of the whiskers represent the minimum and max-
imum value. The dots represent the outliers. The percentage of positive tested horses for each aller-
gen is indicated on the top. 
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tested negative with the allergens were also tested negative using WBE, except for one 
horse (results not shown) [16]).  
 
Intradermal test 
An intradermal test was performed on 7 IBH affected horses and 7 healthy horses to test 
whether recombinant allergens and C. obsoletus WBE were able to induce type I 
hypersensitivity (IgE mediated) immediate (0.5 h and 1 h) and late phase (4 h and 24 h) 
skin reactions in vivo.  
At 30 min post injection all horses showed a clearly visible wheal at the histamine 
injection site, which remained visible until 4 hours after injection (Table 3). After 24 
hours these wheals had disappeared. The wheal diameters induced by the histamine 
injection and the negative control (saline) did not differ significantly between IBH 
affected and healthy horses for any of the time points. The most noticeable skin reactions 
for WBE and allergens were observed after 1 h and 4 h (Table 3, Figure 7). All IBH 
affected horses showed positive skin reactions for WBE from time point 1 h onwards, 
while only 1 healthy horse reacted positive at 0.5 and 24 h and 2 healthy horses at 1 h and 
4 h. There was a significant difference between IBH affected and healthy horses for WBE 
at each time point (p < 0.01).  
For all allergens at least one IBH affected horse showed a positive type I hypersensitivity 
  IBH affected horses Healthy horses 
Injection Number of positives* Number of positives* 
  0.5 hr 1 hr 4 hr 24 hr   0.5 hr 1 hr 4 hr 24 hr 
Saline 0 0 0 0   0 0 0 0 
Histamine 7 7 7 0   7 7 7 0 
WBE 5 7 7 7   1 2 2 1 
Cul s 1 E.coli 1 3 2 1   0 0 0 0 
Cul o  1 E. coli 0 5 1 0   0 0 0 0 
Cul s 1 Baculo 2 4 4 1   0 0 2 1 
Cul o 1 Baculo 2 3 4 0   0 0 1 0 
Cul o 2 0 0 0 1   0 0 0 0 
Cul o 3 0 2 2 0   0 0 0 0 
Cul o 4 2 5 4 4   1 0 1 1 
Cul o 5 2 3 6 5   0 1 2 1 
Cul o 6 1 1 1 1   0 0 0 0 
Cul o 7 2 3 3 3   0 0 0 0 
Table 3: Results intradermal skin test of seven IBH affected horses and seven healthy control 
horses to C. obsoletus WBE and recombinant allergens.  
* Cut-off = highest wheal diameter provoked by saline 
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skin reaction, but for Cul o 2 this was only the case in the late phase (at 24 h) of the 
reaction (Table 3). The highest number of IBH affected horses with positive skin reactions 
was observed for the baculovirus expressed allergens and Cul o 4 and Cul o 5. For these 
allergens, positive skin reactions were also observed for 1 or 2 healthy horses at different 
time points.  
A significant difference between IBH affected and healthy horses was only observed with 
the wheal diameters provoked by Cul o 4 after 1 h. However, the means of the wheal 
diameters of the IBH affected horses were always larger than the ones of the healthy 
horses and for each allergen and WBE.  
There was no significant difference between the wheal diameters provoked by Cul o 1 
versus Cul s 1 for either the baculovirus or E. coli expressed variants. Although more 
horses were tested positive with the baculovirus expressed Cul o 1 or Cul s1 compared to 
E. coli expressed Cul o 1 or Cul s 1, there was no significant difference between the wheal 
diameters provoked by baculovirus versus E. coli produced proteins.   
Discussion 
In this study we report the identification and production of 7 C. obsoletus recombinant 
allergens that can be used to diagnose IBH with a sensitivity of 92 % and specificity of 85 
% when combining the results of each single allergen IgE ELISA. A maltase from C. 
sonorensis (Cul s 1) was the first allergen described to be associated with IBH [14], but C. 
sonorensis is not native in the Netherlands. To evaluate if the maltase from C. obsoletus 
(Cul o 1) is better for IBH diagnosis in the Netherlands than Cul s 1, both were expressed 
in E.coli as well as in a baculovirus/insect cell expression system.  Horses with IBH 
showed a higher average IgE-binding to E.coli produced Cul o 1 than to Cul s 1 and more 
IBH affected horses scored positive with Cul o 1 (43 %) than with Cul s 1 (22 %). These 
findings are in agreement with previously reported data, where ELISA with WBE of C. 
obsoletus resulted in better diagnosis than such an ELISA with WBE of C. sonorensis 
[16]. Some horses did show IgE-binding with Cul s 1, which is most likely due to cross-
reactivity between shared epitopes between Cul o 1 and Cul s 1, since the horses that were 
used in this study are unlikely to be exposed to the North-American C. sonorensis. 
Reactivity to Cul s 1 was also observed previously in a histamine release test and 
intradermal skin test using horses from Germany that most likely have not been exposed 
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to C. sonorensis [14]. The maltase from C. nubeculosus (Cul n 8) was used in a similar 
ELISA as described here by Schaffartzik et al. [12] and resulted in a positive test result for 
21.7 % of the IBH-affected horses, comparable to the reactivity that we found for Cul s 1, 
whereas we found over 40 % of our horses to be tested positive with Cul o 1. Although we 
tested different horses, it is likely that for these horses in Switzerland better results would 
be obtained with the maltase from C. obsoletus as it is also one of the most abundant 
species found in this country [27].  
To compare potential differences between the immunoreactivity between the maltase 
expressed in a prokaryotic system and the same maltase expressed in an eukaryotic 
system, we produced this allergen in both E. coli as well as a baculovirus expression 
system. The E. coli system has the advantage that it is easy to handle and often results in 
high expression levels of the recombinant protein. However proteins expressed in E. coli 
often accumulate in insoluble inclusion bodies, and therefore require chemical refolding 
procedures to obtain the protein in a native, biological active form [28, 29]. The 
baculovirus expression system is characterized by post-translational processing and 
therefore often results in the production of (glycosylated) biologically active soluble 
proteins [29].  
Baculovirus expression can display better IgE-binding to certain allergens compared to E. 
coli expressed allergens [30, 31]. However, some studies report no difference between E. 
coli and baculovirus expressed allergens in relation to their IgE-binding properties in vitro 
or skin prick reactivity in vivo in allergic individuals [32, 33] and an E. coli expressed 
allergen has shown to have similar immunological properties as its natural form [28]. This 
suggests that for some allergens glycosylation and correct folding obtained by an 
eukaryotic system might be important for biological activity, but for other allergens a 
prokaryotic system might be sufficient. Here, we report Cul o 1 and Cul s 1 expressed in 
E. coli to be at least as suitable in IgE-binding compared to the same allergens expressed 
in the baculovirus expression system in horses with IBH.  
The high background values within the healthy horses tested in ELISA with baculovirus 
expressed Cul o 1 and Cul s 1, compared to E. coli expressed proteins, might be due to 
antibodies to N-glycans present on the baculovirus expressed allergens. Insect cells 
produce structural different N-glycans than mammalian cells [34]. Horses are constantly 
exposed to different types of insects and therefore the presence of pre-existing antibodies 
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against insect produced N-glycans is not unlikely. This kind of antibody will not bind to 
the unglycosilated E. coli expressed allergens. Also non-specific binding to minor 
contaminations in the purified protein fraction can not be excluded, but the allergens 
seemed pure as shown by SDS-PAGE and silverstaining 
Because of the easy-handling of E. coli cells and the high expression of Cul o 1 and Cul s 
1 compared to the baculovirus expression system, 6 additional allergens from C. obsoletus 
were expressed solely in E. coli. These allergens were found based on similarity searches 
within the C. obsoletus RNA database using previously described allergens from C. 
nubeculosus [12, 13]. Similar genes of four described allergens from C. nubeculosus were 
not found in the RNA database. Either similar genes for these proteins are not present in 
the C. obsoletus specific RNA database or the database is not yet complete.  
Sequence analysis revealed different percentages of amino acid similarities between the 
individual cloned allergens and the allergens from C. nubeculosus or C. sonorensis [12-
14]. The highest similarity was found for maltase and lowest similarity with a secreted 
salivary protein (Cul n 4, 33 %). Even though Cul o 1 and Cul s 1 have a high amino acid 
identity (78 %), Cul o 1 clearly has a higher IgE reactivity with IBH affected horses 
compared to Cul s 1. We found lower sequence similarities for the allergens Cul o 2 – Cul 
o 7 with their similar C. nubeculosus allergen (33 – 75 %) and therefore the difference 
between reactivity with IgE for these allergens might even be higher when compared with 
their similar allergen derived from C. nubeculosus. We already previously reported C. 
obsoletus to have more IgE-binding proteins compared to C. nubeculosus and C. 
sonorensis as detected by western blot analysis in all tested IBH affected horses [16].  
The IgE-binding capacity of each allergen was determined by ELISA for both IBH 
affected as wells as healthy horses. IBH-affected horses that were tested positive ranged 
from 38 – 67 %, depending on the allergen. Although we tested different horses, we report 
higher percentages of positive tested horses with our C. obsoletus allergens, than was 
reported for the corresponding allergen from C. nubeculosus by [12, 13]. However, to be 
more conclusive about the cross-reactivity between these allergens, they should be tested 
together in the same ELISA for the same horses.  
When IgE-binding ELISA results to Cul o 1 to Cul o 7 are combined, a sensitivity of 92 % 
and a specificity of 85 % is obtained, which is close to the sensitivity and specificity 
obtained with the same ELISA using C. obsoletus WBE [16]. Horses that did not show 
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positive test results with any of the seven recombinant allergens, also did not show 
positive test results with WBE (data not shown). A possible explanation for the lack of 
reactivity, might be that these horses are sensitised to other specific allergens e.g. from 
other insects that were able to cause IBH but were not included in this study. Schaffartzik 
et al. [12] reported 11 allergens from C. nubeculosus, while we were able to express 7 
allergens based on similarity searches with these allergens. Cul n 3 and Cul n 5 were both 
reported to show IgE reactivity with a large percentage of horses [12] and therefore 
similar C. obsoletus allergens might exist that are crucial for diagnosis of some horses by 
ELISA. However we were not yet able to find complete genes coding for the proteins 
similar to Cul n 3 and Cul n 5 in the C. obsoletus RNA database and were therefore not 
able to clone and express these allergens.  
Thus, our findings show that serum IgE of IBH affected horses recognize the E. coli 
produced C. obsoletus allergens and can therefore be used as a diagnostic tool for IBH in 
horses where C. obsoletus is the most abundant species. However, to provide information 
about the capability of the recombinant allergens to induce a Type I hypersensitivity 
reaction (immediate  and late phase) in vivo, an intradermal test was performed. Type I 
skin reactions were observed for all allergens within IBH affected horses.   
Some healthy horse showed type I skin reactions with WBE, Cul o 4, Cul o 5 and the 
baculovirus expressed allergens. These horses might be asymptomatic cases of IBH. 
Indeed, type I hypersensitivity reactions after intradermal injection with Culicoides 
allergens are more often reported in healthy horses [12, 13, 26, 35]. Thus, horses might be 
sensitised to Culicoides allergens without showing clinical signs of IBH. On the whole, 
greater skin reaction in response to the recombinant allergens were observed for IBH 
affected horses compared to healthy horses. Interestingly, Type I skin reactions in IBH 
affected horses, provoked by WBE or individual allergens were stronger after 1 and 4 
hours than after 30 min. Other studies also reported greater wheals after 1 and 4 hours 
compared to 30 min after intradermal injections with Culicoides WBE [26, 36]. This 
suggests that the immediate reaction induced by degranulation of mast cells in horses 
provoked by allergens of Culicoides spp probably peaks after 30 min. Wheals measured at 
4 hour are more likely to be caused by the influx of other inflammatory cells, which 
contribute to the late phase of the response.  
In conclusion, the 7 recombinant allergens Cul o 1 – Cul o 7, expressed in E. coli, provide 
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essential tools to determine IgE-binding of horses to individual components of C. 
obsoletus and are capable to induce immediate and delayed skin reactions in horses in 
vivo. These allergens can be useful to determine the sensitisation profile (component 
resolved diagnosis) of horses and may contribute to the development of allergen-specific 
immunotherapy for individual horses suffering from IBH.  
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Supplementary data 
 
Supplementary figure 1: Alignment of Cul o 1 and Cul s 1 with an identity of 78 % on amino acid 
level. The amino acids highlighted in grey represent the predicted signal peptide. The underlined 
amino acids within the boxes represent the places of the polymorphisms of Cul o 1 of isoforms 1. 
Amino acids underlined: isoform 1 = A/S/E, isoform 2 = S/T/E, isoform 3 (A/T/D)  
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Supplementary figure 3: Alignment of Cul o 3 and Cul n 1 with an identity of 70 % on amino acid 
level. The amino acids highlighted in grey represent the predicted signal peptide.  
Supplementary figure 2: Alignment of Cul o 2 and Cul n 2 with an identity of 75 % on amino acid 
level. The amino acids highlighted in grey represent the predicted signal peptide. 
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Supplementary figure 4: Alignment of Cul o 4 and Cul n 11 with an identity of 51 % on amino 
acid level. The amino acids highlighted in grey represent the predicted signal peptide.  
Supplementary figure 6: Alignment of Cul o 6 and Cul n 9 with an identity of 40 % on amino acid 
level. The amino acids highlighted in grey represent the predicted signal peptide.  
Supplementary figure 5: Alignment of Cul o 5 and Cul n 7 with an identity of 41 % on amino 
acid level. The amino acids highlighted in grey represent the predicted signal peptide.  
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Supplementary figure 7: Alignment of Cul o 7 and Cul n 4 with an identity of 33 % on amino acid 
level. The amino acids highlighted in grey represent the predicted signal peptide.  
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Abstract 
Culicoides species of the Obsoletus complex belong to the most important species of 
midge involved in causing Insect Bite Hypersensitivity (IBH) in horses in The 
Netherlands. The aim of the current study was to evaluate seven different Obsoletus 
complex derived recombinant allergens (Cul o 1 – Cul o 7) and to compare these with 
Obsoletus complex whole body extract (WBE) in an IgE ELISA using sera of 194 
clinically-confirmed cases of IBH and 175 unaffected horses were assessed. The highest 
test accuracy was obtained with WBE, followed by Cul o 2, 3 and 5. Two ELISAs with a 
combination of recombinant allergens, combi-1 (Cul o 3, 5 and 7) and combi-2 (Cul o 1, 
2, 5 and 7) were additionally performed and both resulted in high test accuracies close to 
that obtained with WBE. Combi-1 resulted in the best sensitivity and specificity, both 
89%. Both combi-1 and combi-2 performed less well with samples collected in winter, but 
over 70% of the IBH affected horses could still be identified. In conclusion, a combination 
of three Obsoletus complex recombinant allergens (Cul o 3, 5 and 7) could potentially 
replace Obsoletus complex WBE in an IgE ELISA for diagnosis of IBH in horses. 
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Introduction 
Culicoides midges are the primary cause of a worldwide, seasonal recurrent skin allergy in 
horses, called Insect Bite Hypersensitivity [1]. The welfare of affected horses is 
compromised, as a result of severe itch which leads to rubbing, scratching and localized 
hair loss, with excoriations and sometimes secondary infection [2, 3]. Affected horses 
generally develop IgE antibodies against allergens from Culicoides species [4-6]. 
Culicoides obsoletus is often reported as the most abundant midge species attracted to 
horses in different countries [7-10]. Whole body extracts (WBE) of this particular species 
have been shown to be more immunoreactive in different in vitro diagnostic tests for IBH 
compared to WBE of other common non-native Culicoides species [11]. Based on this 
species WBE a diagnostic IgE ELISA with high sensitivity and specificity has been 
developed. 
C. obsoletus is often identified purely based on wing characteristics. C. obsoletus is part 
of the Obsoletus complex, which in central and northern Europe also includes C. scoticus 
and C. chiopterus [12]. C. dewulfi has also been considered a part of this group for a long 
time due to its morphologically similarity, but was recently described to belong to a 
different taxonomic group [13]. However, because female midges of all these species are 
morphologically very difficult to distinguish, these species are often referred as Obsoletus 
complex, when identification is based on morphology.  
Insect whole body extracts are complex mixtures containing many proteins and other 
molecules. Like other natural allergenic extract preparations, they can be contaminated 
with allergens from other sources and other unwanted components, like proteases which 
can interfere with allergenicity testing [14, 15]. Moreover, they are difficult to standardize 
and do not provide information about disease-eliciting allergen content. Additionally, 
Obsoletus complex insects still need to be collected from the wild, because so far they 
have not been successfully maintained in laboratory bred colonies [16]. For these reasons, 
defined recombinant allergens are an attractive alternative. Moreover, an individual’s IgE 
reactivity profile can be more precisely determined with recombinant allergens, thus 
allowing component resolved diagnostics (CRD). Subsequently, those allergens to which 
the patient carries specific IgE can be selected for tailor made specific immunotherapy 
[17].  
We previously identified and produced seven recombinant allergens from Obsoletus 
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complex that were cloned based on similarities to previously described allergens for C. 
nubeculosus and C. sonorensis [18-21]. We found a maltase of Obsoletus complex (Cul o 
1) to result in better in vitro diagnosis compared to its homolog from C. sonorensis, a 
species that horses were not exposed to, thus showing the importance to use the dominant 
Culicoides species that feeds on horses for diagnosis on allergen level as well.  
In this study we evaluated seven individual Obsoletus complex derived recombinant 
allergens with Obsoletus complex WBE in an IgE ELISA using sera of a large number of 
IBH affected and unaffected horses. Two combinations of several of these recombinant 
allergens were used to design an IgE ELISA with sensitivity and specificity comparable to 
the previously developed Obsoletus complex WBE ELISA.    
 
Material and methods 
Preparation of Obsoletus complex WBE and  allergens 
Culicoides insects from the Obsoletus complex were collected from the wild and WBE 
was prepared as previously described [11]. Copy DNA encoding 7 Obsoletus complex 
allergens (Cul o 1, 2, 3, 4, 5, 6 and 7, Genbank accession numbers KC339671-KC339677) 
were cloned and expressed in E. coli and the recombinant proteins were purified as 
previously described [18]. 
 
Horses and blood sampling 
A total of 194 IBH affected (105 Shetland ponies and 89 Icelandic horses) and 175 
healthy control (97 Shetland ponies and 78 Icelandic horses) horses were included in this 
study. Horses were selected by a strict protocol and according to a case-control design 
described in detail by [22, 23]. In a previous study 103 of the clinically confirmed IBH 
affected horses and 100 healthy control horses were already used to evaluate a diagnostic 
ELISA [11]. Fourteen clinically confirmed IBH affected Shetland ponies with mild IBH 
symptoms and 11 healthy control ponies were used to compare IgE ELISA results from 
serum collected in IBH season (August 2011) versus serum collected off season (March 
2011). The remaining 180 IBH affected horses that were used in this study to evaluate the 
IgE ELISA showed clinical symptoms (mild to severe), while the 164 healthy controls did 
not show any symptoms despite similar exposure to Culicoides spp. IBH affected horses 
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and healthy controls were matched on various factors as described by [22]. Most of the 
Icelandic horses were not imported, but born in The Netherlands (> 85%). Blood samples 
of these horses were collected in The Netherlands during autumn of 2009 and 2010. All 
serum samples were frozen in aliquots not later than 24 hours after blood sampling and 
stored at -20 oC until use. Blood sampling was approved by the Board on Animal Ethics 
and Experiments from Wageningen University. 
 
ELISA 
Specific IgE serum levels against WBE or recombinant Cul o 1 to Cul o 7 were 
determined in an indirect ELISA as previously described [18]. In short, Costar 384-wells 
plates were coated with 20 µl/well of 10 µg/ml Obsoletus complex WBE or recombinant 
allergen, except for Cul o 5, which was coated at 5 µg/ml. Two ELISAs with a 
combination of only a few allergens were also performed. Combi-1 containing allergens 
Cul o 3, Cul o 5 and Cul o 7, coated as a mix at concentrations of 2.5 µg/ml, 1.25 µg/ml 
and 2.5 µg/ml respectively for each of the allergens and combi-2, containing allergens Cul 
o 1, Cul o 2, Cul o 5 and Cul o 7, coated as a mix at concentrations of 2.5 µg/ml, 2.5 µg/
ml, 1.25 µg/ml and 2.5 µg/ml respectively for each of the allergens. After coating, wells 
were incubated with horse serum samples diluted 1:5 in a 1.5% casein buffer (SDT 
GmbH, Baesweiler, Germany). IgE binding was detected by mouse monoclonal anti-
equine IgE-176 [24], followed by goat anti-mouse peroxidase conjugate (multispecies 
adsorbed, AbD Serotec, Oxford, UK). High sensitivity tetramethylbenzidine (SDT 
GmbH) was used as a substrate. The reaction was stopped with 1% HCL. Absorbance was 
measured with a multi-mode microplate reader (SpectraMax M5, Molecular Devices, 
Sunnyvale, US) at a wave length of 450 nm corrected for 650 nm. For each ELISA, sera 
of all the IBH affected and healthy horses were tested on the same 384-wells plate to 
avoid “between plate” OD value differences. Optimal coating concentrations were 
determined prior to the experiment by titration. 
 
SDS-PAGE and Western blotting 
SDS-PAGE and western blotting were performed as previously described [11]. For WBE 
20 µg/protein/lane was loaded and recombinant allergens were pooled and 100 ng/
individual allergen/lane was loaded on a 15% SDS-PAGE gel. Separated proteins were 
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transferred to a nitrocellulose membrane (Protrans, Schleicher & Schuell, Bioscience 
GmbH) by means of electrophoresis. IgE binding was detected with a monoclonal 
antibody against horse IgE (αIgE-176) [24], followed by goat anti-mouse IgG horseradish 
peroxidase (Dako, 1:1000 in milk powder/TBS-Tween). 
 
Statistical analysis 
The Mann–Whitney U test was used to compare OD450nm values or log2 dilutions of the 
standard from IBH affected horses with those from healthy horses against WBE or 
allergens using IBM SPSS statistics, version 19. Results were considered significant at p ≤ 
0.05.  
The overall diagnostic performance of each ELISA (allergens and WBE) was determined 
from receiver-operating characteristic (ROC) curves [25], computed in IBM SPSS 
statistics, version 19. The cut-off value of each ELISA was set as the value that 
corresponds to a balanced optimal sensitivity and specificity.  
The predicted probability of IBH-status (IBH or healthy) for a certain OD450nm value 
expressed as log2 IgE titres was determined by logistic regression. The analysis was 
performed with the PROC LOGISTIC of SAS (SAS Inc, V9.2).   
 
Results 
IgE ELISAs with Obsoletus complex allergens 
ROC analysis was performed on the IgE ELISA data of all individual recombinant 
allergens and WBE of Obsoletus complex tested on 194 IBH affected and 175 healthy 
control Shetland ponies and Icelandic horses. The test accuracies (area under the curve 
(AUC), sensitivity, specificity) were obtained from the analysis and the cut-off values 
determined by these ROC curves (Table 1, Figure 1). The highest test accuracy based on 
the AUC was obtained for WBE, followed by Cul o 2 and Cul o 3. For all allergens and 
WBE, IBH affected horses had significantly higher OD450nm values than healthy horses 
(Figure 2, p < 0.001). The highest percentage of positive tested IBH affected horses based 
on the cut-off determined by the ROC curve, was obtained for WBE (86 %). Within 
individual allergens, Cul o 3 resulted in the highest percentage of positive tested IBH 
affected horses (85%) and with Cul o 1 the lowest percentage of IBH affected horses was 
tested positive (76%). The proportion of false positive tested horses within the healthy  
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control group ranged from 15-24% among the recombinant allergens.  
Nearly half (46%) of the IBH affected horses had positive test results with all seven 
allergens, followed by 21 % of these horses reacting to 6 allergens and 16 % to five 
allergens (Figure 3). Only 1% of IBH affected had no positive test results with any of the 
allergens. In contrast, most healthy horses (61%) had a negative test result with all of the 
allergens, followed by 21% of these horses reacting to 1 allergen and 11% to 2 allergens. 
Only 1 % of the healthy horses had positive test results with all 7 allergens.  
 
Western blot analysis 
Four IBH affected horses that were tested in the ELISAs showed high OD450nm values 
with WBE, but did not have IgE reactions with any of the 7 allergens or a relatively low 
OD450nm value for just one allergen, suggesting that other allergens present in the WBE are 
responsible for the high signal in this ELISA. Western blot analysis using Obsoletus 
complex WBE and a pool of all 7 recombinant allergens was performed on these horses to 
evaluate the presence of other allergens in the extract. Sera of all four horses showed IgE-
Figure 1: ROC curves of IgE ELISA against Obsoletus complex whole body extract (WBE) and 
recombinant allergens (Cul o 1 – Cul o 7) on sera samples of 180 insect bite hypersensitivity (IBH) 
affected and 164 healthy horses 
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Figure 2: IgE levels presented as OD450nm values against Obsoletus complex whole body extract 
(WBE) and 7 recombinant allergens (Cul o 1 – Cul o 7) from sera of 180 insect bite hypersensitivity 
(IBH) affected and 164 healthy horses. Individual values are presented as squares. The horizontal 
lines crossing each group of squares represent the median of the measurements. The dotted horizon-
tal lines crossing the two groups (IBH and healthy) within each ELISA represent the cut-off deter-
mined by the ROC curves. Lines connecting two groups denote a statistically significant difference 
with the p value indicated on top. The percentage of positive tested horses for each allergen or WBE 
is indicated on top of the figure. 
Figure 3: Percentages (y-axis) of insect bite hypersensitivity (IBH) affected and healthy horses and 
the number of different recombinant allergens to which they react (x-axis). IgE reactivity is defined 
as an OD450nm values in the IgE ELISAs above the cut-off levels as determined by the ROC curves 
(Fig. 1).  
 6 
152  
Evaluation of a diagnostic ELISA 
binding with a protein band of around 15 kDa in WBE and three of the horses also to a 
band of 20 kDa (Fig. 4). Two horses also showed IgE reactivity with some higher MW 
proteins present in the WBE and with Cul o 4 in the pool of recombinant allergens, based 
on its MW.  
 
IgEs ELISAs with combination of allergens 
The highest number of IBH affected horses could be discriminated from healthy horses 
with the allergens Cul o 2, Cul o 3 and Cul o 5. However, Cul o 2 and Cul o 3 showed an 
extensive overlap in positive tested horses. Therefore two additional ELISA’s were 
performed with a combination of either Cul o 2 with Cul o 5 and Cul o 7 (Combi-1) or 
Cul o 3 with Cul o 5, Cul o 7 and additionally Cul o 1 (Combi-2). Cul o 1 was included, 
because this allergen was found to result in increased number of positively tested IBH 
affected horses. 
A pool of equal volumes of sera of 17 IBH affected horses with previously determined 
high Culicoides allergen-specific IgE levels was used as a reference serum to generate a 
standard curve with 2x dilution steps, using a start dilution of 1:2.5 (serum:sample buffer). 
Figure 4: Western blot analysis of 4 IBH affected horses (1-4) using Obsoletus complex whole 
body extract (WBE, 20 µg) or a pool of all recombinant allergens (r allergens = Cul o 1 – Cul o 7, 
100 ng each) Proteins were separated on 15 % SDS-PAGE gels and transferred to nitrocellulose 
membranes. Binding of IgE from horse sera was detected with an anti-equine IgE mouse mAb and 
HRP goat anti-mouse IgG. The molecular weight marker (M) is indicated on the left in kDa. 
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For the combination ELISA’s the OD450nm values of tested samples were converted to the 
titer of the corresponding dilution of the reference serum, run on the sample ELISA plate, 
that resulted in the same OD450nm value. The highest reference serum dilution that still had 
an OD450 nm above the cut-off value (OD450 nm = 0.1, average of wells without serum 
incubation + 3 SD) was assigned a titer of 1. This was obtained at a 1280x dilution of the 
reference serum, which sets the titer of the undiluted reference serum at 1280. This 
reference serum can be used in future ELISAs to convert OD450nm values to IgE titers of 
the standard dilutions to avoid test result differences caused by environmental or other 
factors influencing ELISA results.  
A high test accuracy from the ROC curves was observed for both combi-1 (Cul o 3, 5, 7) 
and combi-2 (Cul o 1, 2, 5, 7), which came close to WBE, with slightly better results for 
combi-1 (Figure 5, Table 1). OD450nm values were expressed as log2 IgE titres obtained 
from the standard reference serum. IgE levels of IBH affected horses were significantly 
higher (i.e. corresponded to a lower dilution of the reference sera pool) than those of 
Figure 5: ROC curves of IgE ELISA against Obsoletus complex whole body extract (WBE) and a 
combination of recombinant allergens: combi-1 (Cul o 3, Cul o 5, Cul o 7) and combi-2 (Cul o 1, 
Cul o 2, Cul o5, Cul o 7) on sera samples of 180 insect bite hypersensitivity (IBH) affected and 164 
healthy horses.  
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healthy horses (Figure 6). The highest sensitivity and specificity (89 % and 89 %) was 
obtained with combi-1. 
 
IgE levels in summer versus winter samples 
For 14 IBH affected horses and 11 healthy horses sera samples of both IBH-season 
(August) and off season (March) were available. To test the applicability of the combi 
ELISAs to detect IBH in samples obtained in the off season, an additional ELISA was 
performed on sera of these horses. WBE was included as a positive control, because we 
previously reported no significant difference between OD450nm values in serum obtained in 
off season compared to IBH-season [26]. A significant decrease in the IgE titer was 
Figure 6: IgE levels presented as log2 IgE titers the standard (a pool of 17 insect bite hypersensitivi-
ty (IBH) affected horses), against a combination of recombinant allergens: combi-1 (Cul o 3, Cul o 
5 and Cul o 7) and combi-2 (Cul o 1, Cul o 2, Cul o 5 and Cul o 7) from sera of 180 IBH affected 
and 164 healthy horses. Individual values are presented as squares. The horizontal lines crossing 
each group of squares represent the median of the measurements. The dotted horizontal lines cross-
ing the two groups (IBH and healthy) within each ELISA represent the cut-off determined by the 
ROC curves. Lines connecting two groups denote a statistically significant difference with the p 
value indicated on top. The percentage of positive tested horses for each ELISA is indicated on top 
of the figure. 
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observed with off season sera from IBH affected horses for both combi-1 and combi-2 
ELISA, but not for WBE (Figure 7). Although a significant decrease was observed for the  
whole IBH affected group, for some horses there was only a small decrease in the IgE titer 
observed during off season. Horses showing a clear decrease in IgE titer for combi-1, also 
showed this for combi-2. For WBE, some horses showed an increase in the IgE titer 
during the off season. Although not significant, an overall small decrease in the average of 
the off season samples was observed for healthy horses as well.  
 
Predicted probability of IBH-status related to IgE titers of combi-1 ELISA 
Because best results were obtained with combi-1 ELISA, logistic regression was 
performed to predict the probability of the IBH-status (i.e. IBH affected or healthy) in 
Figure 7: IgE levels presented as log2 IgE titers of the standard (a pool of 17 insect bite hypersensi-
tivity (IBH) affected horses) against Obsoletus complex whole body extracts (WBE) and combina-
tions of recombinant allergens: combi-1 (Cul o 3, Cul o 5 and Cul o 7); combi-2 (Cul o 1, Cul o 2, 
Cul o 5 and Cul o 7) from sera collected during IBH season and off season of 14 IBH affected and 
11 healthy horses. The horizontal lines crossing each group of squares represent the median of the 
measurements. The dotted horizontal lines crossing the four groups (IBH and healthy for both IBH 
season and off season) within each ELISA represent the cut-offs determined by ROC curves. Lines 
connecting two squares denote the measurements of the same horse. Lines connecting two groups 
denote a statistically significant difference with the p value indicated on top. The percentage of 
positive tested horses for each allergen or WBE is indicated on top of the figure. 
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relation to IgE titres of combi-1. Figure 8 shows the predicted probabilities of both IBH-
outcomes related to log2 IgE titres. With values corresponding to a log2 IgE titre of 
approximately 5.0 or higher the probability of being IBH affected is 90-100 %, whereas 
values corresponding to a log2 IgE titre of approximately 1.8 or lower the probability of 
being healthy is 80 – 90 %. At the inflection point at a log2 IgE titre of approximately 3 
the probability of being IBH affected or healthy is equal.   
 
Discussion 
Insect Bite Hypersensitvity is an IgE mediated allergic skin disease in horses caused by 
the bites of Culicoides species [27]. We previously reported a Culicoides species from the 
Obsoletus complex to be a particular important species to be used for reliable diagnosis of 
IBH in countries where this is the main species found feeding on horses [11].  
Although we previously described an IgE ELISA with high sensitivity and specificity 
using Obsoletus complex WBE, to date there is no such test available using recombinant 
allergens. The use of recombinant allergens would provide an attractive alternative for 
WBE, because with these recombinant allergens insects do not need to be collected from 
the wild. Moreover, they are easy to standardize and testing on the individual recombinant 
allergens will enable component-resolved diagnosis of IBH in horses and tailor-made 
Figure 8: Estimated probability to be IBH affected or healthy in relation to the log2 IgE titer against 
combi-1 (Cul o 3, Cul o 5, Cul o 7). Determined by logistic regression analysis of the obtained ELI-
SA data. 
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immunotherapy. In this study we evaluated the IgE reactivity to WBE, 7 individual 
Obsoletus complex recombinant allergens and a combination of few allergens in an IgE 
ELISA for the diagnosis of IBH in horses.   
We found the sensitivity and specificity of the WBE IgE ELISA to be somewhat lower 
than previously reported [11]. The same horses were included in this study, but additional 
horses, selected by the same criteria, were included as well. More healthy horses of this 
additional group were found to be sensitised against allergens. Furthermore, more 
clinically confirmed IBH affected horses of the additional group showed lower IgE levels, 
below the cut-off value, against WBE. However, most of these IBH affected horses did 
show IgE reactivity with one or more of the single allergens, which suggest that clinical 
symptoms of these horses are caused by IBH and not some other skin condition. The 
positive tested healthy horses used in this study did not show clinical symptoms, but some 
of these horses did have clear IgE reactivity against several recombinant allergens as well 
as against WBE. The IgE ELISA described in this study only detects the binding capacity 
to IgE and does not determine whether the allergens can cause cross-linking of FceR1 
bound IgE antibodies on basophils and mast cells, which is necessary for symptoms to 
occur. Furthermore, horses have been reported before to be sensitised to Culicoides 
allergens without showing clinical symptoms [28]. Why these animals do not develop 
clinical allergy despite their sensitisation is still unknown, but regulatory immune 
mechanisms might play a role in suppressing the immune reactions, as regulatory T cells 
have shown to suppress mast cell activation in mice [29] and there is evidence that 
suggests that healthy horses have a higher number of regulatory T cells compared to IBH 
affected horses [30, 31].  
A combination of only three allergens, combi-1 (Cul o 3, Cul o 5 and Cul o 7), resulted in 
a sensitivity and specificity (89% and 89%) slightly higher than that obtained with WBE. 
The corresponding probability curve can be used for individual tested horses to determine 
for a certain titer the probability that the tested horse has IBH.  
Interestingly, nearly 90% of IBH affected horses showed a positive test result with four or 
more recombinant allergens, whereas only 11% of healthy horses did, suggesting that a 
larger number of IgE reactive allergens implies a higher chance of truly having IBH. IBH 
affected horses that did not have IgE reactivity with one of the allergens, but did have IgE 
reactivity with WBE, specifically reacted with proteins of 15 and 20 kDa. A protein of 20 
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kDa was already previously indicated to be an important IgE-binding protein in IBH 
affected horses [11]. The identity of these additional putative allergens is currently under 
investigation.  
We compared IgE levels of sera obtained in the IBH season with those of sera from the 
same horses during the off season. As was previously observed with the WBE IgE ELISA 
[26], again there was no significant difference between these “in-season” and “off season” 
sera. Individuals with hay-fever have also been reported to have high titers of pollen-
specific IgE in the serum even out of season [32]. However when we performed the 
ELISA with a combination of three or four allergens, we did find a significant decrease of 
IgE reactivity during off season, although this decrease was not consistent for all horses. 
A decrease in the test sensitivity during off season was also observed in a histamine 
release test performed by [33].  
In comparison to for instance humans, horses have high levels of IgE [34]. The 
discrepancy between the WBE and the recombinant IgE ELISAs may be due to different 
amounts of coated allergens. The total protein concentrations used for the WBE and 
combi-1 ELISAs were 10 ug/ml and 6.25 ug/ml, respectively. However, in the case of the 
combi-1 ELISA this consisted all of (recombinant) allergens. In contrast, only a small 
fraction of all the proteins in the WBE will actually consists of allergens, which have to 
compete with all the other proteins in the WBE for binding to the well. Therefore, in 
comparison to the recombinant allergens ELISAs, only a small amount of each individual 
allergen will become coated in the WBE ELISA. A drop in IgE titer in the off season may 
therefore not be directly reflected in a drop the OD450 value in the WBE ELISA, because 
the specific IgE might still be in excess of the amount of coated allergen. Coating with 
recombinant allergens can result in a drop of the OD450 value, because allergen-specific 
IgE in serum is much less likely to be present in excess of  much higher amounts of coated 
allergens. Nevertheless, we were still able to detect high IgE reactivity off season in most 
IBH affected horses, even with recombinant allergens and therefore it seems that the 
production of IgE is maintained even in the absence of Culicoides insects or that IgE in 
horses has a long half-life. Serum levels of healthy horses also seemed to decrease during 
off season. Therefore, a lower cut-off level for the IgE ELISA may be more appropriate 
for testing samples collected in the winter season.  
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Conclusions 
A combination of 3 recombinant Obsoletus complex allergens (Cul o 3, 5 and 7) in a 
single IgE ELISA is able to diagnose IBH with a high sensitivity and specificity. The 
individual allergens Cul o 1 – Cul o 7 can be used to develop tailor-made immunotherapy 
as most of the IBH affected horses show sensitivity with at least one of these allergens.  
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Abstract 
Insect bite hypersensitivity (IBH) is a common allergic disease in horses caused by bites 
of Culicoides spp. In The Netherlands, Culicoides obsoletus is the most important species 
involved in IBH. The aim of this study was to identify and quantify the association 
between several factors and IgE levels (OD450nm values) against C. obsoletus whole body 
extract and 7 recombinant allergens. Data from 143 Icelandic horses and 177 Shetland 
ponies were analyzed using multivariable models. Also, the relation between IgE levels 
and severity of symptoms of IBH affected horses was examined. Positive correlations 
(0.06 – 0.44) were found between C. obsoletus specific IgE levels and severity of 
symptoms. IBH status (case or control), breed and the interaction between status and 
breed were significantly associated with log transformed IgE levels against several C. 
obsoletus allergens. Cases had significantly higher IgE levels compared to controls. 
Differences in IgE levels between cases and controls were largest in Icelandic horses. 
Shetland pony controls had significantly higher IgE levels compared to Icelandic horse 
controls, while differences in IgE levels between Shetland pony cases and Icelandic horse 
cases were not significant. Other factors associated with IgE levels were age, month of 
scoring, interaction between IBH status and month of scoring and degree of itchiness. In 
conclusion, severity of symptoms and IgE levels in IBH affected horses against several C. 
obsoletus allergens appeared to be related. Incorporation of the factors associated with C. 
obsoletus specific IgE levels in horses may further improve the interpretation and 
accuracy of IgE ELISA test results.  
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Introduction 
Insect bite hypersensitivity (IBH) is a common allergic disease observed in many horse 
breeds worldwide and is mainly caused by bites of Culicoides spp. Prevalence varied 
greatly, from 7.5% in Shetland ponies to 18.2% in Friesian horses in The Netherlands [1]. 
Insect bite hypersensitivity is accompanied with a severe itch, which results in self-
inflicted trauma. Common clinical symptoms are hair loss, bald spots, thickening of the 
skin, crusting, scaling, and sometimes open wounds and secondary infections [2]. At 
present, fully effective measures to prevent or cure IBH are unavailable [3]. Welfare and 
economic value of affected horses is reduced due to discomfort and disfiguration and 
severely affected horses sometimes need to be euthanized [4, 5].  
So far, diagnosis of IBH is based on observation of clinical symptoms combined with the 
typical seasonality and recurrence of symptoms in subsequent years. Reduced itch after 
elimination of exposure to Culicoides spp. (e.g. stabling, anti-insect blanket) confirms the 
diagnosis, while other conditions causing itch need to be ruled out [6]. In vivo and in vitro 
test results like release of specific allergic mediators [7, 8], wheal size in intradermal 
testing [9, 10] Culicoides spp. specific IgE or IgG determined by ELISA [9, 11] can 
contribute to the accuracy of IBH diagnosis. We recently reported the characteristics of an 
IgE ELISA to discriminate healthy horses from IBH affected horses using C. obsoletus 
whole body extract (WBE) with a sensitivity of 93.2% and specificity of 90.0% [11]. 
Additionally, 7 recombinant allergens of C. obsoletus were identified and produced as 
recombinant proteins and tested for their usefulness to diagnose IBH by ELISA as a 
replacement for WBE [12, 13].  
Various factors might affect in vivo and in vitro test results. For instance, Baselgia et al. 
[7] found a significantly higher sulphidoleukotriene release in IBH affected geldings 
compared to affected mares. In the same study it was reported that during time of 
exposure the proportion of positive test results in IBH affected horses (97%) was 
significantly higher compared to half a year after exposure (74%). However, effects of 
factors on diagnostic test results often are not determined and accounted for. Knowledge 
of these factors might further improve the interpretation of the IgE ELISA test results and 
thereby the differentiation of cases from controls. The aim of our research was to identify 
and quantify factors associated with serum IgE levels against C. obsoletus WBE and 
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recombinant allergens determined by ELISA, in Shetland ponies and Icelandic horses in 
The Netherlands.  
 
Materials and methods 
Study design and data collection 
Both Shetland ponies and Icelandic horses in The Netherlands were selected according to 
a case-control design described in detail by Schurink et al. [14, 15]. In short, cases and 
controls were matched on various factors and selected following a strict protocol to 
increase phenotype reliability (i.e. true healthy or IBH affected). 
Cases were defined as horses with IBH clinical symptoms, whereas controls were free of 
symptoms (despite exposure to Culicoides spp.). An inquiry (for details see [15]) was 
conducted to gain knowledge about history and management of IBH. Clinical symptoms 
were scored by an experienced veterinarian using a score sheet. Severity of hair loss, 
hyperkeratosis, scaling, crusting, excoriation, open wounds and secondary infections on 
the crest, base of the tail, hindquarters, abdomen, shoulder, neck and head was separately 
graded in four categories from mild (category 1) to profound (category 4). The most 
severe symptom on any location was defined as the severity score for IBH clinical 
symptoms of a horse. Blood was collected by jugular venipuncture and allowed to cloth. 
Serum was frozen not later than 24 h after collection and was stored in eppendorf tubes at 
-20 °C until use. Blood sample collection was approved by the Board on Animal Ethics 
and Experiments from Wageningen University (experiments 2009055 and 2010109). 
Data included observations on 143 Icelandic horses and 177 Shetland ponies (Table 1). 
Cases and controls were successfully matched on various factors (Table 1). 
 
Preparation of C. obsoletus whole body extract and recombinant allergens 
Culicoides spp. were aspirated from a horse wearing an anti-insect blanket using a pooter. 
Random samples of the aspirated Culicoides spp. were identified to be C. obsoletus based 
on wing pattern. WBE was prepared as previously described by van der Meide et al. 
(2012) [11]. Seven C. obsoletus allergens (Cul o 1 – Cul o 7, GenBank accession numbers 
KC339671 – KC339677) were recently identified by similarity searches with sequences 
coding for C. nubeculosus and C. sonorensis allergens [16-18] on a C. obsoletus specific 
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transcriptome database and produced as recombinant proteins [12]. 
 
C. obsoletus specific IgE levels 
IgE levels – expressed as OD450nm values – against WBE and recombinant allergens Cul o 
1 through Cul o 7 (single allergens or a combination of allergens; Combi-1 contained Cul 
o 3, 5 and 7, and Combi-2 contained Cul o 1, 2, 5 and 7) were determined by ELISA as 
previously described by van der Meide et al. [11, 13].  
 
Statistical analysis 
Log transformation. IgE levels against C. obsoletus allergens were log transformed 
(referred to as e.g. ln_WBE), as preliminary analysis showed presence of heterogeneous 
variance and deviations from a normal distribution. 
  Icelandic horses   Shetland ponies 
Variable Case Control Total   Case Control Total 
Number 72 71 143   91 86 177 
Sex               
Female 50 42 92   91 86 177 
Male 22 29 51   - - - 
Mean age, yr. (SD) 13.2 (6.0) 12.4 (5.8) 12.8 (5.9)   7.2 (4.5) 8.0 (4.3) 7.6 (4.4) 
Coat colour               
Black 16 11 27   48 45 93 
Bay 13 9 22   3 5 8 
Chestnut 8 14 22   19 22 41 
Other 35 37 72   21 14 35 
Pedigree               
Number of sires 57 60 95   76 77 118 
Year of collection               
2009 - - -   71 67 138 
2010 72 71 143   20 19 39 
Month of collection               
September 21 29 50   45 46 91 
Octobera 51 42 93   46 40 86 
Table 1: Data description. 
a In total 7 Shetland ponies were scored in the first week of November, but grouped with the ponies 
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Breed differences in severity of symptoms. Ordinal logistic regression (LOGISTIC 
procedure SAS® 9.2; SAS Institute Inc. Cary, NC) was used to test whether severity score 
differed between breeds. 
Correlation between IgE levels and severity of symptoms. To test whether severity of IBH 
clinical symptoms of cases was associated with their IgE levels, Spearman correlation 
coefficients were calculated (within breed) between severity score and log transformed 
IgE levels (CORR procedure SAS® 9.2; SAS Institute Inc. Cary, NC). Also, correlations 
among IgE levels against various C. obsoletus specific allergens were calculated. 
Quantification of factors associated with IgE levels. A general linear model (GLM 
procedure SAS® 9.2; SAS Institute Inc., Cary, NC) was used for the analysis of factors 
associated with log transformed IgE levels. Horses from different breeds might respond 
differently to specific C. obsoletus allergens. To investigate this, the factors breed, IBH 
status (case or control) and their interaction were tested for an association with all C. 
obsoletus allergens using data from both Shetland ponies and Icelandic horses 
simultaneously. Identification and quantification of other factors associated with IgE 
levels in a multivariable breed-specific model was performed only on the most promising 
allergens: WBE, Combi-1 and Cul o 2. WBE was included because it contains a mixture 
of all proteins and is therefore likely to contain most or even all relevant allergens 
associated with IBH. Combi-1 resulted in the best sensitivity and specificity obtained with 
a mixture of recombinant allergens (van der Meide et al., unpublished data) and was 
therefore chosen as an alternative for WBE to be included in this study. Finally, Cul o 2 
was one of the best single recombinant allergens to discriminate a large number of cases 
from controls [13]. The factors that were tested for an association with ln_WBE, 
ln_Combi-1 and ln_Culo2 were IBH status, month and year of scoring, age (both linear 
and 2nd order polynomial), coat color, withers height category (mini, small, middle, tall) 
and inbreeding coefficient for Shetland ponies. For Icelandic horses, IBH status, month of 
scoring, age, coat color, import from Iceland and sex were used as independent variables. 
Factors with P <0.25 in a univariable model were further analyzed in a multivariable 
model. For this, a backward elimination procedure was followed by deleting the least 
significant factor. Confounding was considered present in case of a change in β-
coefficient estimate of another factor greater than 25% or a change greater than 0.1 when 
values of estimated β-coefficients were between -0.4 and 0.4. Two-way interactions 
 171 
Chapter 7 
between all factors were tested. 
Not all owners answered all inquiry questions. The available information per case varied, 
while the number of cases with complete information was limited (n = 23 Icelandic horses 
and 65 Shetland ponies). Analysis of inquiry information using a multivariable model 
would decrease power. Answers to inquiry questions were therefore tested separately as 
independent variables in breed-specific univariable models using IBH cases only. Factors 
that were tested for an association with C. obsoletus specific IgE levels were degree of 
itchiness, application of anti-insect blanket, age at start of IBH, number of seasons 
affected, month in which symptoms appear and month in which symptoms regress. 
 
Results 
Descriptive statistics C. obsoletus specific IgE levels and severity of symptoms  
Mean and standard deviation of untransformed IgE levels against C. obsoletus allergens 
are presented in Table 2. Mean IgE level against C. obsoletus allergens showed large 
variations between breeds and also between cases and controls (Table 2). 
In Shetland ponies, more severe symptoms were observed compared to Icelandic horses 
(Table 2). Ordinal logistic regression showed that Shetland ponies had a 1.9 times higher 
probability (95% confidence interval: 1.1 – 3.4 with P = 0.03) to have more severe clinical 
symptoms compared to Icelandic horses (data not shown). 
 
Correlation between IgE levels and severity of symptoms 
In Shetland ponies, correlations between severity of IBH clinical symptoms and log 
transformed C. obsoletus specific IgE levels ranged from 0.16 to 0.44; in Icelandic horses 
correlations ranged from 0.06 to 0.39 (Table 3). In Shetland ponies, correlations between 
severity of symptoms and IgE levels were significantly larger than 0 (more severe 
symptoms, more IgE), except for Cul o 1. However, in Icelandic horses, correlations were 
only significantly positive for Cul o 1, Cul o 7, Combi-1 and Combi-2. 
Correlations among IgE levels against various C. obsoletus specific allergens were 
moderate to high and highly significant (P <0.0001), ranging from 0.61 to 0.97 in 
Icelandic horses and from 0.42 to 0.98 in Shetland ponies (data not shown). However, 
individual differences in response to the various C. obsoletus specific allergens were  
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observed (data not shown), which reflect differences between horses in sensitization 
against allergens. 
 
Factors associated with C. obsoletus specific IgE levels 
IgE levels (mean of both cases and controls) were higher in Shetland ponies compared to 
Icelandic horses for all investigated allergens except Cul o 7 (Table 4). The difference in 
IgE levels between Shetland ponies and Icelandic horses was significant for Cul o 2, Cul o 
4 to 7 and Combi-2 (Table 4). Differences in IgE levels between cases and controls 
against all allergens were highly significant across and within breeds (Table 4). The 
interaction between breed and IBH status was significant for WBE, Cul o 1, 2 and 5. 
These interactions were due to Shetland pony controls having significantly higher IgE 
levels compared to Icelandic horse controls (Table 4), while differences in IgE levels 
between cases of both breeds were not significant. 
  Severity of symptoms 
Traita Icelandic horses Shetland ponies 
ln_WBE 0.06ns 0.31* 
ln_Culo1 0.30* 0.16ns 
ln_Culo2 0.15ns 0.44** 
ln_Culo3 0.18ns 0.41** 
ln_Culo4 0.19ns 0.30* 
ln_Culo5 0.19ns 0.41** 
ln_Culo6 0.14ns 0.30* 
ln_Culo7 0.39* 0.24* 
ln_Combi-1 0.33* 0.30* 
ln_Combi-2 0.39* 0.34* 
Table 3: Spearman correlation coefficients between severity of IBH clinical symptoms and log 
transformed IgE levels against several allergens within breed.  
a Severity of IBH clinical symptoms was defined as the most severe symptom on any location, grad-
ed 1 – 4. Log transformed IgE levels (expressed as OD450nm values) against C. obsoletus whole body 
extract (WBE), Cul o 1 – Cul o 7, a combination of recombinant allergens (Combi-1) containing Cul 
o 3, 5 and 7 and a combination of recombinant allergens (Combi-2) containing Cul o 1, 2, 5 and 7. 
ns P >0.05 
* 0.0001≤ P <0.05  
**P<0.0001 
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Several other factors were tested in breed-specific models for a potential association with  
IgE levels against WBE, Cul o 2 and Combi-1 only (Table 5). In Shetland ponies, 
significantly decreased IgE levels against Cul o 2 were found with age until 15 years-of-
age, as indicated by a positive coefficient for the quadratic term (Table 5). The difference 
between cases and controls regarding IgE levels against Combi-1 was larger in September 
(1.17) compared to October (0.89) (Table 5). In Icelandic horses, IgE levels against WBE 
significantly increased with age and IgE levels against Cul o 2 were significantly higher in 
October compared to September (Table 5). In cases, IgE levels against WBE and Cul o 2 
were significantly higher in October compared to September, whereas differences in IgE 
  Shetland ponies   Icelandic horses 
Factor WBE Cul o 2 Combi-1   WBE Cul o 2 Combi-1 
IBH status <0.0001 <0.0001 <0.0001   <0.0001 <0.0001 <0.0001 
 Case 0.67 0.93 1.26   0.75 0.74 1.20 
Control 0.19 0.28 0.23   0.15 0.17 0.18 
Month of scoring ns ns 0.597   0.241 0.017 ns 
September     0.53   0.31 0.31   
October     0.56   0.35 0.42   
IBH status ×  
month of scoring 
ns ns 0.041   0.031 0.004 ns 
Case September     1.37   0.62b 0.53b   
Case October     1.16   0.89c 1.04c   
Control September     0.20   0.15d 0.18d   
Control October     0.27   0.14d 0.17d   
Age ns 0.007, 
0.041 
ns   0.016 ns ns 
Linear term   -0.0397     0.0029     
Quadratic term   0.0014           
R2 0.55 0.48 0.58   0.70 0.60 0.68 
Table 5:  LS-means and significance (P-value, italicized) of several factors for IgE levels against 
WBE, Cul o 2 and Combi-1 in Icelandic horses and Shetland poniesa  
a Analyses are based on log transformed IgE levels, but LS-means were transformed back to OD450nm 
values for interpretation purposes. LS-mean IgE levels against C. obsoletus whole body extract 
(WBE), Cul o 2 and a combination of recombinant allergens (Combi-1) containing Cul o 3, 5 and 7. 
b, c, d Values with different superscripts differ significantly (P <0.10). 
ns = not significant, several non-significant factors (month of scoring) are presented, as the interac-
tion between IBH status and month of scoring proved to be significant.  
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levels between months in controls were small and not significant (Table 5). Confounding 
of factors was not observed. Coefficients of determination were higher in Icelandic horses 
compared to Shetland ponies (Table 5). 
Answers to inquiry questions were tested for their association with IgE levels against 
WBE, Cul o 2 and Combi-1 in breed-specific univariable models using IBH cases only. In 
Shetland ponies, degree of itchiness was positively associated with IgE levels against Cul 
o 2 (P = 0.018). No such association was present with IgE levels against Combi-1, while 
the association with IgE levels against WBE showed a P-value of 0.082. In Icelandic 
horses, degree of itchiness was not associated with IgE levels. Shetland pony cases with 
anti-insect blanket (n = 23) tended to have higher IgE levels compared to Shetland pony 
cases without anti-insect blanket (P = 0.13 for WBE and P = 0.11 for Combi-1). In 
Icelandic horses, no significant effect of anti-insect blanket was present, 52 out of 60 
cases did wear a blanket. Number of seasons affected, month during which symptoms 
normally appear, month during which symptoms normally regress and age at start of IBH 
did not have a significant effect on any of the tested C. obsoletus specific IgE levels in 
neither Icelandic horses nor Shetland ponies. 
 
Discussion 
The aim of our research was to identify and quantify factors associated with serum IgE 
levels against C. obsoletus WBE and C. obsoletus recombinant allergens determined by 
ELISA. Various factors were identified to be associated with IgE levels in Shetland ponies 
and Icelandic horses in The Netherlands. Severity of IBH clinical symptoms was 
associated with IgE levels against C. obsoletus allergens. Most of the correlations between 
severity score and IgE levels were significantly larger than 0. In agreement with our 
results, Peeters [19] found that the performance and accuracy of their allergen specific IgE 
ELISA in Belgian warmblood horses improved when IBH clinical symptoms at time of 
sampling were more pronounced. In human insect allergic patients, no such a significant 
correlation was found between venom-specific IgE levels and severity of clinical reactions 
[20, 21]. In addition, human studies of atopic asthma, allergic rhinitis and food allergies 
reported no correlation between specific IgE levels and severity of disease [22, 23]. An 
explanation for the presence of a correlation between IgE levels and severity of symptoms 
in horses might be because of the general high serum IgE concentrations in horses 
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compared to humans [24]. In humans, unbound IgE concentrations are very low and IgE 
has a short half-life due to binding to the high-affinity IgE receptor (FceRI) on mast cells 
and basophils (for review: [25]). Due to the much higher concentrations of unbound total 
IgE in horses many mast cells and basophils might already be saturated with IgE, 
increasing the half-life of IgE. Therefore, levels of unbound IgE in horse sera are 
relatively high and give a better representation about the sensitization than in humans. 
Correlations between severity of IBH clinical symptoms and IgE levels against C. 
obsoletus specific allergens were higher and more significant in Shetland ponies 
compared to Icelandic horses. Severity of symptoms was significantly higher in Shetland 
ponies compared to Icelandic horses. In Shetland ponies less preventive and curative 
measures were applied, whereas the vast majority of IBH affected Icelandic horses wore 
anti-insect blankets. Severity of symptoms in Shetland ponies therefore might better 
represent the true exposure to Culicoides spp. and thereby result in higher correlations 
between severity of symptoms and IgE levels against WBE and recombinant allergens. 
The mean IgE level (case and control) against several allergens was significantly higher in 
Shetland ponies compared to Icelandic horses. However, when looking within IBH status, 
significant differences in C. obsoletus IgE levels between Icelandic horses and Shetland 
ponies were only found for control horses. Lower levels were found for the Icelandic 
horse controls. Interestingly, total IgE levels were also reported to be lower in Icelandic 
control horses compared to control horses of other breeds [26]. Breed differences in 
antigen-specific serum antibody levels (including IgE) was also reported for sheep [27]. 
Genetic factors might be of influence, as significant genetic variance against specific IgE 
levels was found in Lipizzan horses [28]. An alternative explanation for higher IgE levels 
in Shetland pony controls might be related to a difference in age: mean age of Shetland 
ponies was 5 years lower than mean age of Icelandic horses (Table 1). An age effect was 
present for IgE levels against Cul o 2 in Shetland ponies and for IgE levels against WBE 
in Icelandic horses (Table 5). In a human allergy study specific IgE levels were reported 
to decrease with age in human patients with insect allergy [29]. In non-allergic individuals 
a similar decrease in IgE levels with increasing age might well exist. As mean IgE levels 
against several C. obsoletus allergens differed significantly between Shetland pony 
controls and Icelandic horse controls, breed specific thresholds can be set to further 
improve the sensitivity and specificity of the IgE ELISA used to diagnose IBH. 
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Differences in IgE levels between cases and controls were highly significant across 
breeds, but were larger in Icelandic horses compared to Shetland ponies. Wilson et al. [26] 
reported significantly higher total IgE levels in Icelandic horses with IBH compared to 
healthy Icelandic horses regardless of where they were born, which was not observed in 
other breeds (including Shetland ponies). Furthermore, total IgE levels of IBH affected 
Icelandic horses were higher than total IgE levels of IBH affected of other breeds. They 
suggested that insect specific IgE may constitute the major component of total serum IgE 
in IBH affected Icelandic horses. However, here we did not observe significantly higher 
C. obsoletus specific IgE levels in IBH affected Icelandic horses compared to IBH 
affected Shetland ponies. 
In our data no significant differences in IgE levels between females and males were 
present. In contrast to Baselgia et al. [7], who reported a significantly higher 
sulphidoleukotriene release in IBH affected geldings compared to affected mares. They 
also reported month of sampling to affect diagnostic outcomes. In agreement, we found a 
significant effect of month of scoring on C. obsoletus specific IgE levels, which is likely 
to be a result of Culicoides spp. activity depending on weather conditions. This is 
supported by our previously observed decrease in IgE levels against recombinant 
allergens in off season sera compared to IgE levels in IBH season sera [13]. 
 
Conclusions and implications 
Severity of IBH clinical symptoms and IgE levels against several C. obsoletus allergens 
appeared to be correlated. Several other factors were found to be associated with IgE 
levels against C. obsoletus (recombinant) allergens. Incorporation of these factors might 
further improve the interpretation and accuracy of the test results and will thereby better 
differentiate cases from controls. 
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Introduction 
Insect bite hypersensitivity (IBH), the most common seasonal recurrent skin allergy in 
horses, is clinically characterized by intense itch and irritation caused by hypersensitivity 
reactions mainly to bites of midges of the genus Culicoides [1-3]. Currently there is no 
fully curative treatment available for IBH, while the need for such a treatment is high 
(Chapter 1). Welfare of affected horses is seriously reduced and owners of such horses 
have to encounter increased costs due to attempts to control the itch and because of 
reduced commercial value of the horses. Severely affected horses sometimes even have to 
be euthanized [2].  
In human studies, specific immunotherapies applied in individuals with type I allergies 
have showed promising results. However, for horse allergies, specific immunotherapy has 
not yet been well investigated, most likely due to the lack of (recombinant) allergens of 
the causative agents of these allergies.  
The research described in this thesis therefore aimed to characterize, identify and produce 
allergens from the causative agent of IBH. Furthermore, this thesis aimed to develop a 
suitable and reliable diagnostic test for IBH. An accurate, reliable diagnostic test with 
allergens is an important part of treatment, because other skin conditions can be ruled out 
and such a test can be applied to determine for which exact components of C. obsoletus 
the IBH horses are allergic. This will enable a tailor-made composition of (recombinant) 
allergens for use in immunotherapy. Finally, increasing our knowledge about the 
immunopathology of IBH was another aim of this thesis. A schematic overview of the 
aim, most important findings and prospects of this thesis is presented in Figure 1. In this 
chapter our most important findings will be summarized and discussed. 
 
Diagnosis of IBH using C. obsoletus  
Observation of clinical signs, combined with well documented medical history and ruling 
out other conditions that may lead to similar symptoms, is assumed to be the gold standard 
to diagnose IBH in horses [4, 5]. In addition, intradermal testing, histamine release tests 
(HRT) and ELISA systems using Culicoides or Simulium whole body extracts (WBE) 
have been evaluated for discrimination of  IBH affected horses and healthy controls [4-9]. 
Serological tests are preferred, because it is easier to take a blood sample, it permits 
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storage of samples until testing, and is more convenient for the veterinarian than 
performing a labor-intensive in vivo intradermal test. Furthermore intradermal tests can be 
painful and cause false positive reactions when injected to deeply [10].   
For these reasons we aimed in our studies described in chapter 2, 5 and 6 to develop an 
easy to perform in vitro test. Previously, WBE for in vitro diagnosis of IBH has been 
reported to show several drawbacks, for instance low sensitivity and/or specificity in 
serological tests and HRT [5, 6, 11]. Additionally, HRT requires fresh blood samples and 
test results have been reported to differ between months of testing [4, 8].  
In chapter 2 we report higher sensitivity and specificity with C. obsoletus WBE 
compared to C. sonorensis and C. nubeculosus WBE in a HRT and ELISA tested on a 
small number of horses. The fact that an ELISA can be performed on samples that have 
been frozen and on a large number of samples at the same time was the decisive factor to 
further evaluate the ELISA with WBE on a large number of horses. This demonstrated a 
Figure 1: Summarizing overview of the main aims and findings of this thesis. C. obsoletus was 
found to be the most important species responsible for IBH in the Netherlands, a diagnostic ELISA 
was developed that we can use in summer as well as winter when clinical symptoms are absent. The 
transcriptome of C. obsoletus was sequenced and assembled which allowed allergen identification. 
C. obsoletus allergens (Cul o 1- Cul o 7) were produced as recombinant proteins that can be used 
for future immunotherapy and research into the mechanisms of immunopathology.  
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high sensitivity and specificity, higher then reported before, and applicability of the 
diagnostic test also for sera samples collected off season (chapter 3). Recombinant 
allergens are an attractive alternative for natural extracts. The assembly and sequencing of 
the C. obsoletus transcriptome described in chapter 4, allowed the identification of 
allergens from C. obsoletus. These allergens were produced as recombinant proteins and 
evaluated for diagnosis in chapters 5 and 6.  Factors that can affect the ELISA test results 
were evaluated in chapter 7.  
 
Choice of Culicoides species important for sensitive diagnosis  
The main difference with other studies that evaluated in vitro diagnostic tests with WBE, 
was our choice to use C. obsoletus WBE. Previous studies performed in the Netherlands 
found C. obsoletus to be most often feeding on horses [12, 13]. These results are 
confirmed by our findings in chapter 2 were we collected insects from a horse using a 
pooter as well as with a ‘Onderstepoort’ light trap. Both capture methods resulted in the 
large majority of collected Culicoides spp to be C. obsoletus, which was even nearly 
100% when collected directly from the horse with a pooter.  
We choose to compare this endogenous species with 2 other Culicoides species, C. 
nubeculosus (Europe) and C. sonorensis (North America), commonly used in IBH studies. 
Our findings, reported in chapter 2, showed that horses had much better IgE reactivity 
with C. obsoletus WBE compared to C. nubeculosus and C. sonorensis WBE, suggesting 
low allergen cross-reactivity between these species. Cross-reactivity between Culicoides 
species has been studied before, but results differ and some report no difference between 
Culicoides species [5, 14], while others do find strong differences [7, 15]. Interestingly, 
Langner et al. [5] compared a native species (C. nubeculosus) with an exotic species (C. 
sonorensis) for that country and found no differences in reactivity. This is in agreement 
with our findings in chapter 2, where we report similar IgE reactivity with C. nubeculosus 
as with C. sonorensis. However, we report much higher IgE reactivity with C. obsoletus. 
Although C. nubeculosus might be found in Europe, in contrast to C. sonorensis, it is not 
commonly reported feeding on horses or only in very small numbers [16]. Furthermore, 
we did not collect any C. nubeculosus when aspirating Culicoides insect from a horse 
(chapter 2). Therefore we conclude that horses are not exposed to all Culicoides species 
present in the country were they are located. This is further enforced by our findings in 
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chapter 2, in which we do demonstrate much stronger IgE reactivity to C. obsoletus than 
to C. nubeculosis and C. sonorensis, and by Wilson et al. [15] and Sloet van 
Oldruitenborgh-Oosterbaan et al. [7], who both found better reactivity with C. obsoletus 
compared to C. nubeculosus as detected by western blot and an intradermal test. 
Moreover, in chapter 5 we compared an allergen (Cul o 1, maltase) of C. obsoletus with 
its homolog from C. sonorensis (Cul s 1) and found more IgE reactivity with Cul o 1 than 
with Cul s 1, suggesting that on single allergen level diagnosis can be improved as well 
when using allergens from C. obsoletus. Furthermore, when we compared salivary 
proteins from C. obsoletus with those from C. nubeculosus and C. sonorensis, large amino 
acid differences were revealed between (sequence-based) similar proteins of the different 
species, as can be concluded from the Venn diagram described in chapter 4 and by 
alignments of similar allergens described in chapter 5. Approximately a quarter of the C. 
nubeculosus salivary gland proteins have an identity of at least 40 % with candidate 
proteins from C. obsoletus (chapter 4). The remaining of the salivary gland proteins thus 
has a lower identity. Although more matching proteins were found between C. sonorensis 
and C. obsoletus, the similarity or cross-reactivity between these two species does not 
seem to be larger than between C. nubeculosus and C. obsoletus when looking at the 
results in chapter 2. We assume that the higher number of matching proteins with C. 
sonorensis is caused by the non salivary proteins that are available for C. sonorensis in the 
public database. Salivary proteins between Anopheles species were reported to be less 
conserved than housekeeping proteins [17]. It is likely that the non-salivary gland part of 
C. sonorensis contains more housekeeping proteins and therefore results in more matches 
with the C. obsoletus transcriptome. The low similarity between salivary proteins of 
different Culicoides species decreases the probability of the presence of cross-reactive IgE
-binding epitopes in the different allergen preparations and necessitates the use of 
allergens from relevant species for the development of diagnostic tools. 
Thus, the use of C. obsoletus allergens so far seems to be crucial for reliable in vitro 
diagnosis of IBH at least in The Netherlands, but probably in many other European 
countries as well. However, this does not exclude the possibility that the use of other 
Culicoides species might also contribute to the improvement of diagnosis. C. pulicaris is 
also reported feeding on horses in relatively high percentages compared to other species,  8 
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although less frequently found than C. obsoletus [12, 13, 16]. It would be interesting for 
further research to compare C. pulicaris with C. obsoletus in in vitro diagnostic tests.  
 
Choice of Culicoides species mainly important for in vitro diagnosis 
The ‘lack of’ cross reactivity between C. obsoletus and other Culicoides species so far 
seems mainly to be observed with in vitro tests. Although Sloet van Olruitenborgh-
Oosterbaan et al. [7] reports an intradermal skin test to be better with C. obsoletus 
compared to C. nubeculosus, it is noteworthy to mention that they compared a 
commercial extract from Greer laboratories with a non-commercial extract prepared and 
stored in a different manner. In chapter 2 we report that insect collection method and 
preparation can have great influence on quality of the extract. Furthermore, we found that 
immediate freezing by liquid nitrogen is important to avoid precipitation in high 
concentration protein extracts and that degradation already starts after only a few freeze 
thaw cycles (data not shown). Although we are not aware of the preparation methods of 
the Greer extract, we know it is stored at 4°C while it is generally known that many 
proteins are not stable at 4°C for longer periods. This is especially a problem in natural 
allergen extracts, like the extract of Greer, because they can contain proteases which 
affect the stability [18]. The findings observed by intradermal tests by Sloet van 
Olruitenborgh-Oosterbaan et al. [7] might therefore not necessary be related to lack of 
cross-reactivity between species, but more related to difference in quality of the used 
extracts. In an intradermal pilot test performed on 1 IBH affected and 1 healthy horse we 
observed clear immediate wheals provoked by C. nubeculosis and C. sonorensis WBE, 
although C. obsoletus WBE resulted in larger wheals (Table 1). The extracts employed 
were prepared and stored in the same manner. Anderson et al. [14] found no differences at 
all in skin reactivity provoked by C. obsoletus compared to reactivity provoked by 5 other 
native and non-native Culicoides spp. for that area [14]. Horses were injected with 0.1 ml 
of a 1% C. obsoletus extract corresponding to approximately 170 insects. 
In our pilot experiment, it seems that at higher doses the intradermal skin test might also 
be successfully performed with non-native species. However, at lower antigen doses the 
intradermal skin test performs better with the local feeding C. obsoletus. Therefore, 
Anderson et al. [14] might have observed differences in skin reactivity if they would have 
used more diluted samples. Several speculations could explain these findings. 
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It is possible that the amount of histamine released by basophils or mast cells might not be 
proportional to the severity of the skin reactions. It could well be that above a certain 
histamine release a maximum wheal size is developed, which does not further increase 
with increasing histamine release. In contrast, the HRT test measures the actual histamine 
release and differences obtained with different Culicoides species as reported in chapter 2 
can therefore be detected. Intradermal tests and in vitro test might therefore not be 
comparable. 
Interestingly, in chapter 7 we report a correlation between C. obsoletus IgE levels and 
severity of the clinical symptoms, suggesting that for C. obsoletus diagnosis by ELISA is 
a good alternative for intradermal test. Such correlation remains to be established for other 
Culicoides species. 
 Langner et al. [5] performed an HRT using C. nubeculosus and C. sonorensis saliva and 
WBE on blood of Icelandic horses located in Germany. Although at 5 µg/ml they were 
able to diagnose all IBH affected horses to be positive, also some control horses were 
tested positive. At a concentration of 0.5 µg/ml WBE they found about half of the IBH 
affected horses to have a positive test result and at a lower concentration only few or no 
horses were tested positive. In agreement, we found only few IBH affected horses to test 
Injection 
(0.1 ml) 
Wheal diameter (mm) 
  IBH affected horse   Healthy control 
  0.5 hr 1 hr   0.5 hr 1 hr 
Saline 10     10   
Histamine 21     20   
C. obsoletus (µg/ml)           
10 22 25   9 8 
1 18 20   10 8 
0.1 16 19   10 7 
C. nubeculosus (µg/ml)           
10 19 20   11 11 
1 19 21   11 10 
0.1 13 15   10 8 
C. sonorensis  (µg/ml)           
10 17 19   11 11 
1 16 17   10 10 
0.1 10 10   9 10 
Table 1: The wheal diameter of one IBH affected horse and one healthy control horse at 5 different 
time points after injection with C. obsoletus, C. nubeculosus and C. sonorensis extract.  
 8 
190  
General Discussion 
positive in the HRT with WBE of  C. nubeculosus and C. sonorensis at a concentration of 
0.5 µg/ml, while 100 % (n = 10) of these horses were tested positive with C. obsoletus 
extract. At the same concentration no control horses were tested positive (chapter 2). It is 
very likely that the diagnosis of these horses located in Germany would have been 
improved with the use of C. obsoletus WBE, because this is also the most abundant 
Culicoides species found in Germany [19]. Langner et al. [5] however did report an 
improvement of the HRT using saliva of C. nubeculosus and C. sonorensis and therefore 
saliva of these species might be as good for in vitro diagnosis of IBH as C. obsoletus 
WBE. However, collecting saliva from Culicoides insects requires the laboratory breeding 
of these insects and special membrane feeding devices to collect the saliva [20], and 
therefore does not seem to be an attractive alternative for C. obsoletus WBE. Furthermore, 
it is very likely that WBE contains all the relevant saliva allergens as IgE reactivity with 
WBE was observed to be very high (chapter 2) and genes coding for salivary allergens 
were present in the C. obsoletus transcriptome (chapter 4 and 5). 
 
Off season diagnosis 
The half-life of IgE in serum in humans is short, only 2-3 days, while IgE bound to Fc 
receptors on basophils and mast cells can survive for long periods up to months [21]. IBH 
is a seasonal allergy; it occurs when Culicoides insects are active, which is during the 
warmer months of the year (April-September in The Netherlands). Due to the short half-
life of IgE it is expected that the developed ELISA, described in chapter 2, is less 
sensitive during the off season. However, as described in chapter 3 and 5, we did not find 
a decrease in C. obsoletus WBE specific IgE levels during the off season, compared to the 
levels during the Culicoides season. However we did find a decrease of IgE levels against 
a combination of three or four recombinant allergens for most of the tested horses in the 
off season, although IgE still remained clearly detectable in most IBH affected horses 
(chapter 5). IgE production might be maintained (at least for some horses) even in the 
absence of allergen contact. This was observed also before by Smurthwaite et al. [22], as 
individuals with hay-fever were found to have high titres of pollen-specific IgE in the 
serum even off season. Not long ago, this would raise questions, because in general 
plasma cells were considered as short-lived end products of B cell differentiation, which 
is actually still true for many plasma cells [23]. However, for some time already there is 
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evidence that at least some IgE-secreting plasma cells in allergic individuals are long-
lived and that long-lived plasma cells can survive in the bone marrow, lymph nodes or 
spleen up to years [24-27]. Moreover, these plasma cells are not affected by antigenic 
challenge or immunosuppression [28, 29]. Thus it might be that horses have long-lived 
plasma cells specific for Culicoides allergens.  
An alternative explanation for the absence of a decrease in IgE ELISA signal in winter-
samples with ELISA plates coated with WBE could be because the molecules of true 
allergens actually bound to the plastic is lower than the number of allergen-specific IgE 
molecules present in a serum dilution of 1:5, even in winter samples, meaning there is an 
excess of IgE in proportion to coated allergens. This phenomenon will occur only after 
coating with WBE and not after coating with purified (recombinant) allergens due to 
competition of the allergens with the many other proteins in the extract for binding to the 
plastic of the well. The fact that horses have relatively high IgE levels in their serum, 
compared to for instance humans [30], will make this phenomenon more likely. 
Therefore, to be more conclusive, the ELISA with WBE should be performed with titrated 
summer and winter sera.  
Baselgia et al. [4] found a decrease in positive test results by HRT using C. nubeculosus 
WBE several months after Culicoides exposure, suggesting that IgE levels decrease, or at 
least the Culicoides specific IgE antibodies bound to basophils in the absence of allergen 
exposure. This study was performed in Switzerland, were horses are likely to be more 
exposed to C. obsoletus than to C. nubeculosus, because it is again the main species found 
in this country [31]. Maybe the number of C. nubeculosus allergen-specific plasma cells 
that are produced is too low to result in long-lived plasma cells or plasma cells specific for 
only few C. nubeculosus allergens to survive, in contrast to C. obsoletus allergen specific 
plasma cells, who are probably relatively more abundant. Another speculation might be 
the choice of test. HRT is based on degranulation of mast cells by cross-linking of bound 
IgE antibodies. For cross-linking to occur the allergen needs to have at least two epitopes. 
A decrease in IgE antibodies will probably have a bigger effect on degranulation induced 
by C. nubeculosus WBE compared to C. obsoletus, because they are likely to bind less 
epitopes of C. nubeculosus allergens than of C. obsoletus. However, to be more 
conclusive, a HRT should be performed in summer as well as winter using C. obsoletus 
WBE or recombinant allergens.  
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Effect of horse breed on IgE ELISA test results 
Our ELISA was tested in two different breeds, Shetland ponies and Icelandic horses. 
Symptoms of these horses varied from mild to profound, but most horses showed severe 
or profound symptoms of IBH. We found breed differences in IgE levels as reported in 
chapter 7, but only within control horses. Differences in serum antigen-specific IgE 
levels can also be observed in different sheep breeds [32].  However, our test seems to be 
applicable for multiple breeds, but the cut-off could be set breed-specifically to obtain the 
highest test sensitivity and specificity.  
Recently a similar serological IgE ELISA test was also described by Peeters [33] who 
reported a sensitivity of 70 % and a specificity of 97 % for horses with severe symptoms 
of IBH during several years. The ELISA was performed with Belgian Warmblood horses 
and a combination of three recombinant allergens plus an Obsoletus group WBE was 
required to reach this sensitivity and specificity. To explain the relatively poor sensitivity 
of their ELISA compared to our ELISA, they suggested that our serological test described 
with WBE in chapter 2 might only be a valuable diagnostic test for IBH for certain 
breeds. Indeed, it has been shown that Icelandic horses imported from Iceland display 
stronger T helper 2 (Th2) type and IgE responses to Culicoides allergens than other horse 
breeds [34, 35]. However, only a small percentage of the Icelandic horses tested in chapter 
7 were imported from Iceland and Icelandic horses born in Culicoides infected countries 
do not seem to be more susceptible for IBH than other breeds [36]. Furthermore, Peeters 
(2013) suggested that our results might differ, because Shetland ponies and Icelandic 
horses are often kept more in the field compared to Warmblood horses [32]. However, 
most of our IBH affected Icelandic horses wore anti-insect blankets and are therefore less 
exposed to insects than Shetland ponies, but their IgE levels were not found to be lower 
than those of Shetland ponies. Therefore we consider our IgE ELISA using C. obsoletus 
WBE or recombinant allergens applicable for different horse breeds. However to be more 
conclusive about the sensitivity and specificity of the ELISA for different breeds, the 
ELISA should also be evaluated on horses of other breeds. 
 
C. obsoletus recombinant allergens 
Diagnosis and treatment of allergic diseases have relied for a long time on natural 
allergenic extracts, which contain many non-allergenic proteins and sometimes allergens 
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from other sources. Furthermore, they are difficult to standardize [37].  
A good alternative is therefore the use of recombinant allergens. Another advantage of the 
use of recombinant allergens is that a patient’s sensitization profile can be determined by 
component resolved diagnosis, enabling possible adaptation of the composition of the 
antigen preparation used for specific immunotherapy to the requirement of the individual 
horse. In chapter 5 we describe the identification and characterization of 7 allergens (Cul 
o 1 – Cul o 7) found by homology searches on a recently sequenced C. obsoletus 
transcriptome (chapter 4) using sequences of previously reported allergens from C. 
nubeculosus and C. sonorensis.  
Cul o 1- Cul o 7 are a good alternative for diagnosis of IBH with WBE and are interesting 
tools for future immunotherapy.  
 
Diagnosis with recombinant C. obsoletus allergens  
In chapter 5, Cul o 1 – Cul o 7 were reported to be valuable allergens for diagnosis of 
IBH after testing them by IgE  ELISA and an intradermal test. Furthermore, our IgE 
ELISA with a combination of only three of these allergens (Combi-1) resulted in a 
sensitivity and specificity of both 89 % close to that obtained with WBE (chapter 6). 
These allergens, for diagnosis therefore provide an attractive alternative for WBE. 
Some clinically healthy horses also showed high IgE levels against one or more allergens. 
Clinically healthy horses are more often reported to be sensitized [12, 38]. These 
sensitized horses might never develop clinical signs of allergy, but in human studies 
asymptomatic sensitization is reported be a risk factor for later allergy development [39]. 
A diagnostic test performed as a decisive factor for treatment can therefore also be 
important for clinically healthy horses. Interestingly, in our study described in chapter 5, 
we report most sensitized clinically healthy horses to have specific IgE only for one or a 
few allergens. On the contrary, most IBH affected horses showed to have specific IgE for 
a large number of allergens. Sensitization to a minimal number of allergens might 
therefore be an important factor for clinical symptoms to occur. To be more conclusive 
about the chances a horse shows (or will show) symptoms of IBH, a positive ELISA result 
with combi-1 should preferentially be followed by testing on the individual allergens. This 
will also allow to determine for which exact components of C.obsoletus the horses are 
allergic, which is important to know for treatment.  
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In chapter 6 we report that additional C. obsoletus allergens seem to be responsible for 
IBH that can be crucial for diagnosis and treatment of some horses. With combi-1 we 
reached a sensitivity of 89 % and this sensitivity might possibly be increased with these 
‘missing’ allergens. Hellberg et al. [34] already reported at least 10 IgE binding proteins 
from C. nubeculosus and a lot IgE binding variety between horses [34], whereas in this 
thesis only 7 allergens were identified and produced as recombinant proteins. 
Furthermore, 11 allergens were described for C. nubeculosus [40, 41]. Since C. obsoletus 
was found to be a more important species for in vitro diagnosis than C. nubeculosus in 
chapter 2, it is likely that at least 11 IgE binding proteins should exist for C. obsoletus as 
well.  
 
Additional candidate allergens 
In chapters 2 and 6 we describe two proteins of 15 and 20 kDa to be present as most 
dominant IgE reactive bands detected by western blot analysis and these are therefore 
interesting candidates for further characterization. Western blot analysis described in 
chapter 6 shows that these proteins are not one of the seven allergens (Cul o 1 – Cul o 7) 
that were identified by homology searches.  
During this research project, we have tried immunoprecipitation and two dimensional 
(2D) gel electrophoresis to isolate these proteins from WBE for characterization by mass 
spectrometry. Most effort was put into 2D gel electrophoresis, because 
immunoprecipitation using total IgE of an IBH affected horse with strong reactivity to the 
15 and 20 kDa protein covalently coupled to sepharose beads was unsuccessful after 
several attempts. 
Preliminary 2D electrophoresis experiments showed that only a spot of 15 kDa (pH > 8) 
could be detected by western blot analysis and no spots of 20 kDa. Strips ranging from pH 
3-10 were used, because these resulted in the best separation of C. obsoletus WBE 
proteins in the area where our spot of interest was found by western blot analysis. The 
western blot and a 2D gel stained with Oriole Fluorescent Gel stain (BioRad) were 
overlaid using a photo manipulator program (Pixlr.com/editor). A protein spot with a MW 
of 15 kDa on the gel matched the spot visualized by western blotting (indicated by a circle 
in Figure 2A and 2B). Additional gels were stained with Oriole and these showed a 
similar spot pattern as shown in Fig. 2B.  The same spot on these gels matched with the 
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Figure 2: (A) Western blot analysis of two dimensional (2D) separated proteins of C. obsoletus 
WBE incubated with sera of 2 IBH affected horses. Binding of IgE from horse sera was detected 
with an anti-equine IgE mouse mAb and HRP goat anti-mouse IgG. The molecular weight marker 
[43] is indicated on the left in kDa. (B) 2D gel with proteins of C. obsoletus WBE, stained with 
Oriole Fluorescent Gel Stain.  8 
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protein spot detected by the western blot analysis. We used a pool of sera of two horses 
showing both IgE reactivity with a 15 and 20 kDa band using western blot analysis of a 
1D gel, although the 20 kDa band was much fainter than the 15 kDa band (Figure 3). A 
possible explanation for the lack of a 20 kDa spot on the 2D gel  might be that the 
isoelectric point of this protein was outside the limits of the strip or, more likely, because 
the protein was not present in sufficient amounts to be detected by 2D gel western blot 
analysis.  
A protein spot of 15 kDa (pI >8) that matched with one of the spots visualised by western 
blot analysis for IgE binding was excised from the 2D gel stained with Oriole fluorescent 
Gel Stain (BioRad, Munchen, Germany), proteolytically digested and identified by Mass 
Spectrometry (MS) analysis. 
MSMS spectra from the MS measurements were searched with Bioworks 3.3.1. against 
the C. obsoletus transcriptome database. A set of common contaminants was added and 
from this a decoy reverse database was constructed using the program SequenceReverser 
from the MaxQuant package [42] and added as well. Bioworks results were filtered to 
show only those contigs for which at least 2 peptides were found. Nearly 70 contigs were 
found to have at least 2 peptides. Candidate proteins within these contigs with an 
isoelectric point close to 8 and/or MW close to 15 kDa were selected for E. coli 
Figure 3: Western blot analysis of a 1 D gel with C. obsoletus WBE incubated with sera of 2 IBH 
affected horses. Binding of IgE from horse sera was detected with an anti-equine IgE mouse mAb 
and HRP goat anti-mouse IgG. Two proteins with a MW of 15 and 20 kDa are visualized.  
 197 
Chapter 8 
expression. However, none of these proteins were found to have a predicted signal 
peptide.  
Two candidate proteins similar to NADH ubiquinone dehydrogenase and a protein similar 
to hypothetical protein from Aedes aegypti (XM_001648736.1) were the most interesting 
candidates because of their MW (close to 15 kDa) and pI (> 8). After purification, all 9 
recombinant proteins, including the NADH ubiquinone dehydrogenase and a hypothetical 
protein from Aedes aegypti, showed no or very low IgE-binding as detected by western 
blot analysis and ELISA (data not shown). These findings suggest that we did not 
characterize the protein of interest of 15 kDa as detected by western blot analysis by 2D 
gelectrophoresis. A possible explanation might be that we did not excise the correct spot 
from the gel, the protein was not present in sufficient amounts or it could not be found in 
one of the contigs of the C. obsoletus RNA database.  
 
Methods for improvement of separation by 2D gel electrophoresis. 
As can be seen in the oriole stained gel (Figure 2B) only spots in the lower MW region 
can be detected, while coomassie stained proteins of C. obsoletus WBE seperated on a 1D 
gel shows many higher MW proteins (chapter 2). It seems that most proteins are not well 
resolved or smeared on the gel, as this is a common limitation in 2D gel electrophoresis 
[44]. This might also explain the absence of detection of the 20 kDa band.  
Isolation and characterization of the proteins might be achieved by preparative separation 
of protein by chromatography methods, like ion exchange chromatography or 
hydrophobic interaction chromatography. Proteins fractions can afterwards be analysed by 
western blot analysis and the protein fraction which contains our protein of interest can be 
further separated by 1D or 2D gelelectrophoresis. Decreasing the complexity of the extract 
is likely to increase the efficiency of resolving and separation of proteins and therefore to 
simplify identification by mass spectrometry.  
 
Identification of a candidate allergen by 1D gelectrophoresis and mass spectometry 
During this research project we anticipated separation of our 15 kDa and 20 kDa protein 
from WBE by 1D gel electrophoresis would be unsuccessful because of the complexity of 
natural allergen extracts. However, we assume that allergens are often highly abundant 
proteins in an extract. For instance, it is suggested that 5 – 20 % of mosquito salivary 
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protein consists of D7 proteins, which are major allergens in most insect species [45]. We 
therefore recently performed a pilot experiment by loading C. obsoletus WBE on a 1D gel 
for separation of proteins based on their MW. A protein band of 15 kDa was excised from 
the gel that was stained with Oriole fluorescent Gel Stain (BioRad), proteolytically 
digested and identified by MS analysis, similar as described in the previous paragraph for 
2D gel electrophoresis. 
As expected, peptide hits were found for many proteins (>100) present in the C. obsoletus 
transcriptome. Nevertheless, one protein was found to be an interesting candidate, because 
this protein showed most peptide hits (13 peptides) was found to have a MW close to 15 
kDa and to have a signal peptide. This protein shows highest sequence similarity with 
odorant binding proteins from Anopheles funestus (34 % identities) and other biting 
insects. There was no similarity hit with genbank accessible Culicoides salivary proteins. 
Sol I 2, a major allergen from the venom of red imported fire ant, shows strucutal (but not 
sequence) homology with odorant binding protein of Dropsohila [46], suggesting that 
odorant binding like proteins from biting insects might serve as allergens. Furthermore, an 
odorant binding protein has recently also be reported to be an allergen present in salivary 
gland, hair and urine of the Siberian hamster [47] and a dog dander allergen has shown 
sequence similarity and cross reactivity with a odorant binding protein present in cow 
dander [48]. These data suggest that the recently identified C. obsoletus odorant binding 
protein might well serve as an allergen for IBH.  
The odorant binding protein of C. obsoletus is currently being cloned and expressed in 
recombinant form to assess this protein as allergen relevant for IBH.  
 
Implications for immunotherapy 
The main disadvantage of current treatment options, like horse blankets, insect repellents, 
corticosteroids and anti-histamines is that they fail to target the mechanisms underlying 
the allergy, often only have short activity and may have several side-effects.  
Allergen-specific immunotherapy is the only causative treatment of allergy at the moment 
and is based on the repeated administration of the disease-eliciting allergens until the 
sensitivity to the administered allergens is reduced through various immunological 
mechanisms [49]. Immunotherapy used in humans with insect allergies has shown to be 
able to shift the cytokine production to Th1 cytokines [50, 51], to increase the production 
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of IL-10 [52], to reduce the histamine release by basophils [53] and to reduce allergen 
specific IgE levels [54]. 
For insect bite hypersensitivity, only a few immunotherapy trials have been described to 
date using WBE of Culicoides spp. but they reported controversial results [55, 56]. One of 
the studies however did report a clear reduction of clinical signs after weekly 
subcutaneous injections with C. variipenis extract and even a complete disappearance of 
symptoms in some horses after two years [55]. Furthermore, a retrospective study on 51 
horses reported on the clinical presentation of equine atopic skin diseases and evaluated 
the response to treatment with allergen-specific immunotherapy based on intradermal 
testing combined with serum testing. Allergen-specific immunotherapy was found to be 
successfully used in the management of different types of atopic skin disease in horses 
[57]. 
In chapter 7 we observed for Shetland ponies a decrease in C. obsoletus specific IgE 
levels with increase in age. This was not observed for Icelandic horses, which might be 
because they were more often protected by insect blankets, therefore being less exposed to 
bites. In contrast, the Shetland ponies were not protected by blankets and therefore the 
decrease in IgE levels with increasing age might well be due to a natural and gradual 
desensitization.  
The use of C. obsoletus WBE as described in chapter 2 could be useful for 
immunotherapy in horses suffering from IBH in The Netherlands. However, the use of 
natural allergen extract has some major bottlenecks. E.g. Injection of these unmodified 
extracts can result in local and severe systemic side effects, due to the presence of 
allergenic materials [58-60]. Because of these side-effects the clinically effective 
maintenance dose can sometimes not be reached. Furthermore, relevant allergens might 
not be present in sufficient amount or exhibit poor immunogenicity [61]. Finally, new 
sensitizations can be induced against allergens present in the extract, which were not 
recognized by the patient before treatment [62, 63].  
The use of recombinant proteins can improve on the use of natural allergen extracts for 
allergen specific immunotherapy.   
Recombinant allergens have the advantages that they can be produced whenever needed 
under defined conditions, reaching milligram or grams quantities by different high level 
expression systems, which makes quality control and standardization possible [37].  
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Many recombinant allergens have showed comparable IgE reactivity in vitro and in vivo 
as its natural allergens [64-66]. Although we did not compare our recombinant allergens 
with their natural form in vivo, as described in chapter 5 and 6 all of our 7 expressed 
recombinant allergens on individual level showed IgE reactivity with a large number of 
IBH affected horses and E. coli expressed maltase showed comparable IgE reactivity to 
baculovirus expressed maltase, which is expected to closely resemble the natural form of 
the protein. Furthermore, in chapter 6 the IgE reactivity of horses to a combination of 3 
recombinant allergens was comparable to the IgE reactivity to C. obsoletus WBE as 
detected by IgE ELISA. For human allergies, cocktails of few recombinant allergens were 
also reported to successfully replace natural allergen extracts for in vitro diagnosis [66]. 
The advantage of such a cocktail of allergens is that each allergen is present in a defined 
concentration and no other irrelevant proteins or proteases are present.  
Another advantage of the use of recombinant allergens is that they allow for a more 
precise diagnosis and by identifying which allergens are responsible for the allergic 
symptoms they form a basis for better prescription of immunotherapy [67]. Many 
successful immunotherapy studies using recombinant allergens have lately been reported 
for human allergies [68]. Recombinant Cul o 1 – Cul o 7 are thus interesting tools for 
future immunotherapy in horses with IBH., because  this panel of recombinant allergens 
will determine for which exact components of C.obsoletus the IBH horses are ‘allergic’ 
and this will enable a tailor-made composition of (recombinant) allergens for use in 
immunotherapy. 
 
Concluding remarks 
 In conclusion, C. obsoletus seems to be the most important causative agent of IBH in The 
Netherlands and its allergens currently provide the most reliably available in vitro 
diagnosis of Insect Bite Hypersensitivity in horses. The transcriptome of C. obsoletus has 
been sequenced and assembled that will allow gene expression analysis and further gene 
discovery. Seven C. obsoletus allergens (Cul o 1 – Cul o 7) were identified that can be 
produced by E. coli as recombinant proteins and used for diagnosis of IBH affected horses 
by ELISA. With a combination of 3 of these allergens a reliable serological diagnostic test 
for IBH was developed that can replace C. obsoletus WBE without losing sensitivity or 
specificity and is applicable in different horse breeds.  
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The panel of available 7 recombinant allergens can be used to determine for which exact 
components of C.obsoletus the IBH horses are allergic and this will enable a tailor-made 
composition of (recombinant) allergens for use in future immunotherapy.  
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Summary 
Insect Bite Hypersensitivity (IBH) is the most common skin allergy in horses and 
involves a Type I (IgE mediated) hypersensitivity reaction. IBH is clinically characterized 
by intense itch and irritation caused by hypersensitivity reactions to bites of insects, 
mainly of the Culicoides species. Welfare of affected horses is seriously reduced and they 
can become unsuitable for riding or showing purposes, because of the discomfort and 
disfigurement. No fully curative treatment is yet available for IBH. Furthermore, current 
diagnostic tests are unreliable because of their low sensitivity and specificity. The goal of 
the research project described in this thesis was to increase our understanding of 
immunological aspects of IBH, with special attention to improving diagnosis by the 
characterization and production of recombinant allergens. 
Chapter 1 firstly gives an overview of the cells of the immune system that are involved 
in this allergy, after which the basic mechanism of a Type I allergy and additionally the 
production of allergens and their use for component resolved diagnosis is discussed. 
Secondly a literature review about research on IBH, with special attention to the currently 
available different diagnostic tests is presented. The chapter is finalized with the research 
aims of this project and a thesis outline. 
Most studies performed on IBH are performed with whole body extracts or allergens from 
laboratory available C. nubeculosus (found in Europe, but rarely found in The 
Netherlands) or C. sonorensis (typical for North America). However, C. obsoletus is 
regularly found to be the Culicoides species mostly found feeding on horses in European 
countries, including the Netherlands, but so far cannot be successfully maintained in 
laboratory bred colonies. 
In the first study, described in chapter 2, we describe the collection of female C. 
obsoletus directly from a horse using a pooter. Collecting these insects alive, not in 
alcohol, is important for the preparation of high quality extracts. Whole body extracts 
(WBE) of the three Culicoides species: C. obsoletus C. nubeculosus and C. sonorensis 
were evaluated for their applicability for diagnosis of IBH in horses in The Netherlands. 
They were tested for IgE binding by ELISA and Western blotting and for their capacity to 
degranulate basophils in a histamine release test. For all tests, best results were obtained 
with C. obsoletus. The ELISA was further evaluated using C. obsoletus extract on 
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approximately 200 IBH affected and healthy horses, which demonstrated high test 
sensitivity and specificity.  
Chapter 3 describes a study in which we compared lesional and non-lesional skin of 
ponies affected by IBH in the IBH season with those of the same animals off season and 
those in skin of healthy ponies in both seasons for their Th1/Th2 immune response 
pattern. C. obsoletus-specific IgE serum levels, skin histopathology and cytokine and 
transcription factor mRNA expression (IL4, IL10, IL13, IFNγ, FoxP3 and CD3ζ) were 
evaluated. C. obsoletus-specific IgE serum levels within each group were the same in the 
IBH season and off season. A significantly higher histopathology score in lesional skin of 
affected ponies than in non-lesional skin and skin of healthy ponies in the IBH season was 
observed. Finally, there was a general up-regulation of the cytokines IL4, IL13 and IFNγ 
in the skin of all horses in the IBH season compared to off season.  
Chapter 4 describes the sequencing and assembly of the transcriptome of C. obsoletus.  
RNA of female C. obsoletus insects collected from the wild was sequenced using Illumina 
paired-end RNA sequencing technology. De novo assembly resulted into 41,223 contigs, 
and the estimated open reading frames (ORFs) were extracted from the contigs and 
resulted in 28,000 candidate genes. Only a quarter of the salivary gland proteins of C. 
nubeculosus was found to match with contigs of C. obsoletus. The remaining salivary 
gland proteins did not match. For C. sonorensis the number of proteins that matched was 
higher, but most likely because of the presence of non-salivary gland proteins which might 
be more conserved. Thus, there appears to be a lot of sequence differences between 
salivary proteins of C. obsoletus, C. nubeculosus and C. sonorensis species, which might 
explains the low cross-reactivity between allergens from C. obsoletus and allergens from 
the other two species.  
In chapter 5 we describe the identification of 7 allergens from C. obsoletus by sequence 
similarity searches on the C. obsoletus transcriptome, with in literature described allergens 
from C. nubeculosus and C. sonorensis. These allergens were cloned and expressed as 
recombinant proteins in E. coli and named Cul o 1 – Cul o 7. A maltase (Cul o 1) and Cul 
s 1 (maltase of C. sonorensis) were additionally expressed in insect cells using the 
baculovirus expression system to compare similar allergens from different species 
produced with different expression systems in diagnostic in vitro and in vivo tests. IBH 
affected horses showed higher IgE levels to Cul o 1 than to Cul s 1. Furthermore, 
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production of these proteins in E. coli was at least as suitable for in vitro diagnosis of IBH 
affected horses as these same proteins produced in the baculovirus expression system. For 
E. coli expressed Cul o 1 – Cul o 7, the frequency of positive test results by ELISA within 
IBH affected horses ranged from 38 % to 67 %. The capability of the allergens to induce 
Type I hypersensitivity reaction in IBH affected horses was demonstrated by an 
intradermal test. 
Additionally, in chapter 6 the applicability of the 7 C. obsoletus derived recombinant 
allergens was further evaluated and compared with C. obsoletus WBE in an IgE ELISA 
using almost 350 IBH affected and healthy horses. The highest test accuracy was obtained 
with WBE, followed by Cul o 2, 3 and 5. Two ELISA’s with a combination of 
recombinant allergens, combi-1 (Cul o 3, 5 and 7) and combi-2 (Cul o 1, 2, 5 and 7) were 
additionally performed and both resulted in high test accuracies close to that obtained 
with WBE. Both combi-1 and combi-2 resulted in a lower test sensitivity with samples 
collected in winter compared to samples collected in IBH season, but most IBH affected 
horses could still also be correctly diagnosed in winter. 
Chapter 7 describes the identification and quantification of the association between 
several factors and IgE levels against C. obsoletus whole body extract and 7 recombinant 
allergens. Furthermore, the relation between IgE levels and severity of symptoms was 
examined. Severity of symptoms and IgE levels against several C. obsoletus allergens 
were found to be related. Breed was found to be associated with IgE levels. Differences in 
IgE levels between cases and controls were found to be largest in Icelandic horses. 
Shetland pony controls had significantly higher IgE levels compared to Icelandic horse 
controls, but differences in IgE levels between Shetland pony cases and Icelandic horse 
cases were not significant. Other factors associated with IgE levels were age, month of 
scoring, interaction between IBH status and month of scoring, degree of itchiness and 
number of seasons horses were affected with IBH. 
In the general discussion (chapter 8) the most important findings of this thesis are 
discussed and presented in a summarizing overview. A 2D gel electrophoresis approach to 
identify additional allergens is discussed and methods for improvement are suggested. An 
odorant binding protein that was recently identified as a new candidate allergen is 
discussed. Finally, we discuss the prospects to use the produced recombinant allergens for 
immunotherapy treatment of IBH affected horses.   
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In conclusion, C. obsoletus allergens currently provide the most reliable diagnosis of 
insect bite hypersensitivity in horses located in countries where this species is the most 
dominant Culicoides species feeding on horses. With a combination of three recombinant 
allergens derived from C. obsoletus we developed the first reliable serological diagnostic 
test for IBH. The panel of all 7 recombinant allergens allows to determine for which exact 
components of C. obsoletus the IBH horses are allergic (“component resolved diagnosis”). 
This will enable a tailor made composition of (recombinant) allergens for use in 
immunotherapy. 
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Staart- en maneneczeem (SME) is de meest voorkomende huidallergie bij paarden en 
betreft een type 1 (IgE gemedieerde) allergische reactie. SME veroorzaakt jeuk en 
huidirritatie door een allergische reactie op insectenbeten, voornamelijk van Culicoides 
insectensoorten. Als reactie op de jeuk kunnen de paarden tot bloedens toe gaan schuren. 
Het welzijn van paarden kan door deze aandoening ernstig worden aangetast en  ze 
kunnen ongeschikt worden om te berijden of voor paardenshows. Momenteel is er geen 
genezende behandeling beschikbaar voor SME. Daarnaast zijn de huidige beschikbare 
diagnostische testen onbetrouwbaar door een lage sensitiviteit en specificiteit van de test. 
Het doel van het onderzoeksproject beschreven in dit proefschrift was om meer inzicht te 
verkrijgen in de immunologische aspecten van SME, en om een betrouwbare 
diagnostische test voor SME te ontwikkelen.  
Hoofdstuk 1 geeft een overzicht van de cellen van het immuunsysteem die een rol spelen 
in SME, en  beschrijft het mechanisme van een type I overgevoeligheidsreactie. 
Vervolgens wordt de productie van recombinant allergenen beschreven en hoe deze 
gebruikt kunnen worden om te diagnosticeren voor welke allergenen een patiënt precies 
allergisch is (component-resolved diagnostics, CRD). Daarna wordt een 
literatuuroverzicht van eerdere onderzoeken naar SME gepresenteerd, met extra aandacht 
voor de verschillende beschikbare diagnostische testen en de overeenkomst met de 
klinische diagnose als gouden standaard. Het hoofdstuk wordt afgesloten met de 
onderzoeksdoelen van dit project en een inhoudelijk overzicht van dit proefschrift.  
De meeste onderzoeken naar SME worden uitgevoerd met extracten van complete insect 
of recombinant allergenen van in het laboratorium te kweken Culicoides stammen, zoals 
C. nubeculosus (komt voor in Europa, maar wordt zelden gevonden in Nederland) of C. 
sonorensis (voorkomend in Noord Amerika). C. obsoletus is echter de Culicoides soort 
die het meest gevonden wordt op paarden in Europese landen, inclusief Nederland, maar 
deze soort kan tot nu toe nog niet gekweekt worden in het laboratorium.  
In hoofdstuk 2, beschrijven we het vangen van vrouwelijke C. obsoletus direct van een 
paard met behulp van een zuigbuis (‘pooter’). Deze studie bevestigt dat het overgrote deel 
van de Culicoides insecten die zich op paarden voeden tot C. obsoletus behoren en laat 
verder zien dat op deze wijze gevangen insecten een veel hogere kwaliteit extract leveren 
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dan Culicoides gevangen met een veelgebruikte val, waarbij de insecten in alcohol terecht 
komen. Complete extracten van 3 Culicoides soorten: C. obsoletus, C. nubeculosus en C. 
sonorensis werden vergeleken voor hun toepasbaarheid voor SME diagnostiek. De 
extracten werden getest op IgE binding aan de hand van ELISA en Western blot en er 
werd getest of ze in staat waren tot het degranuleren van perifere bloed basofiele 
granulocyten door middel van een basofiele degranulatie test. Het C. obsoletus extract gaf 
de beste resultaten in zowel IgE binding in ELISA en Western blot als ook een 
degranulatietest voor basofiele granulocyten. De ELISA gebaseerd op C. obsoletus extract 
werd verder geëvalueerd op een groter aantal paarden (ca. 200) allergische en gezonde 
paarden en liet een hoge test sensitiviteit en specificiteit zien.  
Hoofdstuk 3 beschrijft een onderzoek waarin het Th1/Th2 patroon in lesionale en niet-
lesionale huid van Shetlanders met SME in het SME seizoen wordt vergeleken met het 
Th1/Th2 patroon in de huid van dezelfde dieren buiten het seizoen en met huid van 
gezonde Shetlanders in beide seizoenen. C. obsoletus-specifieke IgE serum niveaus, huid 
histopathologie en cytokinen en transcriptiefactor mRNA expressie (IL4, IL10, IL13, 
IFNγ, FoxP3 en CD3ζ) werden bestudeerd. C. obsoletus-specifieke IgE serum niveaus 
binnen elke groep waren net zo hoog in het SME seizoen als buiten het seizoen. De 
lesionale huid van paarden met SME had een significant hogere histopathologie score dan 
de niet-lesionale huid en huid van gezonde paarden. In de huid van alle paarden werd een 
algemene verhoogde mRNA expressie van de cytokines IL4, IL13 en IFNγ gevonden in 
het SME seizoen in vergelijking met buiten het seizoen.  
Hoofdstuk 4 beschrijft het bepalen van de nucleotidenvolgorde (sequencen) en het 
samenstellen (assembleren) van het transcriptoom van C. obsoletus. RNA van vrouwelijke 
C. obsoletus wild-gevangen insecten werd gesequenced met de Illumina paired-end RNA 
sequencing methode. De novo assemblage resulteerde in 41,223 contigs, waarna de open 
reading frames (ORF’s) werden bepaald wat resulteerde in 28,000 kandidaat genen. 
Slechts een kwart van de eiwitten aanwezig in speekselklierweefsel van C. nubeculosus 
kwam wat betreft sequentie overeen met contigs van C. obsoletus (tenminste 40% identiek 
en tenminste 75 aminozuren in lengte). De overige speekselklier eiwitten kwamen niet 
met elkaar overeen. Het aantal eiwitten van C. sonorensis dat overeenkwam tussen 
contigs en de bepaalde sequentie was hoger, maar dit komt waarschijnlijk door de 
aanwezigheid van andere dan speekselklier eiwitten die meer geconserveerd zijn. Er lijkt 
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dus een groot verschil in de sequenties van de speekseleiwitten van C. obsoletus, C. 
nubeculosus en C. sonorensis te zitten, wat kan verklaren dat IgE tegen speekseleiwitten 
opgewekt door beten van C. obsoletus slecht kruisreageert met extracten van de andere 2 
Culicoides soorten. 
Hoofdstuk 5 beschrijft de identificatie van 7 allergenen van C. obsoletus door middel van 
zoeken naar sequentie overeenkomst in het C. obsoletus transcriptoom met bekende 
allergenen van C. nubeculosus en C. sonorensis beschreven in de literatuur. Deze 
allergenen (Cul o 1 – Cul o 7 genoemd) werden als recombinante eiwitten in E. coli tot 
expressie gebracht. Een van deze allergenen (Cul o 1) en het overeenkomende allergeen 
van  C. sonorensis (Cul s 1) werden daarnaast ook met een baculovirus expressiesysteem 
in insecten cellen geproduceerd. Daarmee kunnen dezelfde eiwitten afkomstig van 
verschillende Culicoides soorten en geproduceerd door verschillende expressiesystemen 
met elkaar worden vergeleken op hun bruikbaarheid in verschillende diagnostische in 
vitro en in vivo testen. Paarden met SME hadden hogere IgE niveaus gericht tegen Cul o 
1 dan tegen Cul s 1. Daarnaast was de productie van deze eiwitten in het E. coli systeem 
minstens net zo goed voor in vitro diagnose van paarden met SME als dezelfde eiwitten 
geproduceerd in het baculovirus expressiesysteem. Met de in E. coli tot expressie 
gebrachte Cul o 1 – Cul o 7, varieerde de frequentie van positieve testresultaten van 
paarden met SME van 38 % tot 67 %. De capaciteit van deze allergenen om een type I 
reactie te veroorzaken in de huid werd aangetoond door middel van een intradermale 
huidtest.  
In hoofdstuk 6 werd de toepasbaarheid van de 7 C. obsoletus allergenen verder 
onderzocht en vergeleken met C. obsoletus compleet extract in een IgE ELISA aan de 
hand van ongeveer 350 SME en gezonde paarden. De beste resultaten werden behaald 
met compleet extract, gevolgd door Cul o 2, 3 en 5. Twee ELISA’s met een combinatie 
van recombinante allergenen, combi-1 (Cul o 3, 5 en 7) en combi-2 (Cul o 1, 2, 5 en 7) 
werden daarnaast ook uitgevoerd en beide ELISA’s resulteerden in een hoge 
betrouwbaarheid die gelijk was aan de ELISA met compleet extract. Zowel combi-1 als 
combi-2 resulteerde in een lagere test sensitiviteit met serum afgenomen in de winter in 
vergelijking met serum afgenomen in het SME seizoen, maar de meeste paarden met 
SME konden in de winter nog steeds juist (in overeenstemming met de klinische 
verschijnselen in de zomer) gediagnostiseerd worden.  
Samenvatting 
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Hoofdstuk 7 beschrijft de identificatie en kwantificering van de relatie tussen 
verschillende SME risico factoren en de IgE serum niveaus tegen C. obsoletus compleet 
extract en de 7 recombinante allergenen. Daarnaast is voor de SME paarden de relatie 
tussen IgE niveaus en ernst van klinische symptomen onderzocht, waarbij de ernst van 
symptomen en de hoogte van de IgE niveaus tegen verschillende C. obsoletus allergenen  
significant positief met elkaar correleerden. Het ras van het paard was geassocieerd met 
de hoogte van de IgE serum niveaus. Het verschil in de IgE niveaus tussen SME paarden 
en gezonde dieren was het hoogst bij de IJslanders. Gezonde Shetlanders hadden 
significant hogere IgE niveaus dan gezonde IJslanders, maar het verschil in IgE niveaus 
tussen Shetlanders met SME en IJlanders met SME was niet-significant. Andere factoren 
die geassocieerd waren met de IgE niveaus waren leeftijd, maand van scoren, interactie 
tussen SME status en maand van scoren, mate van jeuk en het aantal seizoenen dat 
paarden last hadden van SME.  
In de algemene discussie (hoofdstuk 8) worden de belangrijkste bevindingen van dit 
proefschrift bediscussieerd en gepresenteerd in een samenvattend overzicht. Een 2D gel 
elektroforese methode die was toegepast om nieuwe en aanvullende allergenen te 
identificeren wordt bediscussieerd en suggesties ter verbetering worden voorgesteld. Een 
odorant-bindend eiwit dat recent is geïdentificeerd als een kandidaat allergeen wordt 
besproken. Tot slot bediscussiëren we de vooruitzichten om de geproduceerde 
recombinante allergenen te gebruiken voor immunotherapie ter behandeling van paarden 
met klinisch verschijnselen van SME.  
Uit dit proefschrift kan worden geconcludeerd dat C. obsoletus allergenen nu voor de 
meest betrouwbare diagnose van staart- en maneneczeem zorgen bij paarden die 
gelokaliseerd zijn in landen waar deze soort de meest dominante Culicoides soort is die 
zich op paarden voedt. Tevens kunnen daarmee zowel binnen als buiten het 
insectenseizoen SME lijders van niet-lijders worden onderscheiden. Met een combinatie 
van drie recombinant allergenen afkomstig van C. obsoletus hebben we de eerste 
betrouwbare serologische diagnostische test ontwikkeld voor SME. De 7 recombinante 
allergenen kunnen gebruikt worden om te bepalen voor welke componenten van C. 
obsoletus paarden met SME precies allergisch zijn. Dit biedt mogelijkheden om elk paard 
een op maat gemaakte immuuntherapie te geven met de juiste (recombinante) allergenen.  
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